<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-03-03T19:45:39Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:mnkd="http://www.mannkindcorp.com/20131231" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="mnkd-20131231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE126000--1310-K0014_STD_0_20050805_0_714777x709629" unitRef="iso4217_USD_per_Right" decimals="3" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_3001_4">12.228</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <mnkd:CommonStockIssuableUponExerciseOfWarrants contextRef="eol_PE126000--1310-K0014_STD_0_20050805_0_714777x709629" unitRef="shares" decimals="INF" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_3001_3">3426000</mnkd:CommonStockIssuableUponExerciseOfWarrants>
  <mnkd:CommonStockVolumeWeightedAverageTradingPrice contextRef="eol_PE126000--1310-K0014_STD_0_20100810_0_711502x711169_711672x786262" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_3001_2">6.50</mnkd:CommonStockVolumeWeightedAverageTradingPrice>
  <mnkd:StockTradingPeriod contextRef="eol_PE126000--1310-K0014_STD_0_20100810_0_711672x786262" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_4001_3">P10D</mnkd:StockTradingPeriod>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE126000--1310-K0014_STD_0_20100818_0_714378x732890" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_2001_5">6.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1310-K0014_STD_0_20100818_0_714378x732890" unitRef="pure" decimals="4" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_2001_1">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20100818_0_714378x732890" unitRef="iso4217_USD" decimals="-5" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_2001_0">100000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:DebtIssuanceCost contextRef="eol_PE126000--1310-K0014_STD_0_20100818_0_714378x732890" unitRef="iso4217_USD" decimals="-5" id="id_4020747_F9D49940-3D1D-4059-97A8-83EF687FC8E2_1001_0">4200000</mnkd:DebtIssuanceCost>
  <us-gaap:RestructuringReserve contextRef="eol_PE126000--1310-K0014_STD_0_20110210_0_711976x780975" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A4DCD205-6FD6-4788-8C0E-78077DC0ECA7_1001_3">6659000</us-gaap:RestructuringReserve>
  <mnkd:UnitsSoldWarrantPortionConvertibleIntoCommonStock contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0" unitRef="iso4217_USD_per_Right" decimals="1" id="id_4020747_02F60DAA-47E5-4375-8FBA-C6382E03D0F8_2001_2">0.6</mnkd:UnitsSoldWarrantPortionConvertibleIntoCommonStock>
  <mnkd:IssuanceOfCommonStockAndWarrantsGrossValue contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_02F60DAA-47E5-4375-8FBA-C6382E03D0F8_2001_1">86300000</mnkd:IssuanceOfCommonStockAndWarrantsGrossValue>
  <mnkd:UnitsSoldUnderPublicOfferUnderwritten contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0" unitRef="shares" decimals="0" id="id_4020747_02F60DAA-47E5-4375-8FBA-C6382E03D0F8_2001_0">35937500</mnkd:UnitsSoldUnderPublicOfferUnderwritten>
  <mnkd:RestrictedStockAgreedToBePurchasedByLender contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_77D57DB1-A3A6-4DDB-9900-587493513DCA_1_3">77200000</mnkd:RestrictedStockAgreedToBePurchasedByLender>
  <mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0" id="id_4020747_77D57DB1-A3A6-4DDB-9900-587493513DCA_1_1">Each unit consisting of one share of common  stock and a warrant to purchase 0.6 of a share of common stock</mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_711672x768251" unitRef="shares" decimals="INF" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_4001_10">31250000</us-gaap:CommonStockSharesOutstanding>
  <mnkd:RestrictedCommonStockPricePerShare contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_711672x768251" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_4001_11">2.47</mnkd:RestrictedCommonStockPricePerShare>
  <mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_711672x825177" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_5001_2">Each unit consisting of  one share of common stock and a warrant to purchase 0.6 of a share of common  stock</mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_716644x726394" unitRef="shares" decimals="0" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_6001_7">21562500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_716644x726394" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_6001_8">2.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <mnkd:UnitsSoldUnderPublicOfferUnderwritten contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_789193x729060" unitRef="shares" decimals="0" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_8001_1">4687500</mnkd:UnitsSoldUnderPublicOfferUnderwritten>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_789193x729060" unitRef="iso4217_USD_per_Right" decimals="3" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_8001_5">2.256</mnkd:UnitsSoldByUnderwritingPrice>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1310-K0014_STD_0_20120208_0_789193x821037" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_9001_4">2.40</mnkd:UnitsSoldByUnderwritingPrice>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0" unitRef="shares" decimals="INF" id="id_4020747_B25C73A5-51B7-4AE1-9845-81068B6F7F1B_2_1">350000000</us-gaap:CommonStockSharesAuthorized>
  <mnkd:FairValueOfUnitsIssued contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_2_2">1.69</mnkd:FairValueOfUnitsIssued>
  <mnkd:FairValueInputDiscountForLackOfMarketability contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0" unitRef="pure" decimals="4" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_2_6">0.0042</mnkd:FairValueInputDiscountForLackOfMarketability>
  <mnkd:FairValueAssumptionRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0_711672x768251_716421x837810_716644x745094" unitRef="pure" decimals="4" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_2002_3">0.0008</mnkd:FairValueAssumptionRiskFreeInterestRate>
  <mnkd:FairValueInputDiscountForLackOfMarketability contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0_711672x768251_716644x745094" unitRef="pure" decimals="4" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_3002_5">0.0257</mnkd:FairValueInputDiscountForLackOfMarketability>
  <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingPercentageWithInSixMonthsPeriod contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0_713115x812459" unitRef="pure" decimals="2" id="id_4020747_AA71C0CF-2C60-4A5C-97F2-06716395C857_3001_3">0.25</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingPercentageWithInSixMonthsPeriod>
  <mnkd:AggregateAdjustmentOfForwardPurchaseContractToFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0_716421x837810" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B25C73A5-51B7-4AE1-9845-81068B6F7F1B_2001_2">13100000</mnkd:AggregateAdjustmentOfForwardPurchaseContractToFairValue>
  <mnkd:FairValueAssumptionRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_0_20120517_0_716421x837810" unitRef="pure" decimals="4" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_4002_4">0.0018</mnkd:FairValueAssumptionRiskFreeInterestRate>
  <mnkd:AdditionalNumberOfCommonStockToBeIssuedToPlaintiffAttorneys contextRef="eol_PE126000--1310-K0014_STD_0_20120803_0_712948x745900" unitRef="shares" decimals="0" id="id_4020747_CB78F686-6BDD-4757-87C0-76A741B0471D_1001_1">225000</mnkd:AdditionalNumberOfCommonStockToBeIssuedToPlaintiffAttorneys>
  <mnkd:RequiredPaymentByInsurerToPlaintiff contextRef="eol_PE126000--1310-K0014_STD_0_20120803_0_712948x745900" unitRef="iso4217_USD" decimals="0" id="id_4020747_CB78F686-6BDD-4757-87C0-76A741B0471D_1001_0">800000</mnkd:RequiredPaymentByInsurerToPlaintiff>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20130523_0_713879x788580" unitRef="shares" decimals="-5" id="id_4020747_DD6ACD18-CCE3-42B4-A469-B88367A83E27_1001_0">21500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20140217_0" unitRef="shares" decimals="INF" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_2_500008">377208424</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1310-K0014_STD_0_20140228_0_705999x857289_708502x805183_710720x714667_711502x711169_714378x735725" unitRef="pure" decimals="4" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_5001_7">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1310-K0014_STD_0_20140228_0_705999x857289_708502x805183_710720x714667_711502x716112_714378x735725" unitRef="pure" decimals="4" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_6001_6">0.0975</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20140228_0_705999x857289_708502x805183_710720x714667_711502x716112_714378x735725" unitRef="iso4217_USD" decimals="-6" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_6001_0">0</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE126000--1310-K0014_STD_0_20040331_0_713879x809015" unitRef="shares" decimals="INF" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_4001_0">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <mnkd:AggregateOfferingPriceUnderEachAgreement contextRef="eol_PE126000--1310-K0014_STD_0_20130318_0_711502x716112_803904x806301" unitRef="iso4217_USD" decimals="-5" id="id_4020747_3AE7DE53-3DED-48AC-A951-E4D25CC8A1DF_2001_0">50000000</mnkd:AggregateOfferingPriceUnderEachAgreement>
  <mnkd:AggregateOfferingPriceUnderEachAgreement contextRef="eol_PE126000--1310-K0014_STD_0_20140303_0_710720x714667_711502x716112_803904x806301" unitRef="iso4217_USD" decimals="-5" id="id_4020747_877D5D3C-8D1E-4EDB-A5C5-67CCE503697A_1001_0">50000000</mnkd:AggregateOfferingPriceUnderEachAgreement>
  <mnkd:OptionToPurchaseCommonSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20080709_0_841045x778627" unitRef="shares" decimals="0" id="id_4020747_DDE55B61-AECA-4CF1-9DEC-E1616A828D75_2001_0">5417840</mnkd:OptionToPurchaseCommonSharesOutstanding>
  <mnkd:RestrictedStockUnitsShareIssued contextRef="eol_PE126000--1310-K0014_STD_0_20080709_0_841045x778627" unitRef="shares" decimals="0" id="id_4020747_DDE55B61-AECA-4CF1-9DEC-E1616A828D75_2001_2">2246781</mnkd:RestrictedStockUnitsShareIssued>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20120531_0" unitRef="shares" decimals="INF" id="id_4020747_77D57DB1-A3A6-4DDB-9900-587493513DCA_1002_5">350000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20120627_0" unitRef="shares" decimals="INF" id="id_4020747_77D57DB1-A3A6-4DDB-9900-587493513DCA_1003_6">31250000</us-gaap:CommonStockSharesOutstanding>
  <dei:EntityPublicFloat contextRef="eol_PE126000--1310-K0014_STD_0_20130628_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_3_600009">1153987371</dei:EntityPublicFloat>
  <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x737742_714378x735725" unitRef="pure" decimals="4" id="id_4020747_D13D1DF5-E796-4B1D-9CC6-D8C9D2BFB045_1001_0">0.1219</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x737742_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A7FA797F-4C6A-4089-B126-5B773DB6CE8A_1001_0">40000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x737742_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_043DC4DE-F060-42AA-A66D-F98AE73F1E81_3001_3">37100000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x737742_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D13D1DF5-E796-4B1D-9CC6-D8C9D2BFB045_1001_1">3300000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <mnkd:LineOfCreditFacilityInitialAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x737742_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_E2DAA81B-E7FA-4019-A1B3-297A92887F64_1001_0">40000000</mnkd:LineOfCreditFacilityInitialAmount>
  <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x744870_714378x735725" unitRef="pure" decimals="4" id="id_4020747_6B9D0293-77CD-41FD-A51D-35F837F775EC_1001_2">0.1245</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x744870_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_6B9D0293-77CD-41FD-A51D-35F837F775EC_1001_0">40000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x744870_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_6B9D0293-77CD-41FD-A51D-35F837F775EC_1001_1">3700000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x839462_714378x735725" unitRef="pure" decimals="4" id="id_4020747_15E2372D-88C2-46E7-AF95-32351DBEF95B_1001_2">0.1349</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x839462_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_15E2372D-88C2-46E7-AF95-32351DBEF95B_1001_0">40000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x839462_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_15E2372D-88C2-46E7-AF95-32351DBEF95B_1001_1">5000000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <mnkd:ContingentLiability contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883632_711502x716112" unitRef="iso4217_USD" decimals="-5" id="id_4020747_1FF1F0CA-0C5B-4AA5-81F0-B3CAF76B4035_1001_0">90000000</mnkd:ContingentLiability>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883632_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B824EB11-8964-49F2-877E-2E5B57714B7B_2001_1">13100000</us-gaap:OtherLongTermDebtNoncurrent>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883632_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B824EB11-8964-49F2-877E-2E5B57714B7B_2001_0">3200000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883632_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_043DC4DE-F060-42AA-A66D-F98AE73F1E81_4001_4">16300000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883668_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_6C48B433-B1D4-47D4-BC95-5B596945CBAD_2001_0">120000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:AggregatePotentialMilestoneInstallmentPayments contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883669_711502x716112_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A8E4E968-3F92-49ED-924B-619BB743855C_2001_3">90000000</mnkd:AggregatePotentialMilestoneInstallmentPayments>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883669_714378x735725" unitRef="pure" decimals="4" id="id_4020747_8AF134F9-8396-4059-9B9A-0CB1BE2D7B8C_1001_2">0.0975</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883669_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A8E4E968-3F92-49ED-924B-619BB743855C_3001_0">160000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:DebtInstrumentAmountOfTranches contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883669_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A8E4E968-3F92-49ED-924B-619BB743855C_3001_2">40000000</mnkd:DebtInstrumentAmountOfTranches>
  <mnkd:RepaymentAsPercentageOfPrincipalAmount contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_714378x735725" unitRef="pure" decimals="2" id="id_4020747_000AF42F-1D70-4659-9E06-3354EF8626DB_2001_0">0.25</mnkd:RepaymentAsPercentageOfPrincipalAmount>
  <mnkd:LoanCommitmentAssetFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_043DC4DE-F060-42AA-A66D-F98AE73F1E81_5001_2">13400000</mnkd:LoanCommitmentAssetFairValue>
  <mnkd:ShareRegistrationStatementSharesOfCommonStockToBeRegistered contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_708890x840565" unitRef="shares" decimals="-5" id="id_4020747_D999599A-F838-4F05-BBFD-E2F1901AE586_1001_0">12000000</mnkd:ShareRegistrationStatementSharesOfCommonStockToBeRegistered>
  <mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity contextRef="eol_PE126000--1310-K0014_STD_0_20130701_0_711502x716112_821864x769826" unitRef="iso4217_USD" decimals="-5" id="id_4020747_3742A26B-09FE-4EF2-A6B5-084EE81B1143_1001_0">25000000</mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity>
  <mnkd:OperatingLossCarryforwardsSubjectToLimitation contextRef="eol_PE126000--1310-K0014_STD_0_20040831_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_3002_4">216000000</mnkd:OperatingLossCarryforwardsSubjectToLimitation>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_41014_1700180">-185532000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_5001_50">66061000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_41009_1200180">1587858000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_41007_1000180">127793000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_41007_1100180">1278000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_41012_1500180">74000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_41013_1600180">-1774742000</us-gaap:StockholdersEquity>
  <invest:DerivativeNotionalAmount contextRef="eol_PE126000--1310-K0014_STD_0_20101231_0_715632x710071" unitRef="iso4217_USD" decimals="-5" id="id_4020747_73FFAD51-42A2-43E0-B5D7-50CD171BCBF0_1001_0">25500000</invest:DerivativeNotionalAmount>
  <mnkd:RestrictedStockAgreedToBePurchasedByLender contextRef="eol_PE126000--1310-K0014_STD_0_20120630_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_3002_12">77200000</mnkd:RestrictedStockAgreedToBePurchasedByLender>
  <mnkd:FairValueAssumptionRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_0_20120930_0" unitRef="pure" decimals="3" id="id_4020747_9552D370-960C-43B7-8FF7-9B76340AE111_1001_4">0.001</mnkd:FairValueAssumptionRiskFreeInterestRate>
  <mnkd:LossContingencySettlementAgreementStockConsideration contextRef="eol_PE126000--1310-K0014_STD_0_20120930_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_9552D370-960C-43B7-8FF7-9B76340AE111_1001_0">8600000</mnkd:LossContingencySettlementAgreementStockConsideration>
  <mnkd:FairValueAssumptionExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_0_20120930_0" unitRef="pure" decimals="2" id="id_4020747_9552D370-960C-43B7-8FF7-9B76340AE111_1001_3">0.54</mnkd:FairValueAssumptionExpectedVolatilityRate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1001_7">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_3001_3">2.59</us-gaap:SaleOfStockPricePerShare>
  <mnkd:DebtInstrumentAmendedOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251" unitRef="iso4217_USD" decimals="-6" id="id_4020747_1D0BD20F-B6E1-4A00-917F-29D320471E3F_4001_4">350000000</mnkd:DebtInstrumentAmendedOutstanding>
  <mnkd:RestrictedStockAgreedToBePurchasedByLender contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_1D0BD20F-B6E1-4A00-917F-29D320471E3F_4001_5">107400000</mnkd:RestrictedStockAgreedToBePurchasedByLender>
  <mnkd:RestrictedWarrantSalePrice contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251_713115x715581" unitRef="iso4217_USD_per_shares" decimals="3" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_4001_6">0.125</mnkd:RestrictedWarrantSalePrice>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251_713115x715581_714777x709629" unitRef="shares" decimals="0" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_5001_7">30000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1310-K0014_STD_0_20121031_0_713115x715581" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_2001_4">2.00</mnkd:UnitsSoldByUnderwritingPrice>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131031_0_711672x712230_717061x750999" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_4004_6">7900000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131031_0_717061x750999_789193x712230" unitRef="iso4217_USD" decimals="-5" id="id_4020747_BD758B1B-978E-4DF1-A9F7-CF577AB7382C_2001_2">7900000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19920229_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_3014_1700004">-11000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_3009_1200004">890000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_3007_1000004">998000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_3007_1100004">10000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_3013_1600004">-911000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19930228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_5014_1700008">-278000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_5009_1200008">1797000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_5007_1000008">1071000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_5007_1100008">11000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_5013_1600008">-2086000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19940228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_7014_1700013">-908000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_7009_1200013">2723000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_7007_1000013">1090000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_7007_1100013">11000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_7010_1300013">-400000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_7013_1600013">-3242000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19941231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_9014_1700017">-707000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_9009_1200017">4528000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_9007_1000017">1126000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_9007_1100017">11000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_9013_1600017">-5246000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19951231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_11014_1700022">-3108000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_11009_1200022">4942000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_11007_1000022">1127000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_11007_1100022">11000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_11013_1600022">-8061000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19961231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_13014_1700027">-5481000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_13009_1200027">5139000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_13007_1000027">1131000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_13007_1100027">11000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_13013_1600027">-10631000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19971231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_15014_1700033">-7368000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_15009_1200033">5526000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_15007_1000033">1718000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_15007_1100033">17000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_15013_1600033">-12911000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19981231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_17014_1700039">3404000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_17009_1200039">19603000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_17007_1000039">4254000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_17007_1100039">43000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_17013_1600039">-16242000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19991231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_19014_1700043">-746000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_19009_1200043">21129000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_19007_1000043">4496000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_19007_1100043">46000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_19013_1600043">-21921000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21014_1700054">31890000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21009_1200054">65613000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21007_1000054">9249000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21007_1100054">93000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21010_1300054">-2234000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21013_1600054">-46582000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x827132" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21001_400054">193000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x827132" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_21001_500054">15000000</us-gaap:StockholdersEquity>
  <us-gaap:Goodwill contextRef="eol_PE126000--1310-K0014_STD_0_20011212_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_7D01C820-B83B-41F8-B1BD-0A291A865116_1001_4">151400000</us-gaap:Goodwill>
  <mnkd:OwnershipInterest contextRef="eol_PE126000--1310-K0014_STD_0_20011212_0_705999x776793" unitRef="pure" decimals="2" id="id_4020747_7D01C820-B83B-41F8-B1BD-0A291A865116_2001_2">0.69</mnkd:OwnershipInterest>
  <mnkd:OwnershipInterest contextRef="eol_PE126000--1310-K0014_STD_0_20011212_0_705999x831745" unitRef="pure" decimals="2" id="id_4020747_7D01C820-B83B-41F8-B1BD-0A291A865116_3001_0">0.76</mnkd:OwnershipInterest>
  <mnkd:OwnershipInterest contextRef="eol_PE126000--1310-K0014_STD_0_20011212_0_705999x840283" unitRef="pure" decimals="2" id="id_4020747_7D01C820-B83B-41F8-B1BD-0A291A865116_4001_1">0.59</mnkd:OwnershipInterest>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23014_1700067">235018000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23009_1200067">317117000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23007_1000067">12305000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23007_1100067">123000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23010_1300067">-2395000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23013_1600067">-94827000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x827132" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23001_400067">193000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x827132" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_23001_500067">15000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25014_1700081">90773000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25009_1200081">378010000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25007_1000081">16464000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25007_1100081">165000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25010_1300081">-1310000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25013_1600081">-301092000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x827132" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25001_400081">193000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x827132" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_25001_500081">15000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27014_1700095">111577000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27009_1200095">433141000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27007_1000095">19975000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27007_1100095">200000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27010_1300095">-1412000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27013_1600095">-366971000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x780368" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27006_900095">-18153000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x796933" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27011_1400095">-228000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x827132" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27001_400095">193000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x827132" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27001_500095">15000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x831084" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_27005_800095">50000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_29014_1700120">150363000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_29009_1200120">592999000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_29007_1000120">32756000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_29007_1100120">327000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_29013_1600120">-442963000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_31014_1700129">206977000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_31009_1200129">763775000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_31007_1000129">50314000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_31007_1100129">503000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_31013_1600129">-557301000</us-gaap:StockholdersEquity>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_2001_6">22.47</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250" unitRef="pure" decimals="4" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_2001_1">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_2001_0">115000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:DebtIssuanceCost contextRef="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250" unitRef="iso4217_USD" decimals="-5" id="id_4020747_CCFB004F-EB49-4DD3-B2FA-B175041C2C1F_1001_0">3700000</mnkd:DebtIssuanceCost>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250_789193x764239" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_3001_2">15000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_33014_1700142">383487000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_33009_1200142">1170602000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_33007_1000142">73360000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_33007_1100142">734000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_33013_1600142">-787849000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_35014_1700152">364100000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_35009_1200152">1444125000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_35007_1000152">101381000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_35007_1100152">1014000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_35013_1600152">-1081039000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_37014_1700159">86734000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_37009_1200159">1469497000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_37007_1000159">102008000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_37007_1100159">1020000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_37012_1500159">295000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_37013_1600159">-1384078000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_39014_1700168">-59221000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_39009_1200168">1544112000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_39007_1000168">113025000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_39007_1100168">1130000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_39012_1500168">-281000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_39013_1600168">-1604182000</us-gaap:StockholdersEquity>
  <us-gaap:OwnshareLendingArrangementSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_4020747_BDC4B457-3D10-4DAF-9289-9A34B4DD5682_1001_0">9000000</us-gaap:OwnshareLendingArrangementSharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_43014_1700190">-313652000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3001_50">2681000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_9DCD9432-F0C5-4884-807F-748A16500991_1003_0">609000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0" unitRef="shares" decimals="0" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_3002_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0" unitRef="shares" decimals="0" id="id_4020747_1A82A271-72C1-461C-A984-8ACC6688890F_1001_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_43009_1200190">1620535000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_43007_1000190">131523000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_43007_1100190">1315000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_43012_1500190">44000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_43013_1600190">-1935546000</us-gaap:StockholdersEquity>
  <us-gaap:RestructuringReserve contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_711976x780975" unitRef="iso4217_USD" decimals="-3" id="id_4020747_436EA9ED-9340-4A97-B160-5022E89E024B_3001_4">67000</us-gaap:RestructuringReserve>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_713399x793592_715757x715798" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_1001_1" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_713399x817344_715757x715798" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_1002_1" />
  <invest:DerivativeNotionalAmount contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_715632x710071" unitRef="iso4217_USD" decimals="-5" id="id_4020747_73FFAD51-42A2-43E0-B5D7-50CD171BCBF0_1003_0">0</invest:DerivativeNotionalAmount>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20111231_0_715757x715798" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_1003_1" />
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20121220_0" unitRef="shares" decimals="INF" id="id_4020747_46A85CF5-AA81-47E7-8075-C2E03A18F0C1_1001_1">550000000</us-gaap:CommonStockSharesAuthorized>
  <mnkd:RestrictedStockAgreedToBePurchasedByLender contextRef="eol_PE126000--1310-K0014_STD_0_20121220_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_46A85CF5-AA81-47E7-8075-C2E03A18F0C1_2001_2">107400000</mnkd:RestrictedStockAgreedToBePurchasedByLender>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_31">286035082</us-gaap:CommonStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_A75E4CD7-B4F4-4704-89F7-70C304325F45_2001_1">3761031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_27" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_2001_1">3.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_2001_1">18674539</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_02EA77E7-6888-4037-82DB-A80FC2DA058D_2001_1">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_24">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_26" />
  <us-gaap:OwnshareLendingArrangementSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_BDC4B457-3D10-4DAF-9289-9A34B4DD5682_1002_0">9000000</us-gaap:OwnshareLendingArrangementSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_30">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_29">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_25">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_32">286035082</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_BDC4B457-3D10-4DAF-9289-9A34B4DD5682_1002_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:ConvertibleNotesPayable contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1_6">212026000</us-gaap:ConvertibleNotesPayable>
  <us-gaap:InterestPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_1_2">4533000</us-gaap:InterestPayableCurrent>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_21" />
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_16">144775000</us-gaap:LiabilitiesCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_34">-6000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_1_0">10074000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_1_9">101249000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_1_4">1297000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_12">4555000</us-gaap:AccountsPayableCurrent>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_11">750151000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_36">-110679000</us-gaap:StockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_33">1991379000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:PreferredStockValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_23" />
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_13">25777000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:ConvertibleLongTermNotesPayable contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_17">97583000</us-gaap:ConvertibleLongTermNotesPayable>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_18">119635000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:Liabilities contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_20">361993000</us-gaap:Liabilities>
  <us-gaap:ConvertibleNotesPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_15">114443000</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:ConstructionPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_1_3">3878000</us-gaap:ConstructionPayableCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_28">2860000</us-gaap:CommonStockValue>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_37">251314000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_8">230000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_1">609471000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_10">750151000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_6">30928000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_12" />
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_1_8">285210000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:NontradeReceivablesNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_7">313000</us-gaap:NontradeReceivablesNoncurrent>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_9">3134000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_6">183961000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_216BBCAF-A22C-48AF-9E29-E1C6D9D38F8E_1_0">61800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:Assets contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_9">251314000</us-gaap:Assets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_2">61840000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:NontradeReceivablesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_3">450000</us-gaap:NontradeReceivablesCurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_2">65315000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_35">2104912000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A08B420E-844B-4C61-9ABC-A87F9DE6B0E9_2001_1">4867000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_5">2922000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_4">4520000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_1_5">66810000</us-gaap:AssetsCurrent>
  <mnkd:FairValueOfUnitsIssued contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_1001_1">2.40</mnkd:FairValueOfUnitsIssued>
  <mnkd:IncreaseDecreaseInFairValueRecognizedInOtherIncome contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_19F5D4F7-ABD1-4528-8823-432944E294B6_1001_0">12000000</mnkd:IncreaseDecreaseInFairValueRecognizedInOtherIncome>
  <mnkd:AccruedResearchAndClinicalTrialCosts contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_1_1">5995000</mnkd:AccruedResearchAndClinicalTrialCosts>
  <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_3">31490000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
  <mnkd:AvailableBorrowingsUnderLoanAgreement contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_855613EE-F2A3-4D90-9630-496F016AF37A_1002_1">125400000</mnkd:AvailableBorrowingsUnderLoanAgreement>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_9DCD9432-F0C5-4884-807F-748A16500991_1002_0">289000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:LossContingencySettlementAgreementStockConsiderationFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_2003_3">6492056</mnkd:LossContingencySettlementAgreementStockConsiderationFairValue>
  <mnkd:LossContingencySettlementAgreementStockConsideration contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_84522584-72DE-4553-B4EC-1BAC38C05049_1001_0">8600000</mnkd:LossContingencySettlementAgreementStockConsideration>
  <mnkd:AccruedInterestOfRelatedPartyDebt contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_855613EE-F2A3-4D90-9630-496F016AF37A_1002_0">2200000</mnkd:AccruedInterestOfRelatedPartyDebt>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="0" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_3003_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="shares" decimals="0" id="id_4020747_1A82A271-72C1-461C-A984-8ACC6688890F_1002_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <mnkd:DeferredTaxAssetsCapitalizedCosts contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1001_7">6891000</mnkd:DeferredTaxAssetsCapitalizedCosts>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_45009_1200206">1991379000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_45007_1000206">286035000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_45007_1100206">2860000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_45012_1500206">-6000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_45013_1600206">-2104912000</us-gaap:StockholdersEquity>
  <mnkd:LossContingencySettlementAgreementStockConsideration contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709714x708730" unitRef="iso4217_USD" decimals="-5" id="id_4020747_84522584-72DE-4553-B4EC-1BAC38C05049_2001_1">6500000</mnkd:LossContingencySettlementAgreementStockConsideration>
  <mnkd:LossContingencySettlementAgreementStockConsideration contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_709714x813109" unitRef="iso4217_USD" decimals="-5" id="id_4020747_84522584-72DE-4553-B4EC-1BAC38C05049_3001_2">2100000</mnkd:LossContingencySettlementAgreementStockConsideration>
  <mnkd:RelatedPartyTransactionPrincipalAmountOutstandingUnderLoanArrangement contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_711672x768251" unitRef="iso4217_USD" decimals="-3" id="id_4020747_08FD00DD-3E45-4A5C-B54D-7C81CB7F649F_2001_0">119635000</mnkd:RelatedPartyTransactionPrincipalAmountOutstandingUnderLoanArrangement>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712546x710575" unitRef="iso4217_USD" decimals="-5" id="id_4020747_216BBCAF-A22C-48AF-9E29-E1C6D9D38F8E_1001_1">60800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <mnkd:CommonStockIssuedToPlaintiffAttorneys contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x745900" unitRef="shares" decimals="0" id="id_4020747_9C391435-CD95-4205-990B-30DC49C074F8_2001_1">225000</mnkd:CommonStockIssuedToPlaintiffAttorneys>
  <mnkd:LossContingencySettlementAgreementStockConsiderationFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x745900" unitRef="iso4217_USD" decimals="0" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_2001_3">436500</mnkd:LossContingencySettlementAgreementStockConsiderationFairValue>
  <mnkd:FairValueAssumptionRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x768253" unitRef="pure" decimals="4" id="id_4020747_099F95E2-37A4-46F6-82D8-86705FD902F2_4001_2">0.0016</mnkd:FairValueAssumptionRiskFreeInterestRate>
  <mnkd:LossContingencySettlementAgreementStockConsideration contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x768253" unitRef="iso4217_USD" decimals="-5" id="id_4020747_C43C159B-AB33-4550-9610-FD00E9F29A33_2001_0">7700000</mnkd:LossContingencySettlementAgreementStockConsideration>
  <mnkd:FairValueAssumptionExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x768253" unitRef="pure" decimals="2" id="id_4020747_099F95E2-37A4-46F6-82D8-86705FD902F2_4001_1">0.60</mnkd:FairValueAssumptionExpectedVolatilityRate>
  <mnkd:LossContingencySettlementAgreementCashConsideration contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x768253" unitRef="iso4217_USD" decimals="-5" id="id_4020747_16F432FB-9F77-404B-A9A1-7F0CFFE97827_1001_0">16800000</mnkd:LossContingencySettlementAgreementCashConsideration>
  <mnkd:LossContingencySettlementAgreementStockConsiderationFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x786588" unitRef="iso4217_USD" decimals="0" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_2002_3">6055556</mnkd:LossContingencySettlementAgreementStockConsiderationFairValue>
  <mnkd:EscrowDepositOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x786588" unitRef="shares" decimals="0" id="id_4020747_5352706A-A56E-494E-90FF-576C6465539F_2001_1">2777778</mnkd:EscrowDepositOfCommonStock>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_713399x793592_715757x715798" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_3001_5" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_713399x817344_715757x715798" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_3002_5" />
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x732890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1001_3">100000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x732890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1001_5">97583000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x732890" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DAE00F92-3457-4983-9DEE-13696359F2B7_1002_2">63200000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x732890" unitRef="iso4217_USD" decimals="-5" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1003_2">2200000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x732890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1001_4">2417000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x774250" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_2001_0">115000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x774250" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_2001_2">114443000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x774250" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DAE00F92-3457-4983-9DEE-13696359F2B7_1001_2">81900000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x774250" unitRef="iso4217_USD" decimals="0" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_1003_3">192000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x774250" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_2001_1">557000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715757x715798" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_3003_5" />
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x707341" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_1001_2">114245000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x710555" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_2001_7">12266000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x714221" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_3001_3">81382000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x715869" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_4001_1">54948000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x715944" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_5001_0">5273000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x716297" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_6001_6">17000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x740890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_7001_5">11840000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x767832" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_8001_4">5239000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_31">369391972</us-gaap:CommonStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1004_2">9115821</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_27" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_1001_8">12358495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:DerivativeNumberOfInstrumentsHeld contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="Derivative" decimals="INF" id="id_4020747_E92302CE-726E-4C34-BE4A-998B3D6B6EC5_5001_0">4</us-gaap:DerivativeNumberOfInstrumentsHeld>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1001_6">4.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1004_1">24237940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1004_3">13590564</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_02EA77E7-6888-4037-82DB-A80FC2DA058D_1001_5">3.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_24">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_26" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1001_7">4.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1001_8">4.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:OwnshareLendingArrangementSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_BDC4B457-3D10-4DAF-9289-9A34B4DD5682_1003_0">9000000</us-gaap:OwnshareLendingArrangementSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_30">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_29">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_02F60DAA-47E5-4375-8FBA-C6382E03D0F8_2002_3">32843733</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_25">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_1001_7">23533436</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_32">369391972</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_BDC4B457-3D10-4DAF-9289-9A34B4DD5682_1003_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:ConvertibleNotesPayable contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_2_6">98439000</us-gaap:ConvertibleNotesPayable>
  <us-gaap:InterestPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_2_2">2082000</us-gaap:InterestPayableCurrent>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_21" />
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_16">127794000</us-gaap:LiabilitiesCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_34">-4000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_2_0">12193000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_2_9">111060000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_2_4">5706000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_12">3860000</us-gaap:AccountsPayableCurrent>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_11">817000000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_19">13605000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_36">-30713000</us-gaap:StockholdersEquity>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_14">102300000</us-gaap:OtherLongTermDebtNoncurrent>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_33">2261996000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_92B55B45-56B3-425A-9A23-7A70201084D4_1_0">30100000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:PreferredStockValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_23" />
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_13">21634000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:ConvertibleLongTermNotesPayable contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_17">98439000</us-gaap:ConvertibleLongTermNotesPayable>
  <us-gaap:LineOfCredit contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_66C4E67D-DCE8-487D-935B-6CFBD30FA768_1001_1">113500000</us-gaap:LineOfCredit>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_18">49521000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:Liabilities contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_20">289359000</us-gaap:Liabilities>
  <us-gaap:ConstructionPayableCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_2_3">342000</us-gaap:ConstructionPayableCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_28">3697000</us-gaap:CommonStockValue>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_37">258646000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_8">5516000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_1">653896000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-8" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_3001_1">1200000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_10">817000000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_6">41219000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_12" />
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_2_8">287617000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:NontradeReceivablesNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_7">298000</us-gaap:NontradeReceivablesNoncurrent>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_8">837000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_9">2539000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_6">176557000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_216BBCAF-A22C-48AF-9E29-E1C6D9D38F8E_2_0">70800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:Assets contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_9">258646000</us-gaap:Assets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A08B420E-844B-4C61-9ABC-A87F9DE6B0E9_1001_3">40972000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_2">70790000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_2">70091000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A08B420E-844B-4C61-9ABC-A87F9DE6B0E9_1001_4">22126000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_35">2296402000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A08B420E-844B-4C61-9ABC-A87F9DE6B0E9_1001_2">40972000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-8" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_3001_0">1700000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_5">3578000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_4">5485000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_195D5657-C8CB-42A4-93CB-B45BEC3BF829_2_5">76275000</us-gaap:AssetsCurrent>
  <mnkd:DerivativesFairValueLiabilitySharesIssuableToLender contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="-5" id="id_4020747_D2708747-31B2-4539-9CFD-BE15DB12E2FF_1_1">16500000</mnkd:DerivativesFairValueLiabilitySharesIssuableToLender>
  <mnkd:AccruedResearchAndClinicalTrialCosts contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A742C281-2356-4376-9C1C-D4B34EBAB369_2_1">1311000</mnkd:AccruedResearchAndClinicalTrialCosts>
  <mnkd:LoanCommitmentAsset contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_1001_5">13393000</mnkd:LoanCommitmentAsset>
  <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_3">30421000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
  <mnkd:AvailableBorrowingsUnderLoanAgreement contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_855613EE-F2A3-4D90-9630-496F016AF37A_1001_1">30100000</mnkd:AvailableBorrowingsUnderLoanAgreement>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_9DCD9432-F0C5-4884-807F-748A16500991_1001_0">282000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="0" id="id_4020747_D84AED40-8E33-4ACE-A258-AF1FDE08310A_1001_0">8761363</mnkd:ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest>
  <mnkd:AccruedInterestOfRelatedPartyDebt contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_855613EE-F2A3-4D90-9630-496F016AF37A_1001_0">600000</mnkd:AccruedInterestOfRelatedPartyDebt>
  <mnkd:WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_D84AED40-8E33-4ACE-A258-AF1FDE08310A_1001_1">3.40</mnkd:WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="0" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_3004_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="shares" decimals="0" id="id_4020747_1A82A271-72C1-461C-A984-8ACC6688890F_1003_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <mnkd:DeferredTaxAssetsCapitalizedCosts contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_7">7811000</mnkd:DeferredTaxAssetsCapitalizedCosts>
  <mnkd:LoanCommitmentAssetNoncurrentPortion contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_1001_8">5157000</mnkd:LoanCommitmentAssetNoncurrentPortion>
  <mnkd:DeferredTaxAssetsMilestoneRights contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_0B0E5338-625E-4BBE-B76A-8D0F4F2AC786_1002_4">6608000</mnkd:DeferredTaxAssetsMilestoneRights>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_705999x857289_708502x883668_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_6C48B433-B1D4-47D4-BC95-5B596945CBAD_2002_3">113500000</us-gaap:OtherLongTermDebtNoncurrent>
  <mnkd:PercentageBeneficiallyOwnershipOfCompanyStock contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_705999x857289_711502x711169" unitRef="pure" decimals="5" id="id_4020747_792CD197-2F5C-4400-B985-E00006550B79_1001_0">0.09985</mnkd:PercentageBeneficiallyOwnershipOfCompanyStock>
  <mnkd:DebtInstrumentPercentOfPrincipalAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_705999x857289_714378x735725" unitRef="pure" decimals="2" id="id_4020747_5801559F-D43A-4024-9896-FDCA1C59C352_1001_0">0.01</mnkd:DebtInstrumentPercentOfPrincipalAmount>
  <mnkd:LoanCommitmentAssetCurrentPortion contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_708502x744870" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_2001_6">3656000</mnkd:LoanCommitmentAssetCurrentPortion>
  <mnkd:LoanCommitmentAssetCurrentPortion contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_708502x839462" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_3001_7">4580000</mnkd:LoanCommitmentAssetCurrentPortion>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_47009_1200221">2261996000</us-gaap:StockholdersEquity>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A92831DC-5182-49E9-BB29-C718F47A0FEF_1001_2">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_47007_1000221">369392000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_47007_1100221">3697000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_47012_1500221">-4000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_47013_1600221">-2296402000</us-gaap:StockholdersEquity>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_710844x707398" unitRef="iso4217_USD" decimals="-6" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_4001_6">45000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_710844x711886" unitRef="iso4217_USD" decimals="-6" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_5001_7">38000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
  <mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711502x716112_821864x769826" unitRef="iso4217_USD" decimals="-6" id="id_4020747_92B55B45-56B3-425A-9A23-7A70201084D4_1001_1">25000000</mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x712230_717061x772809" unitRef="iso4217_USD" decimals="-5" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_6001_1">30100000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x712230_717061x772809" unitRef="iso4217_USD" decimals="-5" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_6001_0">49500000</us-gaap:LineOfCreditFacilityAmountOutstanding>
  <mnkd:RelatedPartyTransactionPrincipalAmountOutstandingUnderLoanArrangement contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251" unitRef="iso4217_USD" decimals="-3" id="id_4020747_08FD00DD-3E45-4A5C-B54D-7C81CB7F649F_1001_3">49521000</mnkd:RelatedPartyTransactionPrincipalAmountOutstandingUnderLoanArrangement>
  <mnkd:DerivativeFairValueLiabilitySharesIssuableToLender contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716421x756949_716644x745094" unitRef="shares" decimals="-5" id="id_4020747_D2708747-31B2-4539-9CFD-BE15DB12E2FF_1001_0">14700000</mnkd:DerivativeFairValueLiabilitySharesIssuableToLender>
  <mnkd:ForwardPurchaseContractFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716421x756949_716644x745094" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D2708747-31B2-4539-9CFD-BE15DB12E2FF_1001_3">900000</mnkd:ForwardPurchaseContractFairValue>
  <mnkd:ForwardPurchaseContractFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716421x837810_716644x745094" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D2708747-31B2-4539-9CFD-BE15DB12E2FF_2001_4">1100000</mnkd:ForwardPurchaseContractFairValue>
  <mnkd:ForwardPurchaseContractFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716644x745094" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D2708747-31B2-4539-9CFD-BE15DB12E2FF_3001_2">2000000</mnkd:ForwardPurchaseContractFairValue>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_712080x814753" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A92831DC-5182-49E9-BB29-C718F47A0FEF_2001_1">13200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_712546x710575" unitRef="iso4217_USD" decimals="-5" id="id_4020747_216BBCAF-A22C-48AF-9E29-E1C6D9D38F8E_1002_1">67700000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <mnkd:RequiredPaymentToClassMembersAndAttorneys contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_712948x786588" unitRef="iso4217_USD" decimals="-5" id="id_4020747_E3478E6F-0D3B-4E7A-B749-32CAC4FCA085_2001_0">16000000</mnkd:RequiredPaymentToClassMembersAndAttorneys>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x708980" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2FA011D7-9A97-49D3-8897-53128C247972_1001_0">15200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x715834" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2FA011D7-9A97-49D3-8897-53128C247972_2001_1">23200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x800027" unitRef="iso4217_USD" decimals="0" id="id_4020747_2FA011D7-9A97-49D3-8897-53128C247972_3001_3">107000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x843588" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2FA011D7-9A97-49D3-8897-53128C247972_4001_4">3700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x737814" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1001_2">6949202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x737814" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1001_1">16792784</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x788580" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1002_2">2166619</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x788580" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1002_1">6754325</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x788580" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1002_3">13590564</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x809015" unitRef="shares" decimals="INF" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_4004_0">2679007</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x824029" unitRef="shares" decimals="INF" id="id_4020747_17E83760-DF67-4073-8A2C-1C8B285AA112_1003_1">690831</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x732890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1002_3">100000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x732890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1002_5">98439000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x732890" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DAE00F92-3457-4983-9DEE-13696359F2B7_2002_4">102200000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x732890" unitRef="iso4217_USD" decimals="-5" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1002_2">2400000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x732890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_59A5FF45-209B-4EF3-9A99-F4C7655E317C_1002_4">1561000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-3" id="id_4020747_B1A28BD4-C907-4526-A87E-8A56158C5A84_1001_4">102300000</us-gaap:OtherLongTermDebtNoncurrent>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-3" id="id_4020747_B1A28BD4-C907-4526-A87E-8A56158C5A84_1001_0">120000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE00F92-3457-4983-9DEE-13696359F2B7_2003_3">102300000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DAE00F92-3457-4983-9DEE-13696359F2B7_2003_4">107000000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-3" id="id_4020747_B1A28BD4-C907-4526-A87E-8A56158C5A84_1001_1">6500000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
  <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-3" id="id_4020747_B1A28BD4-C907-4526-A87E-8A56158C5A84_1001_2">10834000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725" unitRef="iso4217_USD" decimals="-3" id="id_4020747_B1A28BD4-C907-4526-A87E-8A56158C5A84_1001_3">366000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:ConvertibleNotesPayable contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x774250" unitRef="iso4217_USD" decimals="-3" id="id_4020747_C92460C1-F947-43B8-BE33-C3A3AE097D96_2001_0">0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x774250" unitRef="iso4217_USD" decimals="0" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_1004_3">0</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:OtherDeferredCompensationArrangementsLiabilityCurrent contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x883632" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_4001_3">3151000</us-gaap:OtherDeferredCompensationArrangementsLiabilityCurrent>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x883632" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_4001_0">16276000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x883632" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_4001_4">13013000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x883632" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_4001_1">51000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x883632" unitRef="iso4217_USD" decimals="-3" id="id_4020747_DAE45A6F-24FA-4F8C-B260-B20D204F94E3_4001_2">61000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x707341" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_1002_2">114099000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x710555" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_2002_7">14756000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x714221" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_3002_3">82189000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x715869" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_4002_1">54948000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x715944" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_5002_0">5273000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x716297" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_6002_6">17000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x740890" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_7002_5">11289000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x767832" unitRef="iso4217_USD" decimals="-3" id="id_4020747_9DA6A0B7-C3B7-4562-9619-3D611336941F_8002_4">5046000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_715990x761648" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A92831DC-5182-49E9-BB29-C718F47A0FEF_3001_0">28200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_786923x827982" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_7003_14">47300000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1310-K0014_STD_0_20131231_0_841045x753998" unitRef="shares" decimals="INF" id="id_4020747_3BDEEEFD-6FF8-472A-8FA9-8C5D411F214A_1001_0">203700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629" unitRef="shares" decimals="INF" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_1001_2">17132000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629" unitRef="iso4217_USD" decimals="-5" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_1001_0">175000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsForCommissions contextRef="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629" unitRef="iso4217_USD" decimals="-5" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_1001_5">4500000</us-gaap:PaymentsForCommissions>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629" unitRef="iso4217_USD" decimals="-5" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_1001_7">170200000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <mnkd:OtherOfferingExpenses contextRef="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629" unitRef="iso4217_USD" decimals="0" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_1001_6">300000</mnkd:OtherOfferingExpenses>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629_789193x712230" unitRef="iso4217_USD" decimals="-5" id="id_4020747_279AF3A1-B0D6-4760-A8C1-CFE1AF5439A7_2001_1">87300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982" unitRef="shares" decimals="INF" id="id_4020747_01587AA5-4D7A-41FD-9816-5164B4B00C3F_1001_0">8360000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982" unitRef="iso4217_USD" decimals="-5" id="id_4020747_01587AA5-4D7A-41FD-9816-5164B4B00C3F_1001_5">59700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982_789193x712230" unitRef="shares" decimals="INF" id="id_4020747_01587AA5-4D7A-41FD-9816-5164B4B00C3F_2001_3">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982_789193x712230" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_01587AA5-4D7A-41FD-9816-5164B4B00C3F_2001_4">8.11</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982_789193x764239" unitRef="shares" decimals="INF" id="id_4020747_01587AA5-4D7A-41FD-9816-5164B4B00C3F_3001_1">960000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982_789193x764239" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_01587AA5-4D7A-41FD-9816-5164B4B00C3F_3001_2">7.35</us-gaap:EquityIssuancePerShareAmount>
  <mnkd:IncrementalExpensesToBeRecognizedOverVestingTerm contextRef="eol_PE126000--1310-K0014_STD_2_20100801_0_841045x778627" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DDE55B61-AECA-4CF1-9DEC-E1616A828D75_1002_4">3700000</mnkd:IncrementalExpensesToBeRecognizedOverVestingTerm>
  <mnkd:ClosingBidPriceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x768251" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_2DD4489E-1741-4B9B-9AFC-32043BD01CE8_1001_0">7.15</mnkd:ClosingBidPriceOfCommonStock>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2DD4489E-1741-4B9B-9AFC-32043BD01CE8_1001_1">350000000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:CommonStockMaximumNumberOfSharesAvailableForSaleUnderPurchaseAgreement contextRef="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x786262" unitRef="shares" decimals="0" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2001_0">18200000</mnkd:CommonStockMaximumNumberOfSharesAvailableForSaleUnderPurchaseAgreement>
  <mnkd:PercentageOfPurchasePricePerShare contextRef="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x786262" unitRef="pure" decimals="2" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2001_4">0.92</mnkd:PercentageOfPurchasePricePerShare>
  <mnkd:IncrementalCommonSharesAttributableToCommonStockEquivalents contextRef="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2001_1">700000</mnkd:IncrementalCommonSharesAttributableToCommonStockEquivalents>
  <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890" unitRef="pure" decimals="4" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1001_3">147.0859</us-gaap:DebtInstrumentConvertibleConversionRatio1>
  <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays contextRef="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1001_9">P30D</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays>
  <us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890" unitRef="D" decimals="0" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1001_8">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
  <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890" unitRef="pure" decimals="2" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1001_6">1.00</us-gaap:DebtInstrumentRedemptionPricePercentage>
  <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890" unitRef="pure" decimals="2" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1001_7">1.50</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
  <mnkd:PrincipalAmountPerShare contextRef="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4020747_CBD0ECB7-AD5D-475B-8AB4-5978CEAA1BEE_1001_4">1000</mnkd:PrincipalAmountPerShare>
  <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated contextRef="eol_PE126000--1310-K0014_STD_2_20110210_0" unitRef="Employee" decimals="INF" id="id_4020747_A4DCD205-6FD6-4788-8C0E-78077DC0ECA7_1_1">257</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
  <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent contextRef="eol_PE126000--1310-K0014_STD_2_20110210_0" unitRef="pure" decimals="2" id="id_4020747_A4DCD205-6FD6-4788-8C0E-78077DC0ECA7_1_0">0.41</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
  <us-gaap:RestructuringCharges contextRef="eol_PE126000--1310-K0014_STD_2_20110210_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_A4DCD205-6FD6-4788-8C0E-78077DC0ECA7_1_2">6700000</us-gaap:RestructuringCharges>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrants contextRef="eol_PE126000--1310-K0014_STD_2_20120208_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_1_6">80600000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrants>
  <mnkd:WarrantsExercisableExpirationPeriod contextRef="eol_PE126000--1310-K0014_STD_2_20120208_0_716644x726394" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_1001_9">P4Y</mnkd:WarrantsExercisableExpirationPeriod>
  <us-gaap:ForwardContractIndexedToIssuersEquityShares contextRef="eol_PE126000--1310-K0014_STD_2_20120517_0" unitRef="shares" decimals="INF" id="id_4020747_B25C73A5-51B7-4AE1-9845-81068B6F7F1B_1_0">250000000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x812459" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_AA71C0CF-2C60-4A5C-97F2-06716395C857_1001_5">1.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x812459" unitRef="shares" decimals="INF" id="id_4020747_AA71C0CF-2C60-4A5C-97F2-06716395C857_1001_2">3892500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate contextRef="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x812459" id="id_4020747_AA71C0CF-2C60-4A5C-97F2-06716395C857_1001_4">2014-05-01</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x830452" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_AA71C0CF-2C60-4A5C-97F2-06716395C857_2001_1">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x830452" unitRef="shares" decimals="INF" id="id_4020747_AA71C0CF-2C60-4A5C-97F2-06716395C857_2001_0">3942500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_2_20130523_0_713115x800027" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_6F78D7C4-A9F1-484C-9365-D6843EBC47AB_1001_2">3.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE126000--1310-K0014_STD_2_20130523_0_713115x800027" unitRef="shares" decimals="INF" id="id_4020747_6F78D7C4-A9F1-484C-9365-D6843EBC47AB_1001_0">5598100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_2_20130523_0_713115x843588" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_6F78D7C4-A9F1-484C-9365-D6843EBC47AB_2001_3">6.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE126000--1310-K0014_STD_2_20130523_0_713115x843588" unitRef="shares" decimals="INF" id="id_4020747_6F78D7C4-A9F1-484C-9365-D6843EBC47AB_2001_1">1687900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x744308_710720x714667_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_1001_2">90000000</us-gaap:DebtConversionOriginalDebtAmount1>
  <mnkd:DebtInstrumentConversionOfPrincipalAmountPercentage contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x744308_710720x714667_714378x735725" unitRef="pure" decimals="2" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_1001_1">1.50</mnkd:DebtInstrumentConversionOfPrincipalAmountPercentage>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x805183_710720x714667_714378x735725" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_2001_8">2019-12-31</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x805183_710720x714667_714378x735725" unitRef="iso4217_USD" decimals="-6" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_2001_3">0</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x883669_710720x714667_714378x735725" unitRef="D" decimals="0" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_3001_12">3</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
  <us-gaap:DebtInstrumentConvertibleStockPriceTrigger contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x883669_710720x714667_714378x735725" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_3001_11">5.00</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x883669_710720x714667_714378x735725" unitRef="shares" decimals="INF" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_3001_10">12000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x883669_710720x714667_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_3001_9">60000000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_710720x714667_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_4001_5">20000000</us-gaap:DebtConversionOriginalDebtAmount1>
  <mnkd:DebtInstrumentConversionOfPrincipalAmountPercentage contextRef="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_710720x714667_714378x735725" unitRef="pure" decimals="3" id="id_4020747_1BC74475-4905-42E9-B7C1-282E325080F6_4001_4">0.333</mnkd:DebtInstrumentConversionOfPrincipalAmountPercentage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_2_20130307_0_713115x843588" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_BF950DBD-08BE-4FB5-9529-2D73ED3B9CAA_1001_1">2.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE126000--1310-K0014_STD_2_20130307_0_713115x843588" unitRef="shares" decimals="INF" id="id_4020747_BF950DBD-08BE-4FB5-9529-2D73ED3B9CAA_1001_0">5846000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <mnkd:UnamortizedStockBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_2_20080709_0_841045x778627" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DDE55B61-AECA-4CF1-9DEC-E1616A828D75_1001_3">13900000</mnkd:UnamortizedStockBasedCompensationExpense>
  <mnkd:OptionToPurchaseCommonStockShares contextRef="eol_PE126000--1310-K0014_STD_2_20080709_0_841045x778627" unitRef="shares" decimals="0" id="id_4020747_DDE55B61-AECA-4CF1-9DEC-E1616A828D75_1001_1">4493509</mnkd:OptionToPurchaseCommonStockShares>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_2_20121018_0" unitRef="pure" decimals="3" id="id_4020747_62982962-381F-48DF-A528-A6F87DA0CBDD_1_1">0.023</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_2_20121018_0" unitRef="pure" decimals="4" id="id_4020747_62982962-381F-48DF-A528-A6F87DA0CBDD_1_0">0.0011</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ResearchAndDevelopmentInProcess contextRef="eol_PE126000--1310-K0014_STD_2_20011212_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_7D01C820-B83B-41F8-B1BD-0A291A865116_1_3">19700000</us-gaap:ResearchAndDevelopmentInProcess>
  <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="eol_PE126000--1310-K0014_STD_2_20061212_0_714378x774250" unitRef="pure" decimals="4" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_1001_4">44.5002</us-gaap:DebtInstrumentConvertibleConversionRatio1>
  <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="eol_PE126000--1310-K0014_STD_2_20061212_0_714378x774250" unitRef="pure" decimals="2" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_1001_7">1.00</us-gaap:DebtInstrumentRedemptionPricePercentage>
  <mnkd:PrincipalAmountPerShare contextRef="eol_PE126000--1310-K0014_STD_2_20061212_0_714378x774250" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_1001_5">1000</mnkd:PrincipalAmountPerShare>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE126000--1310-K0014_STD_2_20110303_0_713879x737814" unitRef="shares" decimals="INF" id="id_4020747_FE2119F3-65DD-466E-A0C2-EE53BB075127_1001_1">1467500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="eol_PE126000--1310-K0014_STD_2_20110303_0_713879x737814" unitRef="pure" decimals="2" id="id_4020747_FE2119F3-65DD-466E-A0C2-EE53BB075127_1001_2">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE126000--1310-K0014_STD_2_20110303_0_713879x737814" unitRef="shares" decimals="INF" id="id_4020747_FE2119F3-65DD-466E-A0C2-EE53BB075127_1001_0">1177300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_2_20110303_0_713879x737814" unitRef="iso4217_USD" decimals="-5" id="id_4020747_FE2119F3-65DD-466E-A0C2-EE53BB075127_1001_3">8200000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_2_20121220_0" unitRef="pure" decimals="3" id="id_4020747_62982962-381F-48DF-A528-A6F87DA0CBDD_2_1">0.015</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_2_20121220_0" unitRef="pure" decimals="4" id="id_4020747_62982962-381F-48DF-A528-A6F87DA0CBDD_2_0">0.0000</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ForwardContractIndexedToIssuersEquityShares contextRef="eol_PE126000--1310-K0014_STD_2_20121220_0" unitRef="shares" decimals="INF" id="id_4020747_46A85CF5-AA81-47E7-8075-C2E03A18F0C1_1_0">350000000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1310-K0014_STD_2_20131215_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC8DC72A-82D3-4FC5-819F-7EE769720358_2_8">115000000</us-gaap:RepaymentsOfSeniorDebt>
  <mnkd:StockPriceUsedToForecastFutureLiability contextRef="eol_PE126000--1310-K0014_STD_274_20120930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_9552D370-960C-43B7-8FF7-9B76340AE111_1_2">1.00</mnkd:StockPriceUsedToForecastFutureLiability>
  <mnkd:LossContingencySettlementAgreementStockIssuable contextRef="eol_PE126000--1310-K0014_STD_274_20120930_0" unitRef="shares" decimals="0" id="id_4020747_9552D370-960C-43B7-8FF7-9B76340AE111_1_1">901000</mnkd:LossContingencySettlementAgreementStockIssuable>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="eol_PE126000--1310-K0014_STD_28_20090228_0_711672x712230_717061x772809" unitRef="pure" decimals="2" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_3002_1">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="eol_PE126000--1310-K0014_STD_28_20090228_0_711672x712230_717061x772809" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_3002_2">One-year LIBOR</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289" unitRef="iso4217_USD" decimals="0" id="id_4020747_E2246A5F-0A3C-47AA-A3C8-22BC12F1CCDD_1001_0">500000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:DebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289" unitRef="iso4217_USD" decimals="INF" id="id_4020747_E2246A5F-0A3C-47AA-A3C8-22BC12F1CCDD_1001_2">597529</us-gaap:DebtIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x737742_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_043DC4DE-F060-42AA-A66D-F98AE73F1E81_1001_1">39500000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:DebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x744308" unitRef="iso4217_USD" decimals="INF" id="id_4020747_E2246A5F-0A3C-47AA-A3C8-22BC12F1CCDD_2001_4">128008</us-gaap:DebtIssuanceCosts>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x883632_714378x735725" unitRef="pure" decimals="3" id="id_4020747_B824EB11-8964-49F2-877E-2E5B57714B7B_1001_2">0.175</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsEntityCreditRisk contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x883632_714378x735725" unitRef="pure" decimals="2" id="id_4020747_B824EB11-8964-49F2-877E-2E5B57714B7B_1001_3">0.05</us-gaap:FairValueInputsEntityCreditRisk>
  <mnkd:NumberOfEqualTranches contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x883669_714378x735725" unitRef="Tranche" decimals="0" id="id_4020747_A8E4E968-3F92-49ED-924B-619BB743855C_1001_1">4</mnkd:NumberOfEqualTranches>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_714378x735725" id="id_4020747_000AF42F-1D70-4659-9E06-3354EF8626DB_1001_1">2019-12-31</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_714378x735725" unitRef="iso4217_USD" decimals="0" id="id_4020747_E2246A5F-0A3C-47AA-A3C8-22BC12F1CCDD_3001_1">448737</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:DebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_714378x735725" unitRef="iso4217_USD" decimals="INF" id="id_4020747_E2246A5F-0A3C-47AA-A3C8-22BC12F1CCDD_3001_3">536266</us-gaap:DebtIssuanceCosts>
  <mnkd:ProceedFromIssuanceOfDebtInstrument contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_043DC4DE-F060-42AA-A66D-F98AE73F1E81_2001_0">52900000</mnkd:ProceedFromIssuanceOfDebtInstrument>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_708873x716845_716833x715326_733234x883632" unitRef="pure" decimals="3" id="id_4020747_52525C82-7561-4ED3-9CC1-A672874AF84D_1001_1">0.175</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_716833x715326_733234x883631" unitRef="pure" decimals="2" id="id_4020747_52525C82-7561-4ED3-9CC1-A672874AF84D_2001_2">0.12</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_3_20130701_0_716833x715326_733234x883632" unitRef="pure" decimals="3" id="id_4020747_52525C82-7561-4ED3-9CC1-A672874AF84D_3001_0">0.124</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10014_1700014">1805000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10014_1700016">-2004000</us-gaap:NetIncomeLoss>
  <mnkd:NotesReceivableFromStockholdersCollectionOfStockSubscription contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10014_1700015">400000</mnkd:NotesReceivableFromStockholdersCollectionOfStockSubscription>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10009_1200014">1805000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10007_1000014">36000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <mnkd:NotesReceivableFromStockholdersCollectionOfStockSubscription contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10010_1300015">400000</mnkd:NotesReceivableFromStockholdersCollectionOfStockSubscription>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_10013_1600016">-2004000</us-gaap:NetIncomeLoss>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_31_20140131_0_705999x857289_708502x744870_710720x714667_714378x735725" unitRef="shares" decimals="INF" id="id_4020747_53E1B1FB-A666-48A2-9B59-762871E16BD1_1001_3">7852475</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_31_20140131_0_705999x857289_708502x744870_710720x714667_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_53E1B1FB-A666-48A2-9B59-762871E16BD1_1001_2">40000000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_31_20140131_0_705999x857289_710720x714667_714378x735725" unitRef="shares" decimals="INF" id="id_4020747_53E1B1FB-A666-48A2-9B59-762871E16BD1_2001_1">6559251</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1310-K0014_STD_31_20140131_0_705999x857289_710720x714667_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_53E1B1FB-A666-48A2-9B59-762871E16BD1_2001_0">33500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <mnkd:PercentageOfCommonStockSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_31_20040331_0" unitRef="pure" decimals="2" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_1_3">0.01</mnkd:PercentageOfCommonStockSharesOutstanding>
  <mnkd:PercentageOfShareReservedForShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_31_20040331_0_711502x716112" unitRef="pure" decimals="2" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_1001_4">0.10</mnkd:PercentageOfShareReservedForShareBasedCompensation>
  <mnkd:EmployeeStockPurchasePlanAnnualIncreaseInReservedShares contextRef="eol_PE126000--1310-K0014_STD_31_20040331_0_713879x809015" unitRef="shares" decimals="INF" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_2001_1">700000</mnkd:EmployeeStockPurchasePlanAnnualIncreaseInReservedShares>
  <us-gaap:ForwardContractIndexedToIssuersEquityShares contextRef="eol_PE126000--1310-K0014_STD_31_20120531_0" unitRef="shares" decimals="INF" id="id_4020747_77D57DB1-A3A6-4DDB-9900-587493513DCA_2_4">250000000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
  <mnkd:NetOperatingLossCarryforwardAnnualLimitation contextRef="eol_PE126000--1310-K0014_STD_31_20040831_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_2_5">13000000</mnkd:NetOperatingLossCarryforwardAnnualLimitation>
  <mnkd:LoanAgreementWithRelatedParty contextRef="eol_PE126000--1310-K0014_STD_31_20071031_0_711672x712230" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_1001_0">350000000</mnkd:LoanAgreementWithRelatedParty>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="shares" decimals="INF" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1_0">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_1_0">92000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <mnkd:WarrantExpirationMonthYear contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1_8">2013-10</mnkd:WarrantExpirationMonthYear>
  <mnkd:NetProceedsFromPublicOffering contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1_5">86300000</mnkd:NetProceedsFromPublicOffering>
  <mnkd:AdditionalPurchaseOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="shares" decimals="0" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1_3">4500000</mnkd:AdditionalPurchaseOfCommonStock>
  <mnkd:CommonStockPurchase contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="shares" decimals="0" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1_1">30000000</mnkd:CommonStockPurchase>
  <mnkd:NumberOfSharesOfCommonStockInEachUnit contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="shares" decimals="INF" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_1_1">1</mnkd:NumberOfSharesOfCommonStockInEachUnit>
  <mnkd:CommonStockIssuableUponExerciseOfWarrantsConversionRatio contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="pure" decimals="2" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_1_2">0.75</mnkd:CommonStockIssuableUponExerciseOfWarrantsConversionRatio>
  <mnkd:AdditionalCommonsStockSharesIssuedDuringPeriod contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0" unitRef="shares" decimals="0" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_1_2">6000000</mnkd:AdditionalCommonsStockSharesIssuedDuringPeriod>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0_713115x715581_714777x709629" unitRef="shares" decimals="INF" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_1001_5">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE126000--1310-K0014_STD_31_20121031_0_713115x716908_714777x709629" unitRef="shares" decimals="INF" id="id_4020747_59F458A3-4F1A-419C-85E6-102A4CE61395_2001_4">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_31_20131031_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF76092F-BF40-4AEB-A862-EF6884F7A47D_2_9">89700000</us-gaap:ProceedsFromWarrantExercises>
  <mnkd:LoanAgreementWithRelatedParty contextRef="eol_PE126000--1310-K0014_STD_31_20131031_0_711672x712230" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_1004_0">370000000</mnkd:LoanAgreementWithRelatedParty>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1310-K0014_STD_31_20131031_0_711672x712230_717061x750999" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_2004_4">2020-01-05</us-gaap:DebtInstrumentMaturityDate>
  <mnkd:PrincipalIndebtednessCancelledUnderLoanArrangementAsPaymentForAggregateExercisePriceOfWarrants contextRef="eol_PE126000--1310-K0014_STD_31_20131031_0_711672x712230_717061x750999" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_2004_5">78000000</mnkd:PrincipalIndebtednessCancelledUnderLoanArrangementAsPaymentForAggregateExercisePriceOfWarrants>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_31_20131031_0_717061x750999_789193x712230" unitRef="shares" decimals="0" id="id_4020747_BD758B1B-978E-4DF1-A9F7-CF577AB7382C_1001_0">30000000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:PrincipalIndebtednessCancelledUnderLoanArrangementAsPaymentForAggregateExercisePriceOfWarrants contextRef="eol_PE126000--1310-K0014_STD_31_20131031_0_717061x750999_789193x712230" unitRef="iso4217_USD" decimals="-5" id="id_4020747_BD758B1B-978E-4DF1-A9F7-CF577AB7382C_1001_1">78000000</mnkd:PrincipalIndebtednessCancelledUnderLoanArrangementAsPaymentForAggregateExercisePriceOfWarrants>
  <mnkd:HeadcountReductionPercentage contextRef="eol_PE126000--1310-K0014_STD_31_20021231_0" unitRef="pure" decimals="2" id="id_4020747_E0D584C6-D232-4E9A-9A6E-2143907F053B_2_0">0.50</mnkd:HeadcountReductionPercentage>
  <us-gaap:GainLossOnDispositionOfAssets contextRef="eol_PE126000--1310-K0014_STD_31_20091231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_442474F1-CD31-4DEE-B7CC-0ECF38E7505F_1_0">-12800000</us-gaap:GainLossOnDispositionOfAssets>
  <us-gaap:ForwardContractIndexedToIssuersEquityShares contextRef="eol_PE126000--1310-K0014_STD_31_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_1D0BD20F-B6E1-4A00-917F-29D320471E3F_2_6">350000000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
  <us-gaap:PaymentsForRestructuring contextRef="eol_PE126000--1310-K0014_STD_324_20111231_0_711976x780975" unitRef="iso4217_USD" decimals="-3" id="id_4020747_436EA9ED-9340-4A97-B160-5022E89E024B_4001_2">6189000</us-gaap:PaymentsForRestructuring>
  <us-gaap:RestructuringReserveAccrualAdjustment contextRef="eol_PE126000--1310-K0014_STD_324_20111231_0_711976x780975" unitRef="iso4217_USD" decimals="-3" id="id_4020747_436EA9ED-9340-4A97-B160-5022E89E024B_4001_3">-403000</us-gaap:RestructuringReserveAccrualAdjustment>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700170">14335000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700177">361000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700175">924000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_73FFAD51-42A2-43E0-B5D7-50CD171BCBF0_1_2">-1600000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700179">-170560000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700174">-3392000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700178">-6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700171">16681000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700169">1605000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700176">13580000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:UnrealizedLossOnForeignCurrencyDerivativesBeforeTax contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_73FFAD51-42A2-43E0-B5D7-50CD171BCBF0_1_1">200000</us-gaap:UnrealizedLossOnForeignCurrencyDerivativesBeforeTax>
  <mnkd:StockIssuedDuringPeriodValueShareLendingAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42014_1700173">161000</mnkd:StockIssuedDuringPeriodValueShareLendingAgreement>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200170">14314000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200175">921000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200174">-3402000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200171">16660000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200169">1602000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200176">13580000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueShareLendingAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42009_1200173">71000</mnkd:StockIssuedDuringPeriodValueShareLendingAgreement>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1000170">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1000171">2100000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1000174">962000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1000175">318000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1000169">288000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1100170">21000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1100175">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1100174">10000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1100171">21000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1100169">3000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <mnkd:StockIssuedDuringPeriodValueShareLendingAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1100173">90000</mnkd:StockIssuedDuringPeriodValueShareLendingAgreement>
  <mnkd:StockIssuedDuringPeriodSharesShareLendingAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42007_1000172">9000000</mnkd:StockIssuedDuringPeriodSharesShareLendingAgreement>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42012_1500177">361000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42012_1500178">-6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_42013_1600179">-170560000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_711672x768251" unitRef="shares" decimals="INF" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_1005_2">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_1005_3">16700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2002_5">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20101231_0_711672x786262" unitRef="iso4217_USD" decimals="-5" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2002_6">14100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6014_1700005">888000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6014_1700007">-1175000</us-gaap:NetIncomeLoss>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalContribution contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6014_1700006">20000</mnkd:AdjustmentsToAdditionalPaidInCapitalContribution>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6009_1200005">887000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalContribution contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6009_1200006">20000</mnkd:AdjustmentsToAdditionalPaidInCapitalContribution>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6007_1000005">73000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6007_1100005">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_6013_1600007">-1175000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8014_1700009">526000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8014_1700012">-1156000</us-gaap:NetIncomeLoss>
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8014_10" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8009_1200009">526000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x710802" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8009_10" />
  <mnkd:StockIssuedDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8009_1200011">400000</mnkd:StockIssuedDuringPeriodValueNotesReceivable>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8007_1000009">11000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x713713" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8007_10" />
  <mnkd:StockIssuedDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8007_1000011">8000</mnkd:StockIssuedDuringPeriodValueNotesReceivable>
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x714212" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8012_10" />
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x728560" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8010_10" />
  <mnkd:StockIssuedDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8010_1300011">-400000</mnkd:StockIssuedDuringPeriodValueNotesReceivable>
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x742327" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8003_10" />
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8013_1600012">-1156000</us-gaap:NetIncomeLoss>
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x769283" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8013_10" />
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x780368" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8006_10" />
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x796933" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8011_10" />
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x827132" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8001_10" />
  <mnkd:StockIssuedDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x831084" unitRef="shares" xsi:nil="true" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_8005_10" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12014_1700019">22000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12014_1700021">-2815000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12014_1700020">384000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueServices contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12014_1700018">8000</mnkd:StockIssuedDuringPeriodValueServices>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12009_1200019">22000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12009_1200020">384000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueServices contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12009_1200018">8000</mnkd:StockIssuedDuringPeriodValueServices>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12007_1000019">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_12013_1600021">-2815000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16014_1700028">196000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16014_1700030">135000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16014_1700032">-2280000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16014_1700031">60000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16014_1700029">2000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16009_1200028">190000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16009_1200030">135000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16009_1200031">60000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16009_1200029">2000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16007_1000028">548000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16007_1000031">12000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16007_1000030">27000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16007_1100028">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_16013_1600032">-2280000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18014_1700034">12726000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18014_1700036">25000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18014_1700038">-3331000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18014_1700037">1202000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18014_1700035">150000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18009_1200034">12703000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18009_1200036">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18009_1200037">1200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18009_1200035">150000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18007_1000034">2253000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18007_1000037">215000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18007_1000036">68000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18007_1100034">23000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18007_1100036">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18007_1100037">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_18013_1600038">-3331000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20014_1700040">534000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20014_1700042">-5679000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20014_1700041">995000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20009_1200040">532000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20009_1200041">994000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20007_1000040">162000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20007_1000041">80000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20007_1100040">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20007_1100041">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_20013_1600042">-5679000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700055">78030000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700059">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700066">-48245000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700063">1565000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700062">239000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700060">189000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:StockIssuedDuringPeriodValueServices contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700058">60000</mnkd:StockIssuedDuringPeriodValueServices>
  <mnkd:NotesReceivableFromStockholdersPayments contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700061">28000</mnkd:NotesReceivableFromStockholdersPayments>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700056">3900000</mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalMerger contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700065">171154000</mnkd:AdjustmentsToAdditionalPaidInCapitalMerger>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionIssue contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24014_1700064">2949000</mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionIssue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200055">78000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200059">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200063">1565000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200062">239000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:StockIssuedDuringPeriodValueServices contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200058">60000</mnkd:StockIssuedDuringPeriodValueServices>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200056">3900000</mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalMerger contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200065">171154000</mnkd:AdjustmentsToAdditionalPaidInCapitalMerger>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionIssue contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24009_1200064">2949000</mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionIssue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24007_1000055">3052000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24007_1000059">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24007_1100055">30000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnkd:StockIssuedDuringPeriodSharesServices contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24007_1000057">3000</mnkd:StockIssuedDuringPeriodSharesServices>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24010_1300060">189000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:NotesReceivableFromStockholdersPayments contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24010_1300061">28000</mnkd:NotesReceivableFromStockholdersPayments>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_24013_1600066">-48245000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700068">58815000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700075">1421000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700071">84000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700080">-206265000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700078">268000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700077">251000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <us-gaap:GoodwillImpairmentLoss contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_E0D584C6-D232-4E9A-9A6E-2143907F053B_3_2">151400000</us-gaap:GoodwillImpairmentLoss>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700073">229000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:NotesReceivableFromStockholdersPayments contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700074">1314000</mnkd:NotesReceivableFromStockholdersPayments>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700072">98000</mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700076">1421000</mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionRedemption contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26014_1700079">1921000</mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionRedemption>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200068">58775000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200075">1421000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200071">84000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200078">268000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200077">251000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:NotesReceivableFromStockholdersPayments contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200074">1314000</mnkd:NotesReceivableFromStockholdersPayments>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200072">98000</mnkd:AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock>
  <mnkd:StockIssuedDuringPeriodValueCash contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200070">-2000</mnkd:StockIssuedDuringPeriodValueCash>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200076">1421000</mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionRedemption contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26009_1200079">1921000</mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionRedemption>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26007_1000068">3922000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26007_1000071">3000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26007_1100068">40000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnkd:StockIssuedDuringPeriodSharesCash contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26007_1000069">234000</mnkd:StockIssuedDuringPeriodSharesCash>
  <mnkd:StockIssuedDuringPeriodValueCash contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26007_1100070">2000</mnkd:StockIssuedDuringPeriodValueCash>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26010_1300073">229000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_26013_1600080">-206265000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700084">50000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700089">1017000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700094">-65879000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700092">4501000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700091">253000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700088">105000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:StockIssuedDuringPeriodValueCash contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700083">31847000</mnkd:StockIssuedDuringPeriodValueCash>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700090">1017000</mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalNonCashCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700085">70000</mnkd:AdjustmentsToAdditionalPaidInCapitalNonCashCompensation>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionSales contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28014_1700093">623000</mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionSales>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200084">49965000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200089">1017000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200092">4501000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200091">253000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:NotesReceivableFromOfficersIssue contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200087">225000</mnkd:NotesReceivableFromOfficersIssue>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200090">1017000</mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalNonCashCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200085">70000</mnkd:AdjustmentsToAdditionalPaidInCapitalNonCashCompensation>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionSales contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28009_1200093">623000</mnkd:AdjustmentsToAdditionalPaidInCapitalPutOptionSales>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28007_1000084">3494000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28007_1100084">35000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnkd:StockIssuedDuringPeriodSharesCash contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28007_1000086">17000</mnkd:StockIssuedDuringPeriodSharesCash>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28010_1300088">102000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28013_1600094">-65879000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x780368" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28006_900082">-50000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <mnkd:StockIssuedDuringPeriodValueCash contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x780368" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28006_900083">31847000</mnkd:StockIssuedDuringPeriodValueCash>
  <mnkd:NotesReceivableFromOfficersIssue contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x796933" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28011_1400087">-225000</mnkd:NotesReceivableFromOfficersIssue>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x796933" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28011_1400088">3000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x831084" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_28005_800082">50000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700126">170234000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700124">1951000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700125">-145000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700128">-114338000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700123">495000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700127">-1828000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueExchangeOfWarrants contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32014_1700122">245000</mnkd:StockIssuedDuringPeriodValueExchangeOfWarrants>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32009_1200126">170063000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32009_1200124">1948000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32009_1200125">-146000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32009_1200123">494000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32009_1200127">-1828000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueExchangeOfWarrants contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32009_1200122">245000</mnkd:StockIssuedDuringPeriodValueExchangeOfWarrants>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1000126">17132000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1000124">304000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1000125">40000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1000123">58000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1100126">171000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1100124">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1100125">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1100123">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <mnkd:StockIssuedDuringPeriodSharesExchangeOfWarrants contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32007_1000121">24000</mnkd:StockIssuedDuringPeriodSharesExchangeOfWarrants>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_32013_1600128">-114338000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700136">384670000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700133">2312000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700141">-230548000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700137">-340000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700132">981000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700140">14667000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700139">2074000</mnkd:StockIssuedDuringPeriodValueResearchAgreement>
  <mnkd:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34014_1700131">2694000</mnkd:StockIssuedDuringPeriodValueWarrantsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200136">384440000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200133">2309000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200137">-341000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200132">980000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200140">14667000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200139">2073000</mnkd:StockIssuedDuringPeriodValueResearchAgreement>
  <mnkd:StockCancelledDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200135">-8000</mnkd:StockCancelledDuringPeriodValueNotesReceivable>
  <mnkd:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34009_1200131">2691000</mnkd:StockIssuedDuringPeriodValueWarrantsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000136">23000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000137">102000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000133">263000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000132">86000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100136">230000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100133">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100137">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100132">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <mnkd:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000130">339000</mnkd:StockIssuedDuringPeriodSharesWarrantsExercised>
  <mnkd:StockIssuedDuringPeriodValueResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100139">1000</mnkd:StockIssuedDuringPeriodValueResearchAgreement>
  <mnkd:StockCancelledDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100135">8000</mnkd:StockCancelledDuringPeriodValueNotesReceivable>
  <mnkd:StockCancelledDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000134">844000</mnkd:StockCancelledDuringPeriodSharesNotesReceivable>
  <mnkd:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1100131">3000</mnkd:StockIssuedDuringPeriodValueWarrantsExercised>
  <mnkd:StockIssuedDuringPeriodSharesResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34007_1000138">100000</mnkd:StockIssuedDuringPeriodSharesResearchAgreement>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_34013_1600141">-230548000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700146">249750000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700144">4923000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700145">123000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700151">-293190000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700147">-524000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700143">1065000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700150">17522000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36014_1700149">944000</mnkd:StockIssuedDuringPeriodValueResearchAgreement>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200146">249480000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200144">4917000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200145">123000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200147">-526000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200143">1064000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200150">17522000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36009_1200149">943000</mnkd:StockIssuedDuringPeriodValueResearchAgreement>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1000146">27014000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1000147">146000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1000144">607000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1000145">30000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1000143">124000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1100146">270000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1100144">6000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1100147">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1100143">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <mnkd:StockIssuedDuringPeriodValueResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1100149">1000</mnkd:StockIssuedDuringPeriodValueResearchAgreement>
  <mnkd:StockIssuedDuringPeriodSharesResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36007_1000148">100000</mnkd:StockIssuedDuringPeriodSharesResearchAgreement>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_36013_1600151">-293190000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700161">59724000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700165">-581000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700163">383000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700167">-220104000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700162">-7001000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700166">5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700160">1400000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40014_1700164">20219000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40009_1200161">59640000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40009_1200163">382000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40009_1200162">-7023000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40009_1200160">1397000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40009_1200164">20219000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1000161">8360000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1000162">2240000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1000163">94000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1000160">323000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1100161">84000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1100163">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1100162">22000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40007_1100160">3000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40012_1500165">-581000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40012_1500166">5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_40013_1600167">-220104000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20110331_0_711672x768251" unitRef="shares" decimals="INF" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_1003_8">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1310-K0014_STD_365_20110331_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_1003_10">27800000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20110331_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2003_5">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20110331_0_711672x786262" unitRef="iso4217_USD" decimals="-5" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2003_6">9700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_1_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_1_3">-0.050</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_1_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_1_4">-0.300</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_8E2D0D48-AF6A-43B1-8AC0-D6A18F63F663_1_0">2.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" xsi:nil="true" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1_6" />
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_22">-123837000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" xsi:nil="true" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_1_1" />
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_1_4">34048852</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_18">-1.32</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_2_5">282816</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" id="id_4020747_B334F4E9-396E-4D7E-8A04-8B2153E85FCA_1_2">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_0">50000</us-gaap:SalesRevenueNet>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700182">9540000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_26">6858000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700187">-27000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700185">628000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_11">18000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_18">-87000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_17">-160804000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_65">250000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_8">1541000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_1_6">-27000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_54">17248000</us-gaap:InterestPaid>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_355F9DF3-F088-40CA-8635-7FCEBB492B86_1_0">57200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_12">-160804000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_17">-224000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_1_8">-160834000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_14">3000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_7">-140539000</us-gaap:OperatingIncomeLoss>
  <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_73FFAD51-42A2-43E0-B5D7-50CD171BCBF0_4_2">1300000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_14">-160804000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700184">-543000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700188">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_1_7">-30000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700183">11116000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700181">769000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44014_1700186">11204000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_10" />
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_3">40630000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2CCD153F-8D00-47C3-B7D9-80917E88B817_3_0">1300000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_48">63394000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_4">11204000</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_3">15912000</us-gaap:DepreciationAndAmortization>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_49">-63380000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_2" />
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_74F861B2-5530-405E-9B01-D127328E6D50_1_0">766000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_B334F4E9-396E-4D7E-8A04-8B2153E85FCA_1_0">625000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_1" />
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_445758D9-B950-474B-8B1A-1CDCF6F14278_1_0">777000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_10">10941000</us-gaap:InterestExpenseDebt>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_6">140589000</us-gaap:OperatingExpenses>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_9">-57225000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_8E2D0D48-AF6A-43B1-8AC0-D6A18F63F663_1_1">443000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B40FE96E-FD3B-4D80-9797-B0E2981FB4E3_1_0">21800000</us-gaap:InterestExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_19">2672000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_27">93000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_6">48643000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_2">99959000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E735C6F-B052-4068-9E1D-4D2F1F130ABB_1_0">1700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_7">8582000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC318011-5C42-4E17-ACCF-F50AC3F4DF43_5_1">14600000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_42">53000000</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_4" />
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_25">3828000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_3" />
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A26B142D-4608-4A1A-8A78-6896108503C5_1_0">11204000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_8" />
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_28">-2937000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_9">10883000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E735C6F-B052-4068-9E1D-4D2F1F130ABB_1_1">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B40FE96E-FD3B-4D80-9797-B0E2981FB4E3_1_1">400000</us-gaap:InterestCostsCapitalized>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_20">6045000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="shares" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_1_19">121817000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_6">4000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:RestructuringChargesNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_E308616E-99A4-48E4-8D28-4832078818D8_1_0">6300000</mnkd:RestructuringChargesNetOfTax>
  <mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_47">547000</mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits>
  <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="pure" xsi:nil="true" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_1_2" />
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_67">11116000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_16">830000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1_30">10941000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_483DB2C9-1020-4904-A5BF-E26DEF73D3C5_3_0">111000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_1_11" />
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_707179x753998" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21B9FC62-1588-4493-BDC7-42A12FC52889_1001_1">2000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_707179x768389" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21B9FC62-1588-4493-BDC7-42A12FC52889_2001_0">11202000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44009_1200182">9526000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44009_1200185">626000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44009_1200184">-547000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44009_1200183">11102000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44009_1200181">766000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44009_1200186">11204000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1000182">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1000183">1400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1000184">433000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1000185">214000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1000181">283000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1100182">14000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1100185">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1100184">4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1100183">14000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44007_1100181">3000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44012_1500187">-27000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44012_1500188">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_44013_1600189">-160804000</us-gaap:NetIncomeLoss>
  <mnkd:ConversionOfConvertiblePreferredStockAmountConverted contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711196x713470" unitRef="shares" decimals="-6" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2001_71">50000000</mnkd:ConversionOfConvertiblePreferredStockAmountConverted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x711169" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1001_0">0.0010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x711169" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1001_4">0.7600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x711169" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1001_2">P1Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x716112" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2001_1">0.0243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x716112" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2001_5">0.8300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x716112" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2001_3">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711672x768251" unitRef="shares" decimals="INF" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_1003_2">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_1003_3">11100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_2003_0">3500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_711672x786262" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_2003_1">23800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712080x726565" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A3A7CE56-7FFB-48D6-9E38-AABE288E6AAB_1001_0">5366000</us-gaap:AllocatedShareBasedCompensationExpense>
  <mnkd:RestructuringChargesNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712080x726565" unitRef="iso4217_USD" decimals="-5" id="id_4020747_E308616E-99A4-48E4-8D28-4832078818D8_1001_1">4700000</mnkd:RestructuringChargesNetOfTax>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712080x782834" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A3A7CE56-7FFB-48D6-9E38-AABE288E6AAB_2001_1">5838000</us-gaap:AllocatedShareBasedCompensationExpense>
  <mnkd:RestructuringChargesNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712080x782834" unitRef="iso4217_USD" decimals="-5" id="id_4020747_E308616E-99A4-48E4-8D28-4832078818D8_2001_2">1600000</mnkd:RestructuringChargesNetOfTax>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712382x708177" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_1001_1">19826113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712382x708980" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_2001_0">10082351</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20111231_0_712382x716908" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_4001_3">4140388</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <dei:TradingSymbol contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400000">MNKD</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400001">MANNKIND CORP</dei:EntityRegistrantName>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400005">Yes</dei:EntityCurrentReportingStatus>
  <dei:AmendmentFlag contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D9C56CCA-B8AA-4D32-A997-E29C4D8729DE_1_1">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400007">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D9C56CCA-B8AA-4D32-A997-E29C4D8729DE_1_3">2013</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D9C56CCA-B8AA-4D32-A997-E29C4D8729DE_1_0">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D9C56CCA-B8AA-4D32-A997-E29C4D8729DE_1_2">2013-12-31</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400002">0000899460</dei:EntityCentralIndexKey>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400004">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400003">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D9C56CCA-B8AA-4D32-A997-E29C4D8729DE_1_4">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityVoluntaryFilers contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_77DF10A0-169C-42FC-8A30-EB5F311AE46C_1_400006">No</dei:EntityVoluntaryFilers>
  <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_6A867042-341F-46C3-B23F-982DADD7CD0B_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The following is
 a summary of the carrying values and estimated fair values of the
 Company&amp;#x2019;s senior convertible notes due in 2013 and 2015 and
 the facility financing obligation due in 2019 (in
 millions).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2013 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;114.4&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;81.9&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2015 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;97.6&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;63.2&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;98.4&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;102.2&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2019 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;102.3&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;107.0&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1_4">2.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_404974C8-D896-4C23-8732-6AB8CA354F31_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consist of the following (dollar amounts in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Useful&lt;br /&gt;
 Life&lt;br /&gt;
 (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" rowspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Land&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Buildings&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Building
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,245&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,099&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Machinery and
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3-15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;81,382&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;82,189&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture, fixtures and
 office equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-10&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,239&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,046&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer equipment and
 software&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,840&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,289&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;12,266&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14,756&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;285,210&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;287,617&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(101,249&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(111,060&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total property and
 equipment, net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;183,961&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;176,557&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_EE9A1D8D-64B3-4D1A-B5E3-7CD24CD06DA3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
 dilutive securities outstanding are summarized as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10,082,351&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;18,674,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Conversion of senior
 convertible notes into common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,826,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,826,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,415,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;86,062,440&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,706,240&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vesting of restricted stock
 units&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,140,388&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,761,031&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34,048,852&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;128,324,123&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,475,367&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_94A05407-DE73-44CE-A555-D0C71339D943_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4. Property and
 equipment&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consist of the following (dollar amounts in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Useful&lt;br /&gt;
 Life&lt;br /&gt;
 (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" rowspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Land&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Buildings&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Building
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,245&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,099&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Machinery and
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3-15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;81,382&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;82,189&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture, fixtures and
 office equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-10&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,239&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,046&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer equipment and
 software&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,840&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,289&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;12,266&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14,756&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;285,210&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;287,617&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(101,249&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(111,060&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total property and
 equipment, net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;183,961&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;176,557&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements are amortized over four years which is the shorter of
 the term of the lease or the service lives of the improvements.
 Depreciation and amortization expense related to property and
 equipment for the years ended December&amp;#xA0;31, 2011, 2012 and
 2013, and the cumulative period from February&amp;#xA0;14, 1991 (date
 of inception) to December&amp;#xA0;31, 2013 was $14.6 million, $13.0
 million, $11.5 million and $133.3 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;No asset
 impairment was recognized during the years ended December&amp;#xA0;31,
 2011, 2012 and 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In December
 2009, the Company recognized a loss on disposal of approximately
 $12.8 million in research and development expense related to the
 abandonment of first-generation inhaler specific assets which would
 no longer be used as the Company pursued the commercialization of
 the next-generation device.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_66C4E67D-DCE8-487D-935B-6CFBD30FA768_1_3">2019-12-09</us-gaap:LineOfCreditFacilityExpirationDate1>
  <us-gaap:DebtPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_A9590D97-BCFC-4D55-B9E4-885E8364DF30_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); PADDING-BOTTOM: 0px; FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt;&amp;#xA0;&amp;#x2014;
 On July&amp;#xA0;1 2013, in conjunction with the execution of the
 Facility Agreement, the Company issued Milestone Rights to
 Deerfield whereby the Company agreed to provide Deerfield with
 pre-specified Milestone Payments upon the achievement of 13
 specific Milestone Events related to the commercial release and
 future cumulative net sales of AFREZZA&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;sup style="VERTICAL-ALIGN: baseline; POSITION: relative; BOTTOM: 0.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;.
 The Company analyzed the Milestone Rights under the provisions of
 ASC 815 and determined that the agreement does not meet the
 definition of a freestanding derivative. Since the Company have not
 elected to apply the fair value option to the Milestone Rights
 Purchase Agreement, the Company recorded the Milestone Rights at
 their estimated fair value and accounted for the Milestone Rights
 as a liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The initial fair value
 estimate of the Milestone Rights was calculated using the income
 approach in which the cash flows associated with the specified
 contractual payments were adjusted for both the expected timing and
 the probability of achieving the milestones and discounted to
 present value using a selected market discount rate. The expected
 timing and probability of achieving the milestones was developed
 with consideration given to both internal data, such as progress
 made to date and assessment of criteria required for achievement,
 and external data, such as market research studies. The discount
 rate was selected based on an estimation of required rate of
 returns for similar investment opportunities using available market
 data.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Milestone Rights
 liability will be remeasured as the specified milestone events are
 achieved. Specifically, as each milestone event is achieved, the
 portion of the initially recorded Milestone Rights liability that
 pertains to the milestone event being achieved, will be remeasured
 to the amount of the specified related milestone payment. The
 resulting change in the balance of the Milestone Rights liability
 due to remeasurement will be recorded in our Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon the settlement of each milestone
 payment. As a result, each milestone payment would be effectively
 allocated between a reduction of the recorded Milestone Rights
 liability and an expense representing a return on a portion of the
 Milestone Rights liability paid to the investor for the achievement
 of the related milestone event
 (see&amp;#xA0;Note&amp;#xA0;16).&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
  <us-gaap:DebtDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_AFBD3FA6-0067-48EB-93F0-AEEFC6471599_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;16. Facility financing
 agreement&lt;/b&gt;&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;components of the
 Facility Agreement recorded as of December&amp;#xA0;31, 2013 consist of
 the following (in&amp;#xA0;thousands):&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="88%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2019
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Principal
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;120,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Principal converted to
 equity&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(6,500&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Debt discount-net of
 amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(10,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Unaccreted debt issuance
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net carrying amount of
 facility financing agreement&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;102,300&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company&amp;#x2019;s
 Facility Agreement principal repayment schedule is comprised of
 payments beginning on the third anniversary of each issued tranche,
 totaling $28,375,000 annually, commencing on July&amp;#xA0;1, 2016 and
 ending on December&amp;#xA0;9, 2019, for a total amount of
 $113,500,000.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="91%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;Milestone
 rights&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Initial milestone rights
 fair value&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;16,276&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Debt discount-net of
 amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(51&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Unaccreted debt issuance
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(61&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Less current portion of
 milestone rights included in other current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(3,151&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net carrying amount
 included in other liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;13,013&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;Commitment
 Asset&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Initial commitment asset
 fair value&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;13,393&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Less Tranche 2 portion of
 commitment asset&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(3,656&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Less Tranche 3 portion of
 commitment asset&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(4,580&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Commitment asset value
 included in other assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;5,157&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion of debt
 issuance cost and debt discount in connection with the Deerfield
 financing during the three and twelve months ended
 December&amp;#xA0;31, 2013 are as follows (in
 thousands).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Three&amp;#xA0;months&amp;#xA0;ended&lt;br /&gt;
 December&amp;#xA0;31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Twelve&amp;#xA0;months&amp;#xA0;ended&lt;br /&gt;
 December&amp;#xA0;31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion expense- debt
 issuance cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion expense- debt
 discount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;923&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On July&amp;#xA0;1, 2013, the
 Company entered into the Facility Agreement providing for the sale
 of up to $160.0&amp;#xA0;million of 2019 notes to Deerfield in four
 equal tranches of $40.0 million principal amount. The 2019 notes
 accrue interest at a rate of 9.75%&amp;#xA0;per annum until maturity in
 2019 or their earlier repayment, repurchase, or conversion. A
 portion of the principal amount of the 2019 notes was converted
 into shares of the Company&amp;#x2019;s common stock as described under
 &amp;#x201C;Conversion Option&amp;#x201D; below.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Deerfield purchased the
 first tranche of 2019 notes (the &amp;#x201C;Tranche 1notes&amp;#x201D;) and
 Milestone Rights (as defined below) in the aggregate principal
 amount of $40.0 million on July&amp;#xA0;1, 2013. The closing of the
 second tranche of 2019 notes (the &amp;#x201C;Tranche 2 notes&amp;#x201D;),
 which was subject to achievement and reporting of certain results
 from the Company&amp;#x2019;s two Phase 3 clinical studies of AFREZZA,
 occurred on September&amp;#xA0;5, 2013. Deerfield&amp;#x2019;s purchase of
 the third tranche of 2019 notes occurred on December&amp;#xA0;9, 2013
 (the &amp;#x201C;Tranche 3 Notes&amp;#x201D;), and was subject to the
 repayment of the 2013 notes with the funds made available by the
 purchase of these 2019 notes. Deerfield&amp;#x2019;s obligation to
 purchase the fourth tranche of 2019 notes is subject to receipt of
 marketing approval of AFREZZA by the FDA and the shares of common
 stock issuable upon conversion of all previously sold 2019 notes
 being freely tradable pursuant to an effective registration
 statement filed with the SEC or pursuant to Rule 144 under the
 Securities Act.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company is required
 to repay 25% of the original principal amount of the 2019 notes
 sold in each tranche on the third, fourth, fifth and sixth
 anniversaries of the applicable issue dates of such 2019 notes;
 provided that the entire outstanding principal amount of all 2019
 notes will become due and payable no later than December&amp;#xA0;31,
 2019. The Company is required to repay any outstanding 2019 notes
 in full if the Company completes certain Major Transactions (as
 defined in the Facility Agreement), which include, but are not
 limited to, certain mergers and other change of control
 transactions involving the Company.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Facility Agreement
 includes customary representations, warranties and covenants,
 including, a restriction on the incurrence of additional
 indebtedness, and a financial covenant which requires the
 Company&amp;#x2019;s cash and cash equivalents, which includes available
 borrowings on the principal stockholder note, on the last day of
 each fiscal quarter to not be less than $25.0 million. As discussed
 in Note&amp;#xA0;1 &amp;#x2014; Basis of Presentation, the Company will need
 to raise additional capital to support its current operating
 plans.&amp;#xA0;Due to the uncertainties related to maintaining
 sufficient resources to comply with the aforementioned covenant,
 the 2019 notes have been classified as current liabilities in the
 accompanying balance sheet as of December&amp;#xA0;31, 2013. In the
 event of&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-compliance,&lt;/font&gt;&amp;#xA0;there can be no assurances
 that the holders of the 2019 notes will not exercise remedies
 available to them, which may include, among other things, the
 issuance of a notice of acceleration.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection with the
 issuance of the Tranche 1 notes and Milestone Rights on
 July&amp;#xA0;1, 2013, the Company recorded $52.9 million in value
 received, which consisted of $39.5 million in cash from the
 issuance of the Tranche 1 notes plus a Commitment asset (as
 described further below) with a fair value equal to $13.4 million.
 In exchange, the Company issued to Deerfield the Tranche 1 notes
 and Milestone Rights with estimated fair values equal to $37.1
 million and $16.3 million, respectively. The Tranche 1 notes, the
 Milestone Rights and the Commitment Asset were initially recorded
 at fair value.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Tranche 1 notes are
 classified as short-term debt and are subsequently accounted for at
 amortized cost. The effective interest rate on the Tranche 1 notes
 is 12.19% and a debt discount of approximately $3.3 million
 recognized on the Tranche 1 notes is being amortized to interest
 expense over the term of the Tranche 1 notes using the effective
 interest method.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In accordance with the
 Facility Agreement, the Company reimbursed Deerfield $500,000 for a
 portion of documented expenses for attorneys, accountants and other
 professional advisors, and other out-of-pocket expenses Deerfield
 incurred in connection with the transaction. These costs were
 allocated between the 2019 notes and the Milestone Rights based
 upon their relative fair value resulting in $448,737 being
 allocated to the 2019 notes and included within the debt discount
 with the remainder being allocated to the Milestone Rights. In
 addition, the Company incurred a total of $597,529 in debt issuance
 costs, of which $536,266 was allocated to the 2019 notes and the
 remainder to the Milestone Rights using the relative fair value
 allocation method. A portion of the debt issuance costs, or
 $128,008, related to the fourth tranche of 2019 notes are included
 in other assets.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Commitment Asset
 represents the right to receive additional funding under the
 second, third and fourth tranches of the Facility Agreement. The
 fair value of the Commitment Asset was estimated using the income
 approach by estimating the fair value of the future tranches using
 a market debt rate commensurate with the risk of the future
 tranches and the fair value of the cash expected to be received by
 the Company and assessing the probability of the commitments being
 funded in the future. The Commitment Asset will not be subsequently
 remeasured but it will be monitored for impairment until future
 tranches of 2019 notes are drawn. Upon the drawing of additional
 tranches of 2019 notes, the portion of the Commitment Asset related
 to such tranche will be derecognized resulting in a debt discount
 being recorded on the additional tranches of 2019 notes issued. If
 the additional funding under the fourth tranche ceases to be
 probable of occurring, the Commitment Asset will be impaired and
 will be written off as an expense in the Statement of
 Operations.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Upon the issuance of the
 Tranche 2 notes, the portion of the Commitment Asset attributed to
 the Tranche 2 Notes was derecognized and recorded as a debt
 discount to the Tranche 2 notes. Therefore, the Tranche 2 notes
 were recorded as short-term debt for the $40.0 million received,
 less a $3.7 million debt discount. The effective interest rate on
 the Tranche 2 notes is 12.45% and the debt discount is being
 amortized over the term of the Tranche 2 notes using the effective
 interest method.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Upon the issuance of the
 Tranche 3 notes, the portion of the Commitment Asset attributed to
 the Tranche 3 Notes was derecognized and recorded as a debt
 discount to the Tranche 3 notes. Therefore, the Tranche 3 notes
 were recorded as short-term debt for the $40.0 million received,
 less a $5.0 million debt discount. The effective interest rate on
 the Tranche 3 notes is 13.49% and the debt discount is being
 amortized over the term of the Tranche 3 notes using the effective
 interest method.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection with the
 execution of the Facility Agreement, on July&amp;#xA0;1, 2013, the
 Company issued Milestone Rights to the Milestone Purchasers. The
 Milestone Rights provide the Milestone Purchasers certain rights to
 receive payments of up to $90.0 million upon the occurrence of
 specified strategic and sales milestones, including the first
 commercial sale of an AFREZZA product and the achievement of
 specified net sales figures. The payments due under the Milestone
 Rights are subject to pro rata reduction in the event of certain
 funding failures by Deerfield under the Facility
 Agreement.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Milestone Agreement
 includes customary representations and warranties and covenants by
 the Company, including restrictions on transfers of intellectual
 property related to AFREZZA. The Milestone Rights are subject to
 acceleration in the event the Company transfers its intellectual
 property related to AFREZZA in violation of the terms of the
 Milestone Agreement.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company analyzed the
 Milestone Rights under the provisions of ASC 815 Derivatives and
 Hedging and determined that the instruments do not meet the
 definition of a freestanding derivative. Since the Company has not
 elected to apply the fair value option to the Milestone Rights, the
 Company has initially recorded the Milestone Rights at their
 estimated fair value and accounted for the Milestone Rights as a
 liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The initial fair value
 estimate of the Milestone Rights was calculated using the income
 approach in which the cash flows associated with the specified
 contractual payments were adjusted for both the expected timing and
 the probability of achieving the milestones discounted to present
 value using a selected market discount rate. The Milestone Rights
 were initially recorded as a short-term liability equal to $3.2
 million included in Accrued expenses and other current liabilities
 in the accompanying condensed consolidated balance sheet and a long
 term liability equal to $13.1 million included in Other
 liabilities. In determining the fair value of the Milestone Rights,
 the 13 individual milestone payments were adjusted for both
 (i)&amp;#xA0;the expected timing and (ii)&amp;#xA0;the probability of
 achieving the milestones, and then discounted to present value
 using a discount rate of 17.5%. Once the initial valuation of each
 specified milestone payment was determined, the individual
 milestone payments were then aggregated to arrive at a total fair
 value of $16.3 million. The discount rate was based on the
 estimated cost of equity which was derived using the capital asset
 pricing model. In addition, a 5% risk premium was added to the
 computation of the cost of equity to adjust for non-systemic risk
 factors, such as the Company&amp;#x2019;s lack of product
 diversification and history of financial losses, which were not
 captured in other model inputs.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Milestone Rights
 liability will be remeasured as the specified milestone events are
 achieved. Specifically, as each milestone event is achieved, the
 portion of the initially recorded Milestone Rights liability that
 pertains to such milestone event being achieved will be remeasured
 to the amount of the related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to such
 remeasurement will be recorded in the Company&amp;#x2019;s Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon each such milestone payment being
 paid. As a result, each milestone payment would be effectively
 allocated between a reduction of the initially recorded Milestone
 Rights liability and an expense representing a return on a portion
 of the Milestone Rights liability paid to the Milestone Purchasers
 for the achievement of the related milestone
 event.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company identified
 and evaluated a number of embedded features in the Milestone Rights
 to determine if they represented embedded derivatives requiring
 bifurcation and separate accounting pursuant to ASC 815. There were
 no features in the Milestone Rights that required bifurcation and
 separate accounting&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Security
 Agreement&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection with the
 Facility Agreement, the Company and its subsidiary, MannKind LLC,
 entered into a Guaranty and Security Agreement (the &amp;#x201C;Security
 Agreement&amp;#x201D;) with Deerfield and HS (collectively, the
 &amp;#x201C;Purchasers&amp;#x201D;), pursuant to which the Company and
 MannKind LLC each granted the Purchasers a security interest in
 substantially all of their respective assets, including respective
 intellectual property, accounts, receivables, equipment, general
 intangibles, inventory and investment property, and all of the
 proceeds and products of the foregoing. The Security Agreement
 includes customary covenants by the Company and MannKind LLC,
 remedies of the Purchasers and representations and warranties by
 the Company and MannKind LLC. The security interests granted by us
 and MannKind LLC will terminate upon repayment of the 2019 notes
 and tranche B notes, if applicable (see Note&amp;#xA0;18), in full. Our
 obligations under the Facility Agreement and the Milestone
 Agreement are also secured by certain mortgages on the
 Company&amp;#x2019;s facilities in Danbury, Connecticut and Valencia,
 California.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Registration Rights
 Agreement&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection with the
 Facility Agreement and the sale of the 2019 notes pursuant thereto,
 the Company entered into a Registration Rights Agreement with
 Deerfield (the &amp;#x201C;Registration Rights Agreement&amp;#x201D;),
 pursuant to which the Company agreed to register for sale, the
 shares issuable upon conversion of the 2019 notes within a
 specified time period following the issuance of each tranche of
 2019 notes.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Pursuant to the
 Registration Rights Agreement, the number of aggregate shares of
 Common Stock included in the initial mandatory registration
 statement was 12.0&amp;#xA0;million shares (subject to adjustment in
 the event of a stock split, stock combination, reclassification,
 payment of stock dividends, recapitalization, or other similar
 transactions). (See Note 18.)&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In the event the Company
 is unable to meet certain requirements of the Registration Rights
 Agreement specifically related to the filing of the registration
 statement within specified periods, using its best efforts to
 obtain effectiveness of the registration statement, or maintaining
 the effectiveness of the registration statement, the Company will
 be required to pay additional damages to Deerfield. The additional
 damages are calculated as 1% of Deerfield&amp;#x2019;s original
 principal amount of the relevant tranche of 2019 notes and shall
 accrue until the earlier of (i)&amp;#xA0;the date on which the
 registration failure has been cured and (ii)&amp;#xA0;the date on which
 the shares issuable upon conversion may be disposed of by
 Deerfield.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In accordance with the
 accounting guidance contained in ASC 825-20, the contingent
 obligation to make future payments, or otherwise transfer
 consideration, under a registration payment arrangement should be
 recognized and measured in accordance with ASC 450-20. ASC 450-20
 requires an accrual to be recorded for a contingent payment if it
 is both probable of occurring and the amount of the payment can be
 reasonably estimated. As of December&amp;#xA0;31, 2013, the Company
 determined that it is not probable that it will be obligated to pay
 additional damages to Deerfield pursuant to the Registration Rights
 Agreement, and therefore no accrual for such contingent payment has
 been recorded.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Embedded
 Derivatives&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company identified
 and evaluated a number of embedded features in the notes issued
 under the Facility Agreement to determine if they represented
 embedded derivatives requiring bifurcation and separate accounting
 pursuant to ASC 815. In the Tranche 1 notes, we determined that the
 Contingent Prepayment Option and Tax Gross-Up features were
 embedded derivatives requiring bifurcation from the Tranche 1
 notes. These features were evaluated by the Company and deemed to
 have a de-minimus value. Based on our analysis of the Tranche
 2&amp;#xA0;notes, only one feature (the Tax Gross-Up) was required to
 be bifurcated. Similar to the conclusions reached in our analysis
 of the embedded features contained in the Tranche 1 notes, the Tax
 Gross-Up feature was deemed to have a de-minimus value. In
 analyzing the Tranche 3 notes, we identified four embedded features
 that required bifurcation and separate accounting and the Company
 determined that they should be bundled together as a single,
 compound embedded derivative, bifurcated from the host contract,
 and accounted for at fair value, with changes in fair value being
 recorded in the Statement of Operations. The four embedded
 derivatives contained in the Tranche 3 notes were the Conversion
 Option, Major Transaction Put Option, Acceleration upon a Legal
 Judgment Against the Company in Excess of $100,000, and Tax
 Gross-Up.&amp;#xA0;The four embedded features, discussed in detail
 below, were evaluated together as a single compound derivative to
 determine the fair value of the derivative with the exception of
 the Tax Gross-Up feature which was deemed to have a de-minimus
 value.&amp;#xA0;At the time of the issuance of Tranche 3, management
 determined that the value of these embedded derivatives at
 December&amp;#xA0;9, 2013, and at December&amp;#xA0;31, 2013 was
 immaterial.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Conversion
 Option&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); PADDING-BOTTOM: 0px; FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of December&amp;#xA0;31,
 2013, a portion of the 2019 notes was convertible into fully paid
 shares of the Company&amp;#x2019;s common stock from and after the
 11&lt;/font&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;sup style="VERTICAL-ALIGN: baseline; POSITION: relative; BOTTOM: 0.8ex"&gt;th&lt;/sup&gt;&lt;/font&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;trading
 day following the public release, by the Company, of the Phase III
 data for the Product and until the second business day immediately
 prior to the final payment date, at a conversion price equal to the
 volume weighted average price (&amp;#x201C;VWAP&amp;#x201D;) per share of the
 stock during the 20 trading days immediately preceding the
 Purchaser&amp;#x2019;s election to convert.&amp;#xA0;The number of
 Conversion Shares issuable upon a conversion shall be determined by
 dividing the Conversion Amount by the Conversion
 Price.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The number of shares
 issuable upon conversion of the 2019 notes was limited to the
 extent that Deerfield would otherwise acquire shares, that would
 cause the beneficial ownership of Deerfield and their affiliates to
 exceed 9.985% of the total number of shares of Common Stock then
 issued and outstanding.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The 2019 notes provided
 that Deerfield may exercise this conversion right for (i)&amp;#xA0;up
 to 12.0&amp;#xA0;million shares of stock if the Conversion Price is
 $3.33 per share or less, (ii)&amp;#xA0;up to 6.0&amp;#xA0;million shares of
 stock if the Conversion Price is $6.67 per share or more, and
 (iii)&amp;#xA0;up to $40.0 million of principal if the Conversion Price
 is between $3.33 and $6.67 per share (collectively, the
 &amp;#x201C;Applicable Limits&amp;#x201D;).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of December&amp;#xA0;31,
 2013, Deerfield had converted $6.5 million principal amount of the
 2019 notes to equity, resulting in an issuance of 1,293,224 shares
 of the Company&amp;#x2019;s common stock.&amp;#xA0;Upon the conversion, the
 principal balance of the notes were recorded in equity and the loss
 was recognized in the Statement of Operations for the difference
 between the principal amount of the notes converted and their
 carrying amount (which included unamortized discount and debt
 issuance costs).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Major Transaction Put
 Option&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Facility Agreement
 requires that the Company give Deerfield notice of a Major
 Transaction at least 20&amp;#xA0;days prior to the anticipated
 effective date for such transaction, or if the Company has
 outstanding any class of publicly traded securities, not later than
 2 business days following the public announcement thereof. Upon
 receiving such notice, if the successor entity does not meet the
 Qualification Criteria, then the Purchasers may exercise the put
 option, in their sole discretion, requiring the Company to repay
 the notes in full at an amount equal to the sum of the outstanding
 principal amount of the notes plus all interest accrued and unpaid
 on such date. Furthermore, in the event that the Purchaser
 exercises their rights under the Major Transaction Put Option, the
 obligations under the Milestone Agreement shall not
 terminate.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Acceleration upon a
 Legal Judgment Against the Company in Excess of
 $100,000&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Facility Agreement
 contains various events of default, including an event of default
 triggered in the event that a legal judgment is made against the
 Company in excess of $100,000, and the judgment remains unstayed on
 the appeal, undischarged, unbounded or undismissed for a period of
 90 days from the date of judgment. Upon the occurrence and during
 the continuance of an event of default, the note holders have the
 option to cause the outstanding principal amount of the 2019 notes
 plus all accrued and unpaid interest to become immediately due and
 payable.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 26px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Tax
 Gross-Up&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Facility Agreement
 requires that if the Company is required by law to deduct any tax
 from any amount payable under the Agreement or any other
 Transaction Document, then the sum payable shall be increased by as
 much as necessary to compensate for such deduction.&amp;#xA0;In
 addition, the Company will reimburse Deerfield for any future stamp
 or documentary taxes, or similar other charges or levies, incurred
 by Deerfield. The tax gross-up obligations do not apply to any
 payments under the Milestone Agreement.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_004D11A9-0D55-4B21-874C-4B5782970FB3_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(ii)&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Stock consideration&lt;/i&gt;.
 As of December&amp;#xA0;31, 2012, the Company satisfied the conditions
 of issuing 225,000 shares of its common stock on the Derivative
 Action. With respect to the Securities Action, the issuance of
 2,777,778 shares was initiated prior to year end and subsequently
 settled after year end. The Company concluded that the requirement
 to deliver these shares of common stock met the definition of a
 financial instrument representing a contingent forward contract in
 accordance with ASC 815 and that the forward contract met the
 criteria for equity classification, and further remeasurement
 through settlement was not required. The forward contract to issue
 shares settled on January&amp;#xA0;2, 2013, upon consummation of the
 delivery of these shares. The final fair values of the stock
 consideration are summarized in the following table:&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="52%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Closing&amp;#xA0;Price&lt;br /&gt;
 Per&amp;#xA0;Share&amp;#xA0;on&lt;br /&gt;
 Final&lt;br /&gt;
 Approval&lt;br /&gt;
 Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Final&amp;#xA0;Fair&amp;#xA0;Value&amp;#xA0;of&lt;br /&gt;
 Stock&lt;br /&gt;
 Consideration&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Derivative Action&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;225,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.94&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;436,500&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Securities Action&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,777,778&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2.18&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,055,556&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:2.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,002,778&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,492,056&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1_5">10.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_1_5">187986</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_45E40AD1-3025-465C-835D-D81453EC39EC_1_0">&lt;div&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="90%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Workforce&lt;br /&gt;
 Reduction&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restructuring Balance,
 February&amp;#xA0;10, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,659&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Cash payments&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(6,189&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Adjustment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(403&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restructuring Balance,
 December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;67&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Adjustment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(67&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restructuring Balance,
 December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_FA95A078-3DF5-469F-805E-05D102D0F893_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The following
 table summarizes information about stock options
 outstanding:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;br /&gt;
 per&amp;#xA0;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&lt;br /&gt;
 Value&amp;#xA0;($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at
 January&amp;#xA0;1, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;18,674,539&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.46&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4,867&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:2.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,919,900&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6.63&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:2.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(881,139&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2.60&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:2.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Forfeit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(287,374&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2.93&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:2.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expired&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(187,986&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10.65&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.35&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;40,972&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Vested and expected to vest
 at December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;23,533,436&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.35&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;40,972&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Exercisable at
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,358,495&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.36&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;22,126&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E226B533-DBE7-4233-B429-2D38E7D71D2E_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive
 Loss&lt;/i&gt; &amp;#x2014; Other comprehensive loss is recorded in accordance
 with ASC 220-10-45 &lt;i&gt;Comprehensive Income,&lt;/i&gt; which requires that
 all components of comprehensive loss be reported in the financial
 statements in the period in which they are recognized. Other
 comprehensive loss includes certain changes in stockholders&amp;#x2019;
 equity that are excluded from net income. Specifically, the Company
 includes unrealized gains and losses on its available-for-sale
 securities and cumulative translation gains and losses in other
 comprehensive loss.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_02EA77E7-6888-4037-82DB-A80FC2DA058D_1_4">3.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_3_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1_2">6.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_3_3">-0.043</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E7447A42-AD6B-4DFB-BE1D-F0FD9ACA909F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 unaudited selected quarterly financial data has been prepared on
 the same basis as the audited information and includes all
 adjustments necessary to present fairly the information set forth
 in the Company&amp;#x2019;s consolidated financial statements and notes
 herein. As a development stage enterprise, the Company has
 experienced fluctuations in its quarterly results related to the
 development of its lead product candidate, AFREZZA, and in its
 expansion of the product candidate portfolio. The Company expects
 these fluctuations to continue in the future. Due to these and
 other factors, the quarterly operating results are not indicative
 of the Company&amp;#x2019;s future performance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(38,173&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(42,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,781&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
 common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(38,173&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(42,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,781&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share
 applicable to common stockholders &amp;#x2014;&amp;#xA0;basic and
 diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.22&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per share
 applicable to common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;143,154&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;159,859&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;190,534&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;229,234&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(40,965&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,124&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(50,818&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(53,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
 common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(40,965&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,124&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(50,818&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(53,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share
 applicable to common stockholders &amp;#x2014; basic and
 diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per share
 applicable to common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;280,058&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;284,044&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;296,386&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;337,284&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_C517B714-FAD7-4AC0-96C8-34A11C866EF8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The provision
 for income taxes consists of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="73%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,643&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,540&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59,379&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,199&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,470&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 Allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(57,225&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(60,739&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66,849&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_A75E4CD7-B4F4-4704-89F7-70C304325F45_1_3">2861059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_0953181C-A646-4C88-B1DC-7C8AAB225396_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
 Taxes&lt;/i&gt; &amp;#x2014; The provisions for federal, foreign, state, and
 local income taxes are calculated on pre-tax income based on
 current tax law and include the cumulative effect of any changes in
 tax rates from those used previously in determining deferred tax
 assets and liabilities. Deferred income tax assets and liabilities
 are measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25 &lt;i&gt;Income Taxes,&lt;/i&gt; The Company believes that its income
 tax filing positions and deductions will be sustained on audit and
 does not anticipate any adjustments that will result in a material
 change to its financial position. Therefore, no liabilities for
 uncertain income tax positions have been recorded. If a tax
 position does not meet the minimum statutory threshold to avoid
 payment of penalties, the Company recognizes an expense for the
 amount of the penalty in the period the tax position is claimed in
 the tax return of the Company. The Company recognizes interest
 accrued related to unrecognized tax benefits in income tax expense,
 if any. Penalties, if probable and reasonably estimable, are
 recognized as a component of income tax expense.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against net deferred tax assets.
 Due to uncertainties related to the realization of the
 Company&amp;#x2019;s deferred tax assets as a result of its history of
 operating losses, a valuation allowance has been established
 against the gross deferred tax asset balance. The valuation
 allowance is based on management&amp;#x2019;s estimates of taxable
 income by jurisdiction in which the Company operates and the period
 over which deferred tax assets will be recoverable. In the event
 that actual results differ from these estimates or the Company
 adjusts these estimates in future periods, a change in the
 valuation allowance may be needed, which could materially impact
 the Company&amp;#x2019;s financial position and results of
 operations.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ScheduleOfDebtTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_6FB037FB-A6C1-4BE9-8F8D-05A6D2AEDE9B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The components
 of the Facility Agreement recorded as of December&amp;#xA0;31, 2013
 consist of the following (in&amp;#xA0;thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="88%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2019
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;120,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal converted to
 equity&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(6,500&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Debt discount-net of
 amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unaccreted debt issuance
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net carrying amount of
 facility financing agreement&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102,300&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s Facility Agreement principal repayment schedule is
 comprised of payments beginning on the third anniversary of each
 issued tranche, totaling $28,375,000 annually, commencing on
 July&amp;#xA0;1, 2016 and ending on December&amp;#xA0;9, 2019, for a total
 amount of $113,500,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="91%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Milestone
 rights&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Initial milestone rights
 fair value&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,276&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Debt discount-net of
 amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unaccreted debt issuance
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(61&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less current portion of
 milestone rights included in other current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,151&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net carrying amount
 included in other liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,013&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Commitment
 Asset&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Initial commitment asset
 fair value&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,393&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less Tranche 2 portion of
 commitment asset&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,656&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less Tranche 3 portion of
 commitment asset&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4,580&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Commitment asset value
 included in other assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,157&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_7F1A8AF1-824F-49BA-B944-CBC6CFD11603_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information about the Company&amp;#x2019;s stock-based
 award plans as of December&amp;#xA0;31, 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Restricted&lt;br /&gt;
 Stock Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&amp;#xA0;Available&lt;br /&gt;
 for&lt;br /&gt;
 Future Issuance&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,792,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,949,202&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,754,325&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,166,619&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,590,564&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;690,831&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,590,564&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D99971E8-9AAD-4BC7-9337-4148B9C39394_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;9. Fair Value of
 Financial Instruments&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The carrying
 amounts of financial instruments, which include cash equivalents
 and accounts payable, approximate their fair values due to their
 relatively short maturities. The fair value of the note payable to
 our principal stockholder cannot be reasonably estimated as the
 Company would not be able to obtain a similar credit arrangement in
 the current economic environment.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash
 equivalents consist of highly liquid investments with original or
 remaining maturities of 90 days or less at the time of purchase
 that are readily convertible into cash. As of December&amp;#xA0;31,
 2012 and 2013, the Company held $61.8 million and $70.8 million,
 respectively of cash and cash equivalents, consisting of money
 market funds of $60.8 million and $67.7 million, respectively, and
 the remaining funds in non-interest bearing checking accounts. The
 fair value of these money market funds was determined by using
 quoted prices for identical investments in an active market (Level
 1 in the fair value hierarchy).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 is a summary of the carrying values and estimated fair values of
 the Company&amp;#x2019;s senior convertible notes due in 2013 and 2015
 and the facility financing obligation due in 2019 (in
 millions).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;81.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2015 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;97.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;63.2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;98.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102.2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2019 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;107.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Senior
 convertible notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The senior
 convertible notes due 2013 were paid in full in December,
 consequently, they had a balance of $0. The estimated fair value of
 the 2013 notes was calculated based on quoted prices in an active
 market (Level 1 in the fair value hierarchy). The estimated fair
 value of the senior convertible notes due 2015 was calculated based
 on model derived valuations whose inputs were observable, such as
 the Company&amp;#x2019;s stock price, and &lt;font style="WHITE-SPACE: nowrap"&gt;non-observable,&lt;/font&gt; such as the
 Company&amp;#x2019;s long-term historical volatility, which was
 estimated to be 65% (Level&amp;#xA0;3 in the fair value hierarchy). As
 there is no current observable market for the senior convertible
 notes due 2015, the Company determined the estimated fair value
 using a convertible bond valuation model within a lattice
 framework. The convertible bond valuation model combined expected
 cash outflows with market-based assumptions regarding risk-adjusted
 yields, stock price volatility and recent price quotes and trading
 information regarding Company issued debt instruments and shares of
 common stock into which the notes are convertible.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Facility
 financing agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As discussed in
 Note 16 &amp;#x2014; Facility financing agreement, in connection with
 the Facility Agreement, the Company issued 2019 notes and Milestone
 Rights and recorded the Commitment Asset on July&amp;#xA0;1, 2013. As
 there is no current observable market for the 2019 notes, the
 Company determined the estimated fair value using a bond valuation
 model based on a discounted cash flow methodology. The bond
 valuation model combined expected cash flows associated with
 principal repayment and interest based on the contractual terms of
 the debt agreement discounted to present value using a selected
 market discount rate of 12.4% (Level 3 in the fair value
 hierarchy). On December&amp;#xA0;31, 2013, the market discount rate was
 12.7%. The estimated fair value of the Milestone Rights was
 calculated using the income approach in which the cash flows
 associated with the specified contractual payments were adjusted
 for both the expected timing and the probability of achieving the
 milestones discounted to present value using a selected market
 discount rate (Level 3 in the fair value hierarchy). The expected
 timing and probability of achieving the milestones, starting in
 2014, was developed with consideration given to both internal data,
 such as progress made to date and assessment of criteria required
 for achievement, and external data, such as market research
 studies. The discount rate (17.5%)&amp;#xA0;was selected based on an
 estimation of required rate of returns for similar investment
 opportunities using available market data. The fair value of the
 Commitment Asset was estimated using the income approach by
 estimating the fair value of the future tranches using a market
 debt rate (12%)&amp;#xA0;commensurate with the risk of the future
 tranches and the fair value of the cash expected to be received by
 the Company and assessing the probability of the commitments being
 funded in the future based on the operational hurdles required for
 funding being met (Level 3 in the fair value hierarchy). At
 December&amp;#xA0;31, 2013, the carrying value of the Milestone Rights
 and Commitment Asset approximates their respective estimated fair
 values.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Derivatives&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Four embedded
 features that required bifurcation and separate accounting were
 identified in the facility financing obligation and the Company
 determined should be bundled together as a single, compound
 embedded derivative, bifurcated from the host contract, and
 accounted for at fair value, with changes in fair value being
 recorded in the Statement of Operations. The four embedded
 derivatives contained in the facility financing obligation were the
 Conversion Option, Major Transaction Put Option, Acceleration upon
 a Legal Judgment Against the Company in Excess of $100,000, and Tax
 Gross-Up.&amp;#xA0;The four embedded features were evaluated together
 as a single compound derivative to determine the fair value of the
 derivative.&amp;#xA0;The estimated fair value of the embedded
 derivative was calculated using Level 3 inputs and by applying a
 cumulative probability percentage to the values derived from a
 Black-Karasinski lattice model for the major transaction put option
 (0.8%), the conversion option feature (0.0%), and the acceleration
 upon a legal judgment against the Company in excess of $100,000
 feature (0.1%). The Tax Gross-Up feature was evaluated using a
 Level 2 analysis based on the withholding requirements (i.e., the
 tax laws) on interest payments between the US and the British
 Virgin Islands and was determined to be de-minimus. As of
 December&amp;#xA0;9, 2013 and December&amp;#xA0;31, 2013, management
 determined the impact of the valuation of the embedded derivative
 was immaterial (see Note 16).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
 of foreign exchange hedging contracts equals the carrying value at
 each balance sheet date. The fair value of these contracts was
 determined using methodologies based on market observable inputs
 (Level 2 in the fair value hierarchy), including foreign currency
 spot rates. The Company used derivative financial instruments to
 manage its exposure to foreign currency exchange risks related to
 quarterly purchases on insulin. The Company does not use derivative
 financial instruments for trading or speculative purposes, nor does
 it use leveraged financial instruments. Credit risk related to
 derivative financial instruments was considered minimal and was
 managed by requiring high credit standards for counterparties and
 through periodic settlements of positions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 entered into foreign exchange hedging contracts with notional
 amounts totaling $25.5 million and zero at December&amp;#xA0;31, 2010
 and 2011, respectively. The Company recorded an unrealized loss on
 the foreign exchange hedging contracts of $0.2 million at
 December&amp;#xA0;31, 2010. The Company recorded a realized loss of
 $1.6&amp;#xA0;million and a realized gain of $1.3 million for the years
 ended December&amp;#xA0;31, 2010 and 2011, respectively, on the
 execution of quarterly foreign exchange hedging contracts. The
 Company terminated these contracts during the quarter ended
 March&amp;#xA0;31, 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s derivative financial instruments are not designated
 as hedging instruments, and gains or losses resulting from changes
 in the fair value are reported in other income (expense), in the
 consolidated statements of operations. Derivative financial
 instruments are recognized as other assets or other current
 liabilities in the financial statements and measured at fair
 value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The estimated
 fair values in connection with the February 2012 The Mann Group
 Common Stock Purchase Agreement (&amp;#x201C;The February 2012 Forward
 Purchase Contract&amp;#x201D;) and the October 2012 The Mann Group
 Common Stock and Warrant Purchase Agreement (&amp;#x201C;The October
 2012 Forward Purchase Contract&amp;#x201D;) was based on forward
 purchase contract valuations (Level 3 in the fair value hierarchy)
 (see Note 10).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 roll-forward provides a summary of the changes in fair value of the
 Company&amp;#x2019;s Level 3 forward purchase contracts during the year
 ended December&amp;#xA0;31, 2012 (in thousands) :&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="61%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;The&amp;#xA0;February&amp;#xA0;2012&lt;br /&gt;
 Forward Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;The&amp;#xA0;October&amp;#xA0;2012&lt;br /&gt;
 Forward&amp;#xA0;Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Beginning
 Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Issuance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;28,237&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;29,317&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Adjustments to fair value
 included in other income (expense)&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;12,011&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(13,248&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,237&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Transfers to additional
 paid-in-capital&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(13,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(14,989&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(28,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Ending Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_3_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_607FC521-E784-4A58-A5AF-D1AACE067E6A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the three and twelve months ended
 December&amp;#xA0;31, 2013 are as follows (in thousands).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Three&amp;#xA0;months&amp;#xA0;ended&lt;br /&gt;
 December&amp;#xA0;31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Twelve&amp;#xA0;months&amp;#xA0;ended&lt;br /&gt;
 December&amp;#xA0;31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion expense- debt
 issuance cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion expense- debt
 discount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;923&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
  <us-gaap:ReceivablesPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E527E762-C31F-4729-A52D-92B8E1289C93_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;State
 Research and Development Credit Exchange Receivable&lt;/i&gt; &amp;#x2014; The
 State of Connecticut provides certain companies with the
 opportunity to exchange certain research and development income tax
 credit carryforwards for cash in exchange for foregoing the
 carryforward of the research and development credits. The program
 provides for an exchange of research and development income tax
 credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_02EA77E7-6888-4037-82DB-A80FC2DA058D_1_3">3.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_B1492F14-DCE9-4E39-8C9B-F91D5D3E08DD_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;to estimate the
 number of stock option awards that will eventually vest. The
 Company calculated the fair value of employee stock options granted
 during the years ended December&amp;#xA0;31, 2011, 2012 and 2013 using
 the following assumptions:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0.10%&amp;#xA0;&amp;#x2014;&amp;#xA0;2.43%&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0.32%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.16%&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0.94%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.82%&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expected lives&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.1&amp;#xA0;&amp;#x2014;&amp;#xA0;6.1
 years&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.4&amp;#xA0;&amp;#x2014;&amp;#xA0;6.1
 years&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2.64&amp;#xA0;&amp;#x2014;&amp;#xA0;5.77&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;76%&amp;#xA0;&amp;#x2014;&amp;#xA0;83%&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;70%&amp;#xA0;&amp;#x2014;&amp;#xA0;84%&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;75.83%&amp;#xA0;&amp;#x2014;&amp;#xA0;86.26%&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_CC35F2C3-1E70-42E5-A1E4-945BAB18A313_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Principles
 of Consolidation&lt;/i&gt; &amp;#x2014; The consolidated financial statements
 include the accounts of the Company and its wholly-owned
 subsidiaries.&amp;#xA0;Intercompany balances and transactions have been
 eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_3586A76F-CFD1-483C-9327-78B4A7041182_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Restructuring Charges&lt;/i&gt;&amp;#x2014; The Company made estimates
 and judgments regarding the amount and timing of our restructuring
 expense and liability, including current and future period
 termination benefits, lease termination costs, and other exit costs
 to be incurred when related actions take place. We have also
 assessed the recoverability of certain long-lived assets employed
 in the business and, in certain instances shortened the expected
 useful life of the assets based on changes in their expected use.
 When we determine that the useful lives of assets are shorter than
 we had originally estimated, we record additional depreciation to
 reflect the assets&amp;#x2019; new shorter useful lives. Severance and
 other related costs and asset-related charges are reflected within
 our consolidated statement of operations as a component of total
 restructuring charges incurred. Actual results may differ from
 these estimates.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E327A356-CD64-473B-854E-5ABE1A0BA446_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;17. Selected quarterly
 financial data (unaudited)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 unaudited selected quarterly financial data has been prepared on
 the same basis as the audited information and includes all
 adjustments necessary to present fairly the information set forth
 in the Company&amp;#x2019;s consolidated financial statements and notes
 herein. As a development stage enterprise, the Company has
 experienced fluctuations in its quarterly results related to the
 development of its lead product candidate, AFREZZA, and in its
 expansion of the product candidate portfolio. The Company expects
 these fluctuations to continue in the future. Due to these and
 other factors, the quarterly operating results are not indicative
 of the Company&amp;#x2019;s future performance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(38,173&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(42,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,781&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
 common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(38,173&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(42,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,781&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share
 applicable to common stockholders &amp;#x2014;&amp;#xA0;basic and
 diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.22&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per share
 applicable to common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;143,154&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;159,859&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;190,534&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;229,234&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(40,965&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,124&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(50,818&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(53,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
 common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(40,965&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,124&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(50,818&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(53,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share
 applicable to common stockholders &amp;#x2014; basic and
 diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per share
 applicable to common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;280,058&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;284,044&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;296,386&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;337,284&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_66628B43-39B8-46E6-B508-E6ECAE236C22_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Salary and related
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10,074&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,193&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and clinical trial
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,995&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,311&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4,533&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,082&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,878&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;342&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,297&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,706&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses and other
 current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;25,777&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,634&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_3_4">-0.307</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_1_6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_3CD42164-2BA3-481C-86D3-94F546681EE9_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;5. Accrued expenses and
 other current liabilities&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Salary and related
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10,074&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,193&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and clinical trial
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,995&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,311&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4,533&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,082&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,878&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;342&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,297&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,706&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses and other
 current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;25,777&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,634&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:LongTermDebtTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_63CB2AE7-643F-4A06-8305-BC072557E7A2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;7. Senior convertible
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Senior
 convertible notes consist of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2013
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;115,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(557&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,443&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2015
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,417&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,561&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;97,583&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;98,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Senior convertible
 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;212,026&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;98,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;18, 2010, the Company completed a Rule 144A offering of
 $100.0 million aggregate principal amount of 5.75% Senior
 Convertible Notes due 2015 (the &amp;#x201C;2015 notes&amp;#x201D;). The 2015
 notes are governed by the terms of an indenture dated as of
 August&amp;#xA0;24, 2010 (the &amp;#x201C;2015 Note Indenture&amp;#x201D;). The
 2015 notes bear interest at the rate of 5.75%&amp;#xA0;per year on the
 principal amount, payable in cash semi-annually in arrears on
 February&amp;#xA0;15 and August&amp;#xA0;15 of each year, beginning
 February&amp;#xA0;15, 2011. The Company had accrued interest of $2.2
 million and $2.4 million as of December&amp;#xA0;31, 2012 and 2013,
 respectively, related to the 2015 notes. The 2015 notes are
 general, unsecured, senior obligations of the Company and
 effectively rank junior in right of payment to all of the
 Company&amp;#x2019;s secured debt, to the extent of the value of the
 assets securing such debt, and to the debt and all other
 liabilities of the Company&amp;#x2019;s subsidiaries. The maturity date
 of the 2015 notes is August&amp;#xA0;15, 2015 and payment is due in
 full on that date for unconverted securities. Holders of the 2015
 notes may convert, at any time prior to the close of business on
 the business day immediately preceding the stated maturity date,
 any outstanding principal into shares of the Company&amp;#x2019;s common
 stock at an initial conversion rate of 147.0859 shares per $1,000
 principal amount, which is equal to a conversion price of
 approximately $6.80 per share, subject to adjustment. Except in
 certain circumstances, if the Company undergoes a fundamental
 change: (1)&amp;#xA0;the Company will pay a make-whole premium on the
 2015 notes converted in connection with a fundamental change by
 increasing the conversion rate on such Notes, which amount, if any,
 will be based on the Company&amp;#x2019;s common stock price and the
 effective date of the fundamental change, and (2)&amp;#xA0;each holder
 of 2015 notes will have the option to require the Company to
 repurchase all or any portion of such holder&amp;#x2019;s notes at a
 repurchase price of 100% of the principal amount of the notes to be
 repurchased plus accrued and unpaid interest, if any. The Company
 may elect to redeem some or all of the 2015 notes if the closing
 stock price has equaled 150% of the conversion price for at least
 20 of the 30 consecutive trading days ending on the trading day
 before the Company&amp;#x2019;s redemption notice. The redemption price
 will equal 100% of the principal amount of the 2015 notes to be
 redeemed, plus accrued and unpaid interest, if any, to, but
 excluding, the redemption date, plus a make-whole payment equal to
 the sum of the present values of the remaining scheduled interest
 payments through and including August&amp;#xA0;15, 2015 (other than
 interest accrued up to, but excluding, the redemption date). The
 Company will be obligated to make the make-whole payment on all the
 2015 notes called for redemption and converted during the period
 from the date the Company mailed the notice of redemption to and
 including the redemption date. The Company may elect to make the
 make-whole payment in cash or shares of its common stock, subject
 to certain limitations. Under the terms of the 2015 Note Indenture,
 the conversion option can be net-share settled and the maximum
 number of shares that could be required to be delivered under the
 contract, including the make-whole shares, is fixed and less than
 the number of authorized and unissued shares less the maximum
 number of shares that could be required to be delivered during the
 contract period under existing commitments. Applying the
 Company&amp;#x2019;s sequencing policy, the Company performed an
 analysis at the time of the offering of the 2015 notes and each
 reporting date since and concluded that the number of available
 authorized shares at the time of the offering and each subsequent
 reporting date was sufficient to deliver the number of shares that
 could be required to be delivered during the contract period under
 existing commitments.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 incurred approximately $4.2 million in issuance costs which are
 recorded as an offset to the 2015 notes in the accompanying
 condensed consolidated balance sheets. These costs are being
 charged to interest expense using the effective interest method
 over the term of the 2015 notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The 2015 notes
 contain provisions that upon an acceleration of certain
 indebtedness, which would include the 2019 notes described in Note
 16, that the holders may elect to accelerate the Company&amp;#x2019;s
 repayment obligations under the notes if such acceleration is not
 cured, waived, rescinded or annulled. There can be no assurance
 that the holders would not choose to exercise these rights in the
 event such events were to occur.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 December&amp;#xA0;12, 2006, the Company completed an offering of $115.0
 million aggregate principal amount of 3.75% 2013 notes, including
 $15.0 million aggregate principal amount of the 2013 notes sold
 pursuant to the underwriters&amp;#x2019; over-allotment option that was
 exercised in full. The 2013 notes are governed by the terms of an
 indenture dated as of November&amp;#xA0;1, 2006 and a First
 Supplemental Indenture, dated as of December&amp;#xA0;12, 2006 (the
 &amp;#x201C;2013 Note Indenture&amp;#x201D;). The 2013 notes bear interest at
 the rate of 3.75%&amp;#xA0;per year on the principal amount, payable in
 cash semi-annually in arrears on June&amp;#xA0;15 and December&amp;#xA0;15
 of each year, beginning June&amp;#xA0;15, 2007. The Company had accrued
 interest of $192,000 and $0 as of December&amp;#xA0;31, 2012 and
 December&amp;#xA0;31, 2013, respectively. The 2013 notes are general,
 unsecured, senior obligations of the Company and effectively rank
 junior in right of payment to all of the Company&amp;#x2019;s secured
 debt, to the extent of the value of the assets securing such debt,
 and to the debt and all other liabilities of the Company. Holders
 may convert, at any time prior to the close of business on the
 business day immediately preceding the stated maturity date, any
 outstanding 2013 notes into shares of the Company&amp;#x2019;s common
 stock at an initial conversion rate of 44.5002 shares per $1,000
 principal amount of 2013 notes, which is equal to a conversion
 price of approximately $22.47 per share, subject to adjustment.
 Except in certain circumstances, if the Company undergoes a
 fundamental change: (1)&amp;#xA0;the Company will pay a make-whole
 premium on the 2013 notes converted in connection with a
 fundamental change by increasing the conversion rate on such 2013
 notes, which amount, if any, will be based on the Company&amp;#x2019;s
 common stock price and the effective date of the fundamental
 change, and (2)&amp;#xA0;each holder of the 2013 notes will have the
 option to require the Company to repurchase all or any portion of
 such holder&amp;#x2019;s 2013 notes at a repurchase price of 100% of the
 principal amount of the 2013 notes to be repurchased plus accrued
 and unpaid interest, if any. Under the terms of the 2013 Note
 Indenture, the conversion option can be net-share settled and the
 maximum number of shares that could be required to be delivered
 under the contract, including the &lt;font style="WHITE-SPACE: nowrap"&gt;make-whole&lt;/font&gt; shares, is fixed and less
 than the number of authorized and unissued shares less the maximum
 number of shares that could be required to be delivered during the
 contract period under existing commitments. Applying the
 Company&amp;#x2019;s sequencing policy, the Company performed an
 analysis at the time of the offering of the 2013 notes and each
 reporting date since and concluded that the number of available
 authorized shares at the time of the offering and each subsequent
 reporting date was sufficient to deliver the number of shares that
 could be required to be delivered during the contract period under
 existing commitments. On December&amp;#xA0;15, 2013,&amp;#xA0;per the
 agreement, the Company paid $115.0 million on the notes, thus
 settling the debt.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 incurred approximately $3.7 million in debt issuance costs which
 were recorded as an offset to the debt in the accompanying balance
 sheet. These costs were fully accreted as of December&amp;#xA0;31,
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion of
 debt issuance expense in connection with the notes offerings during
 the years ended December&amp;#xA0;31, 2011, 2012, and 2013 were $1.3
 million, $1.4 million, and $1.4 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:InterestExpensePolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_13B30196-DD74-44A7-94F2-E5C5264C93C2_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Interest
 Expense&lt;/i&gt; &amp;#x2014; Interest costs are expensed as incurred, except
 to the extent such interest is related to construction in progress,
 in which case interest is capitalized. Interest expense, net of
 interest capitalized, for the years ended December&amp;#xA0;31, 2011,
 2012 and 2013 was $21.8 million, $21.6 million and $21.5 million,
 respectively. Interest costs capitalized for the years ended
 December&amp;#xA0;31, 2011, 2012, and 2013 were $0.4 million, $0.3
 million, and $0.4 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:InterestExpensePolicyTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_958AD5D8-6D78-4035-BEB5-E7A49201C8CC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Goodwill and
 Identifiable Intangibles&lt;/i&gt; &amp;#x2014; As a result of the merger with
 AlleCure and CTL on December&amp;#xA0;12, 2001, as described in Note 1,
 goodwill of $151.4 million was recorded at the entity level in
 2001. Upon adoption of ASC 350-10 &lt;i&gt;Intangibles- Goodwill and
 Other,&lt;/i&gt; the Company adopted a policy of testing goodwill and
 intangible assets with indefinite lives for impairment at least
 annually, as of December&amp;#xA0;31, with any related impairment
 losses being recognized in earnings when identified. In December
 2002 the Company concluded that the major AlleCure product
 development program should be terminated and that the clinical
 trials of the CTL product should be halted and returned to the
 research stage. As a result of this determination, the Company
 closed the CTL facility and reduced headcount for AlleCure and CTL
 by approximately 50%. In connection with the annual test for
 impairment of goodwill as of December&amp;#xA0;31, 2002, the Company
 determined that on the basis of the internal study, the goodwill
 recorded for the AlleCure and CTL units was potentially impaired.
 The Company performed the second step of the annual impairment test
 as of December&amp;#xA0;31, 2002 for each of the potentially impaired
 reporting units and estimated the fair value of the AlleCure and
 CTL programs using the expected present value of future cash flows
 which were expected to be negligible. Accordingly, the goodwill
 balance of $151.4 million was determined to be fully impaired and
 an impairment loss was recorded in 2002. Subsequent to
 December&amp;#xA0;31, 2002, the Company had no goodwill or intangibles
 with indefinite lives included on its balance sheets.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <us-gaap:FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_2175A030-D1D8-488C-A46A-1BD1E34983F1_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The following
 roll-forward provides a summary of the changes in fair value of the
 Company&amp;#x2019;s Level 3 forward purchase contracts during the year
 ended December&amp;#xA0;31, 2012 (in thousands) :&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="61%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;The&amp;#xA0;February&amp;#xA0;2012&lt;br /&gt;
 Forward Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;The&amp;#xA0;October&amp;#xA0;2012&lt;br /&gt;
 Forward&amp;#xA0;Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Beginning Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Issuance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,080&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;28,237&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;29,317&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Adjustments to fair value
 included in other income (expense)&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,011&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(13,248&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,237&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Transfers to additional
 paid-in-capital&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(13,091&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(14,989&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(28,080&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Ending Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_8E2D0D48-AF6A-43B1-8AC0-D6A18F63F663_3_0">3.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_087ECEB1-F788-45FC-8B85-E014B4BB96CC_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;8. Restructuring
 charges&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;10, 2011, the Company announced that following
 receipt of the Complete Response letter from the United States Food
 and Drug Administration regarding the new drug application for
 AFREZZA, it implemented a restructuring to streamline operations,
 reduce operating expenses, extend the cash runway and focus its
 resources on securing the FDA&amp;#x2019;s approval of the NDA for
 AFREZZA. In connection with the restructuring, the Company reduced
 its total workforce by approximately 41% to 257 employees. The
 Company recorded charges of approximately $6.7 million for employee
 severance and other related termination benefits and recognized an
 initial liability of $6.7 million in February 2011, which
 approximated fair value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="90%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Workforce&lt;br /&gt;
 Reduction&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restructuring Balance,
 February&amp;#xA0;10, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,659&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Cash payments&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(6,189&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Adjustment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(403&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restructuring Balance,
 December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;67&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Adjustment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(67&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restructuring Balance,
 December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;During the year
 ended December&amp;#xA0;31, 2011, the Company adjusted the
 restructuring balance based on the election of certain termination
 benefits by a portion of the terminated employees.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The remaining
 restructuring balance as of December&amp;#xA0;31, 2011 consists of
 severance and related termination benefits for employees still to
 be terminated.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The net $6.3
 million of costs associated with the restructuring are included in
 &amp;#x201C;Research and development&amp;#x201D; and &amp;#x201C;General and
 administrative&amp;#x201D; operating expenses in the consolidated
 statements of operations as $4.7 million and $1.6 million,
 respectively, for the year ended December&amp;#xA0;31, 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_CDF519D2-E914-4944-8A3E-B6238F246CA2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
 Equipment&lt;/i&gt; &amp;#x2014; Property and equipment are recorded at cost
 and depreciated using the &lt;font style="WHITE-SPACE: nowrap"&gt;straight-line&lt;/font&gt; method over the
 estimated useful lives of the related assets. Leasehold
 improvements are amortized over the term of the lease or the
 service lives of the improvements, whichever is shorter.
 Maintenance and repairs are expensed as incurred. Assets under
 construction are not depreciated until placed into
 service.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" xsi:nil="true" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_3_6" />
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_02DE6B88-4592-4930-921C-6068210C52AF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
 Cash Equivalents&lt;/i&gt; &amp;#x2014; The Company considers all highly
 liquid investments with original or remaining maturities of 90 days
 or less at the time of purchase, that are readily convertible into
 cash to be cash equivalents. As of&amp;#xA0;December&amp;#xA0;31,
 2012&amp;#xA0;and&amp;#xA0;2013, cash equivalents were comprised of cash
 and money market accounts with maturities less than 90 days from
 the date of purchase.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_22">-128732000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_7D70CAC4-4486-4B91-B1D6-E31B1B0FEE6A_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Employee-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;11,202&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,224&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,181&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Consultant-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;68&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;11,204&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
  <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_882D6113-9579-4607-B0FA-FC422C318256_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Contingencies&lt;/i&gt; &amp;#x2014; Contingencies are recorded in
 accordance with ASC 450 &lt;i&gt;Contingencies.&lt;/i&gt; Accordingly, the
 Company records a loss contingency for a liability when it is both
 probable that a liability has been incurred and the amount of the
 loss can be reasonably estimated. These accruals represent
 management&amp;#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure.&amp;#xA0;Significant judgment is
 required in both the determination of probability and the
 determination as to whether an exposure is reasonably estimable.
 Because of uncertainties related to these matters, accruals are
 based only on the best information available at the time. As
 additional information becomes available, the Company reassesses
 the potential liability related to pending claims and litigation
 and may revise our estimates. These revisions in the estimates of
 the potential liabilities could have a material impact on our
 consolidated results of operations and financial
 position.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_C79412AB-98B6-4D50-AF16-8E5DE24CF8E6_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;14. Employee benefit
 plans&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 administers a 401(k) Savings Retirement Plan (the &amp;#x201C;MannKind
 Retirement Plan&amp;#x201D;) for its employees. For the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013, the Company contributed
 $777,000, $571,000 and $533,000 respectively, to the MannKind
 Retirement Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_0270712F-1ED0-46B3-9A4C-3D16F4CE41A1_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;11. Net loss per common
 share&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic net loss
 per share excludes dilution for potentially dilutive securities and
 is computed by dividing loss applicable to common stockholders by
 the weighted average number of common shares outstanding during the
 period excluding the shares loaned under the share lending
 arrangement (see Note 10). As of December&amp;#xA0;31, 2011, 2012 and
 2013, 9,000,000 shares of the Company&amp;#x2019;s common stock, which
 were loaned to a share borrower pursuant to the terms of a share
 lending agreement, as described in Note&amp;#xA0;10, were issued and
 are outstanding, and holders of the borrowed shares have all the
 rights of a holder of the Company&amp;#x2019;s common stock. However,
 because the share borrower must return all borrowed shares to the
 Company (or, in certain circumstances, the cash value thereof), the
 borrowed shares are not considered outstanding for the purpose of
 computing and reporting basic or diluted earnings (loss) per share.
 Diluted net loss per share reflects the potential dilution that
 could occur if securities or other contracts to issue common stock
 were exercised or converted into common stock. Potentially dilutive
 securities are excluded from the computation of diluted net loss
 per share for all of the periods presented in the accompanying
 statements of operations because the reported net loss in each of
 these periods results in their inclusion being antidilutive.
 Antidilutive securities, which consist of stock options, restricted
 stock units, warrants, and shares that could be issued upon
 conversion of the 2015 senior convertible notes and the 2019 notes,
 that are not included in the diluted net loss per share calculation
 exclude the 9,000,000&amp;#xA0;shares of the Company&amp;#x2019;s common
 stock loaned under the share lending arrangement as of
 December&amp;#xA0;31, 2012 and 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
 dilutive securities outstanding are summarized as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10,082,351&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;18,674,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Conversion of senior
 convertible notes into common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,826,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,826,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,415,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;86,062,440&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,706,240&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vesting of restricted stock
 units&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,140,388&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,761,031&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34,048,852&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;128,324,123&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,475,367&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_1_3">881139</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D0BE26AB-7287-4D00-AE70-6C73790D3B5A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt; &amp;#x2014; Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_61514532-026B-47BB-96BD-F98B05680243_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;6. Related-party
 arrangements&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
 2007, the Company entered into a $350.0 million loan arrangement
 (the &amp;#x201C;Loan Arrangement&amp;#x201D;) with its principal
 stockholder. The Loan Arrangement has been amended from time to
 time. In February 2009, the promissory note underlying the Loan
 Arrangement was revised as a result of the principal stockholder
 being licensed as a finance lender under the California Finance
 Lenders Law. Accordingly, the lender was revised to The Mann Group.
 Until January&amp;#xA0;1, 2013, interest on outstanding principal
 amounts accrued at a fixed rate equal to the one-year LIBOR rate as
 reported by the &lt;i&gt;Wall Street Journal&lt;/i&gt; on the date of such
 advance plus 3%&amp;#xA0;per annum. Based on the amended terms of the
 agreement, the rate was fixed at 5.84% going forward. On
 October&amp;#xA0;31, 2013, the promissory note was further amended to,
 among other things, extend the maturity date of the loan to
 January&amp;#xA0;5, 2020, extend the date through which the Company can
 borrow under the Loan Arrangement to December&amp;#xA0;31, 2019,
 increase the aggregate borrowing amount under the Loan Arrangement
 from $350.0 million to $370.0 million, provide that repayments or
 cancellations of principal under the Loan Arrangement will not be
 available for reborrowing, and to cancel $78.0 million of principal
 indebtedness under the Loan Arrangement as payment for the
 aggregate exercise price of warrants, in accordance with the Common
 Stock and Warrant Purchase Agreement entered into with The Mann
 Group on October&amp;#xA0;18, 2012 (the &amp;#x201C;Mann Group
 Warrants&amp;#x201D;). The note payable to our principal stockholder is
 excluded from current liabilities due to the amendment on
 October&amp;#xA0;31, 2013 and presented as a non-current liability as
 of December&amp;#xA0;31, 2013. In addition, the Company and The Mann
 Group agreed to capitalize into principal $7.9&amp;#xA0;million of
 accrued interest that became due and payable upon cancellation of
 the $78.0 million of principal indebtedness.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2013, the total principal amount outstanding
 under the Loan Arrangement was $49.5&amp;#xA0;million, and the amount
 available for future borrowings was $30.1 million. Interest is due
 and payable quarterly in arrears on&amp;#xA0;the first day of each
 calendar quarter for the preceding quarter, or at such other time
 as the Company and The Mann Group mutually agree. All or any
 portion of accrued and unpaid interest that becomes due and payable
 may be paid-in-kind and capitalized as additional borrowings at any
 time and would be classified as non-current upon mutual agreement
 of both parties. The Mann Group can require us to prepay up to
 $200.0 million in advances that have been outstanding for at least
 12 months (less approximately $105.0 million aggregate principal
 amount that has been cancelled in connection with two common stock
 purchase agreements &amp;#x2014; a Common Stock Purchase Agreement
 between us and The Mann Group dated August 2010 and The Mann Group
 Common Stock Purchase Agreement). If The Mann Group exercises this
 right, the Company will have 90 days after The Mann Group provides
 written notice (or the number of days to maturity of the note if
 less than 90&amp;#xA0;days) to prepay such advances. Subject to the
 foregoing, in the event of a default under our loan arrangement
 with The Mann Group, all unpaid principal and interest either
 becomes immediately due and payable or may be accelerated at The
 Mann Group&amp;#x2019;s option, and the interest rate will increase to
 the one-year LIBOR rate calculated on the date of the initial
 advance or in effect on the date of default, whichever is greater,
 plus 5%&amp;#xA0;per annum. All borrowings under the Loan Arrangement
 are unsecured. The Loan Arrangement contains no financial
 covenants. There are no warrants associated with the Loan
 Arrangement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2010,
 the Company entered into a letter agreement confirming a previous
 commitment by The Mann Group to not require the Company to prepay
 amounts outstanding under the amended and restated promissory note,
 if the prepayment would require the Company to use its working
 capital resources. In addition, The Mann Group entered into a
 subordination agreement with Deerfield pursuant to which The Mann
 Group agreed with Deerfield not to demand or accept any payment
 under the Loan Arrangement until the Company&amp;#x2019;s payment
 obligations to Deerfield under the Facility Agreement have been
 satisfied in full.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;10, 2010, the Company entered into a common stock
 purchase agreement with The Mann Group. Under this common stock
 purchase agreement, the Company was required to issue and sell, and
 The Mann Group was obligated to purchase, the same number of shares
 of the Company&amp;#x2019;s common stock that Seaside 88, LP
 (&amp;#x201C;Seaside&amp;#x201D;) purchased on each closing date under its
 agreement with the Company. The price of the shares that the
 Company sold to The Mann Group under the agreement was equal to the
 greater of $7.15 per share (the closing bid price of the
 Company&amp;#x2019;s common stock on August&amp;#xA0;10, 2010) and the
 closing bid price of the Company&amp;#x2019;s common stock on the
 trading day immediately preceding the applicable closing date. The
 aggregate purchase price for the shares of common stock the Company
 issued and sold to The Mann Group was paid by cancelling an equal
 amount of the outstanding principal under the $350.0&amp;#xA0;million
 loan arrangement provided by The Mann Group. An August 2010
 amendment and restatement of the Company&amp;#x2019;s promissory note
 issued to The Mann Group in connection with the Loan Arrangement
 also provided for the cancellation of indebtedness under the note
 as described above and the elimination of the Company&amp;#x2019;s
 ability to reborrow under the note the amount of any indebtedness
 that was cancelled. The common stock purchase agreement with The
 Mann Group terminated upon termination of the Seaside agreement in
 the quarter ended September&amp;#xA0;30, 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In the fourth
 quarter of 2010, the Company issued and sold a total of 2,100,000
 shares of common stock to Seaside for net proceeds of $14.1 million
 in accordance with the Company&amp;#x2019;s common stock purchase
 agreement with Seaside. During the quarter ended March&amp;#xA0;31,
 2011, the Company issued and sold a total of 1,400,000 shares of
 common stock to Seaside for net proceeds of $9.7 million. No
 additional shares of common stock were sold to Seaside under this
 agreement subsequent to the quarter ended March&amp;#xA0;31, 2011. As
 of December&amp;#xA0;31, 2011, the Company had issued and sold a total
 of 3,500,000 shares of common stock to Seaside for net proceeds of
 $23.8&amp;#xA0;million in accordance with the agreement. The agreement
 with Seaside terminated during the quarter ended September&amp;#xA0;30,
 2011. Concurrently, with the sales to Seaside, the Company issued
 and sold a total of 2,100,000 and 1,400,000 shares of common stock
 to The Mann Group, an entity controlled by the Company&amp;#x2019;s
 principal stockholder, in 2010 and 2011, respectively, for a total
 purchase price of $16.7 million and $11.1 million, respectively,
 which was paid by the cancellation of outstanding principal under
 the Company&amp;#x2019;s amended and restated promissory note with The
 Mann Group.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 February&amp;#xA0;8, 2012, the Company sold $86.3 million worth of
 units in an underwritten public offering, with each unit consisting
 of one share of common stock and a warrant to purchase 0.6 of a
 share of common stock. Concurrent with this public offering, The
 Mann Group agreed to purchase $77.2 million worth of restricted
 shares of common stock to be paid, at the discretion of the
 Company, by cash or by cancellation of principal indebtedness under
 the amended loan arrangement, subject to stockholder approval to
 increase the number of authorized shares. In May 2012, the
 Company&amp;#x2019;s stockholders approved an increase in the authorized
 shares of common stock from 250,000,000 to 350,000,000. On
 June&amp;#xA0;27, 2012, the Company completed the closing of the sale
 of 31,250,000 share of its common stock through the cancellation of
 outstanding indebtedness under the loan agreement (see Note
 10).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
 2012, the Company sold $92.0 million worth of units in an
 underwritten public offering, with each unit to purchase one share
 of common stock and a warrant to purchase at 0.75 of a share of
 common stock. Concurrent with the underwritten public offering, the
 Company entered into a Common Stock and Warrant Purchase Agreement
 on October&amp;#xA0;18, 2012, in which the Company was required to
 issue and sell and The Mann Group was obligated to purchase
 40,000,000 restricted shares of the Company&amp;#x2019;s common stock at
 a purchase price of $2.59 per share (the consolidated closing bid
 price of the Company&amp;#x2019;s common stock on October&amp;#xA0;17,
 2012), and 40,000,000 warrants to purchase up to an aggregate of
 30,000,000 restricted shares of the Company&amp;#x2019;s common stock at
 a purchase price of $0.125 for each share of the Company&amp;#x2019;s
 common stock underlying the warrants, in exchange for cancellation
 of outstanding principal under the amended and restated promissory
 note with The Mann Group.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The restricted
 shares sold to The Mann Group may not be sold, pledged, assigned or
 transferred unless (i)&amp;#xA0;the shares have been registered with
 the Securities and Exchange Commission or (ii)&amp;#xA0;the restricted
 shares are exempt from SEC registration requirements and the
 Company has obtained an opinion from the Company&amp;#x2019;s counsel
 that the shares may be sold lawfully without
 registration.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As a result of
 the special meeting of the Company&amp;#x2019;s stockholders held on
 December&amp;#xA0;20, 2012 in which the Company&amp;#x2019;s stockholders
 approved an amendment to its Amended and Restated Certificate of
 Incorporation to increase the authorized shares of its common stock
 from 350,000,000 shares to 550,000,000 shares, the Company
 completed the closing of the Common Stock and Warrant Purchase
 Agreement. The aggregate purchase price for the shares and warrants
 that the Company issued to The Mann Group was approximately $107.4
 million and was paid for by cancelling principal indebtedness owed
 to The Mann Group under the amended and restated promissory note.
 The cancelled principal amount became available for reborrowing
 until the October&amp;#xA0;31, 2013 amendment discussed above.
 Additionally, in accordance with the terms of the note, the Company
 elected to capitalize the accrued and unpaid interest on the
 cancelled principal amount that became due upon the closing (see
 Note 10).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The principal
 amount outstanding under the Loan Arrangement as of
 December&amp;#xA0;31, 2012 and 2013, respectively, subsequent to the
 completion of the common stock purchase agreements was as follows
 (in&amp;#xA0;thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="90%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount
 outstanding at December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;119,635&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalization of accrued
 and unpaid interest due and payable as of October&amp;#xA0;31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,886&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Reduction of principal
 indebtedness related to the issuance of common stock pursuant to
 The Mann Group Warrants completed on October&amp;#xA0;31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(78,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount
 outstanding at December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;49,521&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of&amp;#xA0;
 December&amp;#xA0;31, 2012 and December&amp;#xA0;31, 2013, the Company had
 accrued and unpaid interest of $2.2&amp;#xA0;million and $0.6 million,
 recorded in accrued expenses and other current liabilities and
 other liabilities, respectively, which related to the amount
 outstanding and had $125.4 million and $30.1 million, respectively,
 of available borrowings. Interest expense on the Company&amp;#x2019;s
 note payable to our principal stockholder for the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013 was $10.9 million, $10.5
 million and $6.3 million, respectively.&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In connection
 with certain meetings of the Company&amp;#x2019;s board of directors and
 on other occasions when the Company&amp;#x2019;s business necessitated
 air travel for the Company&amp;#x2019;s principal stockholder and other
 Company employees, the Company utilized the principal
 stockholder&amp;#x2019;s private aircraft, and the Company paid the
 charter company that manages the aircraft on behalf of the
 Company&amp;#x2019;s majority shareholder approximately $111,000,
 $200,000 and $82,000, respectively, for the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013 on the basis of the
 corresponding cost of commercial airfare.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company has
 entered into indemnification agreements with each of its directors
 and executive officers, in addition to the indemnification provided
 for in its amended and restated certificate of incorporation and
 amended and restated bylaws (see Note 13).&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_FC04B11B-F394-465E-9C36-40815156D647_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal tax benefit
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax benefit, net of
 federal benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent items&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Intercompany transfer of
 intellectual property&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.7&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective income tax
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_C62A4448-9409-4AC4-8513-49521D957635_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation&lt;/i&gt; &amp;#x2014; As of December&amp;#xA0;31, 2013, the Company
 had three active stock-based compensation plans, which are
 described more fully in Note 12. The Company accounts for all
 share-based payments to employees, including grants of stock awards
 and the compensatory elements of the employee stock purchase plan
 in accordance with ASC 718&lt;i&gt;.&lt;/i&gt; ASC 718 &lt;i&gt;Compensation &amp;#x2014;
 Stock Compensation&lt;/i&gt; (&amp;#x201C;ASC 718&amp;#x201D;) requires all
 share-based payments to employees, including grants of stock
 options, restricted stock units, performance-based awards and the
 compensatory elements of employee stock purchase plans, to be
 recognized in the income statement based upon the fair value of the
 awards at the grant date. The Company uses the Black-Scholes option
 valuation model to estimate the grant date fair value of employee
 stock options and the compensatory elements of employee stock
 purchase plans. Restricted stock units are valued based on the
 market price on the grant date. The Company evaluates stock awards
 with performance conditions as to the probability that the
 performance conditions will be met and estimates the date at which
 the performance conditions will be met in order to properly
 recognize stock-based compensation expense over the requisite
 service period.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E4F6DEAE-EDFF-4FFD-ABDC-F4A8BB94B8FF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Segment
 Information&lt;/i&gt; &amp;#x2014; In accordance with Accounting Standards
 Codification (&amp;#x201C;ASC&amp;#x201D;) 280-10-50 &lt;i&gt;Segment
 Reporting&lt;/i&gt;, operating segments are identified as components of
 an enterprise about which separate discrete financial information
 is available for evaluation by the chief operating decision-maker
 in making decisions regarding resource allocation and assessing
 performance. To date, the Company has viewed its operations and
 manages its business as one segment operating in the United States
 of America.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" xsi:nil="true" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_3_1" />
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_C37AC5D5-7FF2-4931-831A-700CD0BA34C8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2. Summary of
 significant accounting policies&lt;/b&gt;&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Financial Statement
 Estimates&amp;#xA0;&lt;/i&gt;&amp;#x2014; The &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies and controls, and in developing the estimates
 and assumptions that are used in the preparation of these financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical trial
 expenses, valuation of forward purchase contracts, valuation of
 Milestone Rights, valuation of the Commitment Asset, valuation of
 stock-based compensation and the determination of the provision for
 income taxes and corresponding deferred tax assets and liabilities
 and any valuation allowance recorded against net deferred tax
 assets.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Cash and Cash
 Equivalents&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company
 considers all highly liquid investments with original or remaining
 maturities of 90 days or less at the time of purchase, that are
 readily convertible into cash to be cash equivalents. As
 of&amp;#xA0;December&amp;#xA0;31, 2012&amp;#xA0;and&amp;#xA0;2013, cash equivalents
 were comprised of cash and money market accounts with maturities
 less than 90 days from the date of
 purchase.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Concentration of
 Credit Risk&amp;#xA0;&lt;/i&gt;&amp;#x2014; Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;State Research and
 Development Credit Exchange Receivable&amp;#xA0;&lt;/i&gt;&amp;#x2014; The State of
 Connecticut provides certain companies with the opportunity to
 exchange certain research and development income tax credit
 carryforwards for cash in exchange for foregoing the carryforward
 of the research and development credits. The program provides for
 an exchange of research and development income tax credits for cash
 equal to 65% of the value of corporation tax credit available for
 exchange. Estimated amounts receivable under the program are
 recorded as a reduction of research and development
 expenses.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); PADDING-BOTTOM: 0px; FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt;&amp;#xA0;&amp;#x2014;
 On July&amp;#xA0;1 2013, in conjunction with the execution of the
 Facility Agreement, the Company issued Milestone Rights to
 Deerfield whereby the Company agreed to provide Deerfield with
 pre-specified Milestone Payments upon the achievement of 13
 specific Milestone Events related to the commercial release and
 future cumulative net sales of AFREZZA&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;sup style="VERTICAL-ALIGN: baseline; POSITION: relative; BOTTOM: 0.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;.
 The Company analyzed the Milestone Rights under the provisions of
 ASC 815 and determined that the agreement does not meet the
 definition of a freestanding derivative. Since the Company has not
 elected to apply the fair value option to the Milestone Rights
 Purchase Agreement, the Company recorded the Milestone Rights at
 their estimated fair value and accounted for the Milestone Rights
 as a liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The initial fair value
 estimate of the Milestone Rights was calculated using the income
 approach in which the cash flows associated with the specified
 contractual payments were adjusted for both the expected timing and
 the probability of achieving the milestones and discounted to
 present value using a selected market discount rate. The expected
 timing and probability of achieving the milestones was developed
 with consideration given to both internal data, such as progress
 made to date and assessment of criteria required for achievement,
 and external data, such as market research studies. The discount
 rate was selected based on an estimation of required rate of
 returns for similar investment opportunities using available market
 data.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Milestone Rights
 liability will be remeasured as the specified milestone events are
 achieved. Specifically, as each milestone event is achieved, the
 portion of the initially recorded Milestone Rights liability that
 pertains to the milestone event being achieved, will be remeasured
 to the amount of the specified related milestone payment. The
 resulting change in the balance of the Milestone Rights liability
 due to remeasurement will be recorded in our Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon the settlement of each milestone
 payment. As a result, each milestone payment would be effectively
 allocated between a reduction of the recorded Milestone Rights
 liability and an expense representing a return on a portion of the
 Milestone Rights liability paid to the investor for the achievement
 of the related milestone event
 (see&amp;#xA0;Note&amp;#xA0;16).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Commitment
 Asset&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 In connection with issuance of the first tranche of 2019 notes and
 the Milestone Rights, the Company recorded the Commitment Asset on
 July&amp;#xA0;1, 2013.&amp;#xA0;The Commitment Asset represents the right
 to receive additional funding under future tranches of 2019 notes
 pursuant to the Facility Agreement. The initial value of the
 Commitment Asset was calculated using the income approach by
 estimating the fair value of the future tranches using a market
 debt rate commensurate with the risk of the future tranches and the
 fair value of the cash expected to be received by us and assessing
 the probability of the commitments being funded in the future based
 on the operational hurdles required for funding being met. The
 Commitment Asset attributable to each future tranche of 2019 notes
 under the Facility Agreement is derecognized and recorded as a debt
 discount on the 2019 notes when issued. The debt discount is
 amortized using the effective interest rate method over the life of
 the 2019 notes. Prior to derecognition occurring, the Company
 monitors the Commitment Asset on an ongoing basis to determine
 whether an impairment indicator is present that would result in a
 full or partial write down of the Commitment Asset as a result of
 events that may lead to the subsequent tranches of 2019 notes not
 being issued. Based on the monitoring procedures performed through
 December&amp;#xA0;31, 2013, the Company did not identify any indicators
 of impairment.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Fair Value of
 Financial Instruments&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company
 utilizes fair value measurement guidance prescribed by GAAP to
 value its financial instruments. The guidance includes a definition
 of fair value, prescribes methods for measuring fair value,
 establishes a fair value hierarchy based on the inputs used to
 measure fair value and expands disclosures about the use of fair
 value measurements. The valuation techniques utilized are based
 upon observable and unobservable inputs. Observable inputs reflect
 market data obtained from independent sources, while unobservable
 inputs reflect internal market assumptions. These two types of
 inputs create the following fair value
 hierarchy:&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 53px; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Level&amp;#xA0;1&amp;#xA0;&amp;#x2013;
 Quoted prices for identical instruments in active
 markets.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 53px; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Level&amp;#xA0;2&amp;#xA0;&amp;#x2013;
 Quoted prices for similar instruments in active markets; quoted
 prices for identical or similar instruments in markets that are not
 active; and model-derived valuations whose inputs are observable or
 whose significant value drivers are
 observable.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 53px; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Level&amp;#xA0;3&amp;#xA0;&amp;#x2013;
 Significant inputs to the valuation model are
 unobservable.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The carrying amounts
 reflected in the consolidated balance sheets for cash equivalents,
 other current assets, accounts payable, and accrued expenses and
 other, approximate fair value due to their relatively short
 maturities.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Goodwill and
 Identifiable Intangibles&amp;#xA0;&lt;/i&gt;&amp;#x2014; As a result of the
 merger with AlleCure and CTL on December&amp;#xA0;12, 2001, as
 described in Note 1, goodwill of $151.4 million was recorded at the
 entity level in 2001. Upon adoption of ASC 350-10&amp;#xA0;&lt;i&gt;Intangibles- Goodwill and
 Other,&amp;#xA0;&lt;/i&gt;the
 Company adopted a policy of testing goodwill and intangible assets
 with indefinite lives for impairment at least annually, as of
 December&amp;#xA0;31, with any related impairment losses being
 recognized in earnings when identified. In December 2002 the
 Company concluded that the major AlleCure product development
 program should be terminated and that the clinical trials of the
 CTL product should be halted and returned to the research stage. As
 a result of this determination, the Company closed the CTL facility
 and reduced headcount for AlleCure and CTL by approximately 50%. In
 connection with the annual test for impairment of goodwill as of
 December&amp;#xA0;31, 2002, the Company determined that on the basis of
 the internal study, the goodwill recorded for the AlleCure and CTL
 units was potentially impaired. The Company performed the second
 step of the annual impairment test as of December&amp;#xA0;31, 2002 for
 each of the potentially impaired reporting units and estimated the
 fair value of the AlleCure and CTL programs using the expected
 present value of future cash flows which were expected to be
 negligible. Accordingly, the goodwill balance of $151.4 million was
 determined to be fully impaired and an impairment loss was recorded
 in 2002. Subsequent to December&amp;#xA0;31, 2002, the Company had no
 goodwill or intangibles with indefinite lives included on its
 balance sheets.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Property and
 Equipment&amp;#xA0;&lt;/i&gt;&amp;#x2014; Property and
 equipment are recorded at cost and depreciated using
 the&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;straight-line&lt;/font&gt;&amp;#xA0;method over the estimated
 useful lives of the related assets. Leasehold improvements are
 amortized over the term of the lease or the service lives of the
 improvements, whichever is shorter. Maintenance and repairs are
 expensed as incurred. Assets under construction are not depreciated
 until placed into service.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Impairment of
 Long-Lived Assets&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company
 evaluates long-lived assets for impairment whenever events or
 changes in circumstances indicate that the carrying value of an
 asset may not be recoverable in accordance with ASC
 360-10-35&lt;i&gt;Property Plant and Equipment.&amp;#xA0;&lt;/i&gt;Assets are considered to
 be impaired if the carrying value may not be recoverable based upon
 management&amp;#x2019;s assessment of the following events or changes in
 circumstances:&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;significant changes in the Company&amp;#x2019;s strategic business
 objectives and utilization of the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;loss of legal ownership or title to the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;a significant adverse change in legal factors or in the
 business climate that could affect the value of a&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;long-lived&lt;/font&gt;&amp;#xA0;asset (asset group), including
 an adverse action or assessment by a regulator; or&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;the impact of significant negative industry or economic
 trends.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;If the Company believes
 an asset to be impaired, the impairment recognized is the amount by
 which the carrying value of the assets exceeds the fair value of
 the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized. No asset impairment was recognized during
 the years ended December&amp;#xA0;31, 2011, 2012 and 2013,
 respectively.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Income
 Taxes&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 The provisions for federal, foreign, state, and local income taxes
 are calculated on pre-tax income based on current tax law and
 include the cumulative effect of any changes in tax rates from
 those used previously in determining deferred tax assets and
 liabilities. Deferred income tax assets and liabilities are
 measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Income tax positions are
 considered for uncertainty in accordance with ASC
 740-10-25&amp;#xA0;&lt;i&gt;Income
 Taxes,&lt;/i&gt;&amp;#xA0;The
 Company believes that its income tax filing positions and
 deductions will be sustained on audit and does not anticipate any
 adjustments that will result in a material change to its financial
 position. Therefore, no liabilities for uncertain income tax
 positions have been recorded. If a tax position does not meet the
 minimum statutory threshold to avoid payment of penalties, the
 Company recognizes an expense for the amount of the penalty in the
 period the tax position is claimed in the tax return of the
 Company. The Company recognizes interest accrued related to
 unrecognized tax benefits in income tax expense, if any. Penalties,
 if probable and reasonably estimable, are recognized as a component
 of income tax expense.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Significant management
 judgment is involved in determining the provision for income taxes,
 deferred tax assets, deferred tax liabilities, and any valuation
 allowance recorded against net deferred tax assets. Due to
 uncertainties related to the realization of the Company&amp;#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the gross
 deferred tax asset balance. The valuation allowance is based on
 management&amp;#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&amp;#x2019;s financial
 position and results of operations.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Contingencies&amp;#xA0;&lt;/i&gt;&amp;#x2014; Contingencies are
 recorded in accordance with ASC 450&amp;#xA0;&lt;i&gt;Contingencies.&lt;/i&gt;&amp;#xA0;Accordingly,
 the Company records a loss contingency for a liability when it is
 both probable that a liability has been incurred and the amount of
 the loss can be reasonably estimated. These accruals represent
 management&amp;#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure.&amp;#xA0;Significant judgment is
 required in both the determination of probability and the
 determination as to whether an exposure is reasonably estimable.
 Because of uncertainties related to these matters, accruals are
 based only on the best information available at the time. As
 additional information becomes available, the Company reassesses
 the potential liability related to pending claims and litigation
 and may revise our estimates. These revisions in the estimates of
 the potential liabilities could have a material impact on our
 consolidated results of operations and financial
 position.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation&amp;#xA0;&lt;/i&gt;&amp;#x2014; As of
 December&amp;#xA0;31, 2013, the Company had three active stock-based
 compensation plans, which are described more fully in Note 12. The
 Company accounts for all share-based payments to employees,
 including grants of stock awards and the compensatory elements of
 the employee stock purchase plan in accordance with ASC
 718&lt;i&gt;.&amp;#xA0;&lt;/i&gt;ASC
 718&amp;#xA0;&lt;i&gt;Compensation
 &amp;#x2014; Stock Compensation&lt;/i&gt;&amp;#xA0;(&amp;#x201C;ASC 718&amp;#x201D;)
 requires all share-based payments to employees, including grants of
 stock options, restricted stock units, performance-based awards and
 the compensatory elements of employee stock purchase plans, to be
 recognized in the income statement based upon the fair value of the
 awards at the grant date. The Company uses the Black-Scholes option
 valuation model to estimate the grant date fair value of employee
 stock options and the compensatory elements of employee stock
 purchase plans. Restricted stock units are valued based on the
 market price on the grant date. The Company evaluates stock awards
 with performance conditions as to the probability that the
 performance conditions will be met and estimates the date at which
 the performance conditions will be met in order to properly
 recognize stock-based compensation expense over the requisite
 service period.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;&amp;#xA0;&amp;#x2014; The Company has issued
 warrants to purchase shares of its common stock. Warrants have been
 accounted for within equity in accordance with the provisions of
 ASC 815-40, Contracts in an Entity&amp;#x2019;s Own Stock, previously
 EITF Issue No. 00-19:&amp;#xA0;&lt;i&gt;Accounting for Derivative
 Financial Instruments Indexed to, and Potentially Settled in, a
 Company&amp;#x2019;s Own Stock&lt;/i&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Forward
 Contracts&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company has
 entered into agreements with The Mann Group whereby the Company
 agreed to sell and The Mann Group agreed to purchase common stock
 and/or warrants. These agreements have been accounted for as
 forward contracts, having met the definition of derivative
 instruments in accordance with the provisions of ASC
 815&amp;#xA0;&lt;i&gt;Derivatives
 and Hedging&lt;/i&gt;. The Company determines the fair value of the
 forward contract upon its issuance, records fair value adjustments
 of the forward contract to Other income (expense) during the
 reporting period and through the settlement of the forward
 contract, and reclassifies the forward contract to equity upon
 settlement of the forward contract.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Comprehensive
 Loss&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 Other comprehensive loss is recorded in accordance with ASC
 220-10-45&amp;#xA0;&lt;i&gt;Comprehensive
 Income,&amp;#xA0;&lt;/i&gt;which
 requires that all components of comprehensive loss be reported in
 the financial statements in the period in which they are
 recognized. Other comprehensive loss includes certain changes in
 stockholders&amp;#x2019; equity that are excluded from net income.
 Specifically, the Company includes unrealized gains and losses on
 its available-for-sale securities and cumulative translation gains
 and losses in other comprehensive loss.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Research and
 Development Expenses&amp;#xA0;&lt;/i&gt;&amp;#x2014; Research and
 development expenses consist of costs associated with the clinical
 trials of the Company&amp;#x2019;s product candidates, manufacturing
 supplies and other development materials, including raw material
 purchases of insulin, compensation and other expenses for research
 and development personnel, costs for consultants and related
 contract research, facility costs, and depreciation. Research and
 development costs, which are net of any tax credit exchange
 recognized for the Connecticut state research and development
 credit exchange program, are expensed as incurred consistent with
 ASC 730-10&amp;#xA0;&lt;i&gt;Research and
 Development.&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Clinical Trial
 Expenses&amp;#xA0;&lt;/i&gt;&amp;#x2014; Clinical trial
 expenses, which are reflected in research and development expenses
 in the accompanying statements of operations, result from
 obligations under contracts with vendors, consultants, and clinical
 site agreements in connection with conducting clinical trials. The
 financial terms of these contracts are subject to negotiations
 which vary from contract to contract and may result in payment
 flows that do not match the periods over which materials or
 services are provided to the Company under such contracts. The
 appropriate level of trial expenses are reflected in the
 Company&amp;#x2019;s financial statements by matching period expenses
 with period services and efforts expended. These expenses are
 recorded according to the progress of the trial as measured by
 patient progression and the timing of various aspects of the trial.
 Clinical trial accrual estimates are determined through discussions
 with internal clinical personnel and outside service providers as
 to the progress or state of completion of trials, or the services
 completed. Service provider status is then compared to the
 contractually obligated fee to be paid for such services. During
 the course of a clinical trial, the Company may adjust the rate of
 clinical expense recognized if actual results differ from
 management&amp;#x2019;s estimates.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Interest
 Expense&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 Interest costs are expensed as incurred, except to the extent such
 interest is related to construction in progress, in which case
 interest is capitalized. Interest expense, net of interest
 capitalized, for the years ended December&amp;#xA0;31, 2011, 2012 and
 2013 was $21.8 million, $21.6 million and $21.5 million,
 respectively. Interest costs capitalized for the years ended
 December&amp;#xA0;31, 2011, 2012, and 2013 were $0.4 million, $0.3
 million, and $0.4 million, respectively.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Net Loss Per Share of
 Common Stock&lt;/i&gt;&amp;#xA0;&amp;#x2014; Basic net loss per
 common share is computed by dividing net loss by the
 weighted-average number of common shares outstanding during the
 period, excluding the dilutive effects of converting redeemable
 preferred stock, warrants to purchase redeemable convertible
 preferred stock and options. Diluted net loss per common share is
 computed by dividing the net loss by the sum of the
 weighted-average number of common shares outstanding during the
 period plus the potential dilutive effects of redeemable
 convertible preferred stock and warrants to purchase redeemable
 convertible preferred stock, and options outstanding during the
 period calculated in accordance with the treasury stock method, but
 are excluded if their effect is anti-dilutive. Because the impact
 of these items is anti-dilutive during periods of net loss, there
 was no difference between basic and diluted loss per common share
 for the year ended December&amp;#xA0;31, 2011, 2012 and
 2013.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Restructuring
 Charges&lt;/i&gt;&amp;#x2014; The Company made estimates and judgments
 regarding the amount and timing of our restructuring expense and
 liability, including current and future period termination
 benefits, lease termination costs, and other exit costs to be
 incurred when related actions take place. We have also assessed the
 recoverability of certain long-lived assets employed in the
 business and, in certain instances shortened the expected useful
 life of the assets based on changes in their expected use. When we
 determine that the useful lives of assets are shorter than we had
 originally estimated, we record additional depreciation to reflect
 the assets&amp;#x2019; new shorter useful lives. Severance and other
 related costs and asset-related charges are reflected within our
 consolidated statement of operations as a component of total
 restructuring charges incurred. Actual results may differ from
 these estimates.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Recently Issued
 Accounting Standards&amp;#xA0;&lt;/i&gt;&amp;#x2014; From time to time,
 new accounting pronouncements are issued by the Financial
 Accounting Standards Board (FASB) or other standard setting bodies
 that are adopted by the Company as of the specified effective date.
 Unless otherwise discussed, we believe that the impact of recently
 issued standards that are not yet effective will not have a
 material impact on our financial position or results of operations
 upon adoption.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In February 2013, the
 FASB issued Accounting Standards Update (ASU) 2013-02,
 Comprehensive Income (Topic 220) &amp;#x2014; Reporting of Amounts
 Reclassified out of Accumulated Other Comprehensive
 Income.&amp;#xA0;These amendments do not change the current
 requirements for reporting net income or other comprehensive income
 in the financial statements. These amendments provide for
 additional disclosure requirements for amounts reclassified out of
 accumulated other comprehensive income. These amendments are
 effective prospectively for interim and annual periods beginning
 after December&amp;#xA0;15, 2012. Early adoption is permitted.
 Effective January&amp;#xA0;1, 2013, the Company adopted the new
 requirements as set forth in ASU 2013-02 in the disclosure of
 comprehensive income on the Company&amp;#x2019;s consolidated financial
 statements. The adoption of the new requirements did not have a
 significant impact on the Company&amp;#x2019;s consolidated financial
 statements.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In July 2013, the FASB
 ASU 2013-11, Income Taxes (Topic 740): Presentation of an
 Unrecognized Tax Benefit when a Net Operating Loss Carryforward, a
 Similar Tax Loss, or a Tax Credit Carryforward Exists
 (a&amp;#xA0;consensus of the FASB Emerging Issues Task Force). The
 amendments in this ASU provide guidance on the financial statements
 presentation of an unrecognized tax benefit when a net operating
 loss carryforward, a similar tax loss, or a tax credit carryforward
 exists. An unrecognized tax benefit should be presented in the
 financial statements as a reduction to a deferred tax asset for a
 net operating loss carryforward, a similar tax loss, or a tax
 credit carryforward with certain exceptions, in which case such an
 unrecognized tax benefit should be presented in the financial
 statements as a liability. The amendments in this ASU do not
 require new recurring disclosures. The amendments in this ASU are
 effective for fiscal years, and interim periods within those years,
 beginning after December&amp;#xA0;15, 2013. The Company does not expect
 the adoption of ASU 2013-11 will have an impact on the
 Company&amp;#x2019;s consolidated financial
 statements.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_1_1">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
  <us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_66C4E67D-DCE8-487D-935B-6CFBD30FA768_1_2">2016-07-01</us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_2D49C676-960A-48E3-AEDF-733967788873_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Components of
 the net deferred tax asset as of December&amp;#xA0;31, 2012 and 2013
 are approximately as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred tax
 assets:&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="5"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;609,471&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;653,896&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
 credits&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;65,315&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;70,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
 research&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;31,490&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,421&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Milestone Rights&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,608&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,922&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-qualified stock option
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,928&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;41,219&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized patent
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,891&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,811&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;837&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,134&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;750,151&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(750,151&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_1_4">287374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_3_4">78475367</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_F802CA39-F4BC-4448-B237-31BB757E1420_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Impairment
 of Long-Lived Assets&lt;/i&gt; &amp;#x2014; The Company evaluates long-lived
 assets for impairment whenever events or changes in circumstances
 indicate that the carrying value of an asset may not be recoverable
 in accordance with ASC 360-10-35 &lt;i&gt;Property Plant and
 Equipment.&lt;/i&gt; Assets are considered to be impaired if the carrying
 value may not be recoverable based upon management&amp;#x2019;s
 assessment of the following events or changes in
 circumstances:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;significant changes in the Company&amp;#x2019;s strategic business
 objectives and utilization of the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;loss of legal ownership or title to the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a significant adverse change in legal factors or in the
 business climate that could affect the value of a &lt;font style="WHITE-SPACE: nowrap"&gt;long-lived&lt;/font&gt; asset (asset group),
 including an adverse action or assessment by a regulator;
 or&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;the impact of significant negative industry or economic
 trends.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;If the Company
 believes an asset to be impaired, the impairment recognized is the
 amount by which the carrying value of the assets exceeds the fair
 value of the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized. No asset impairment was recognized during
 the years ended December&amp;#xA0;31, 2011, 2012 and 2013,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E1A2582A-75C1-4D7B-BA91-5DE1715877A4_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Financial
 Statement Estimates&lt;/i&gt; &amp;#x2014; The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies and controls, and in developing the estimates
 and assumptions that are used in the preparation of these financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical trial
 expenses, valuation of forward purchase contracts, valuation of
 Milestone Rights, valuation of the Commitment Asset, valuation of
 stock-based compensation and the determination of the provision for
 income taxes and corresponding deferred tax assets and liabilities
 and any valuation allowance recorded against net deferred tax
 assets.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_4AD5B93C-F0BC-4FC9-8E96-FA40A0F5167C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;1. Description of
 business and basis of presentation&lt;/b&gt;&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Business&amp;#xA0;&lt;/i&gt;&amp;#x2014; MannKind
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Corporation
 and subsidiaries (the &amp;#x201C;Company&amp;#x201D;) is a biopharmaceutical
 company focused on the discovery, development and commercialization
 of therapeutic products for diseases such as diabetes. The
 Company&amp;#x2019;s lead product candidate, AFREZZA, (insulin human
 [rDNA origin]) inhalation powder, is an ultra rapid-acting insulin
 therapy that is in late-stage clinical investigation for the
 treatment of adults with type 1 or type 2 diabetes for the control
 of hyperglycemia.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;AFREZZA consists of the
 Company&amp;#x2019;s proprietary Technosphere particles onto which
 insulin molecules are loaded. These loaded particles are then
 aerosolized and inhaled deep into the lung using the
 Company&amp;#x2019;s AFREZZA inhaler.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Basis of
 Presentation&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company is
 considered to be in the development stage as its primary activities
 since incorporation have been establishing its facilities,
 recruiting personnel, conducting research and development, business
 development, business and financial planning, and raising capital.
 It is costly to develop therapeutic products and conduct clinical
 studies for these products. From its inception through
 December&amp;#xA0;31, 2013, the Company has reported accumulated net
 losses of $2.3 billion, which include a goodwill impairment charge
 of $151.4 million and cumulative negative cash flow from operations
 of $1.7 billion. At December&amp;#xA0;31, 2013, the Company&amp;#x2019;s
 capital resources consisted of cash and cash equivalents of $70.8
 million. These factors raise substantial doubt about the
 Company&amp;#x2019;s ability to continue as a going concern. The
 financial statements do not include any adjustments that might
 result from the outcome of these
 uncertainties.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of December&amp;#xA0;31,
 2013, the Company had $30.1 million principal amount of available
 borrowings under the loan arrangement with The Mann Group, or the
 Loan Arrangement, although the Company anticipates using a portion
 of these available borrowings to capitalize accrued interest into
 principal as it becomes due and payable under the Loan Arrangement,
 upon mutual agreement of the parties (see Note 6). As described in
 Note 16, the Facility Agreement contains a financial covenant that
 requires the Company&amp;#x2019;s cash and cash equivalents, which
 include available borrowings under this Loan Arrangement, on the
 last day of each fiscal quarter to not be less than $25 million
 (see Note 16). Based on our current expectations, the Company
 believes that its existing capital resources will enable it to
 continue planned operations at least into the third quarter of
 2014. However, the Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company will need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available whether through the sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Capital resources
 potentially available to the Company include proceeds from the
 exercise of warrants issued in its February 2012 public offering,
 the Company&amp;#x2019;s at-the-market issuance sales agreements (see
 Note 18) and issuance of additional&amp;#xA0;2019 notes and/or tranche
 B notes (see Note 18) to Deerfield, as more fully described
 below:&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In February 2012, the
 Company sold in an underwritten public offering 35,937,500 units at
 an aggregate price to the public of $86.3 million, with each unit
 consisting of one share of common stock and a warrant to purchase
 0.6 of a share of common stock. As of December&amp;#xA0;31, 2013, there
 were 32,843,733 warrants outstanding that, if exercised, would
 result in proceeds of $47.3 million.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On March&amp;#xA0;18, 2013,
 the Company entered into at-the-market issuance sales agreements
 with two sales agents, under which the Company was permitted to
 issue and sell shares of its common stock having an aggregate
 offering price of up to $50.0 million under each agreement
 (provided that in no event was the Company permitted to issue and
 sell more than $50.0 million of shares of its common stock under
 both agreements in the aggregate) from time to time through either
 of the sales agents. As of December&amp;#xA0;31, 2013 the Company had
 sold $48.9 million in common stock through these agreements, net of
 fees, and no further sales through these agreements are
 permitted.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On July&amp;#xA0;1, 2013, the
 Company entered into the Facility Agreement, providing for the sale
 of up to $160.0 million of 2019 notes to Deerfield in four equal
 tranches of $40.0 million principal amount. In connection with the
 Facility Agreement, on July&amp;#xA0;1, 2013 the Company also entered
 into a Milestone Rights Purchase Agreement with Deerfield Private
 Design Fund and Horizon Sant&amp;#xE9; FLML S&amp;#xC1;RL (&amp;#x201C;HS&amp;#x201D;
 and together with Deerfield Private Design Fund, the
 &amp;#x201C;Milestone Purchasers&amp;#x201D;), pursuant to which, the Company
 sold the Milestone Purchasers certain rights to receive payments of
 up to $90.0 million upon the occurrence of specified strategic and
 sales milestones including the first commercial sale of an AFREZZA
 product and the achievement of specified net sales figures (see
 Note 16).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On July&amp;#xA0;1, 2013,
 Deerfield purchased the first tranche of 2019 notes and the
 Milestone Rights for an aggregate of $40.0 million. The closing of
 the second tranche of 2019 notes, which was subject to achievement
 and reporting of certain results from the Company&amp;#x2019;s two Phase
 3 clinical studies of AFREZZA, occurred on September&amp;#xA0;5, 2013.
 The closing of the third tranche of 2019 notes occurred in
 conjunction with the payment, at maturity, of the 2013 notes on
 December&amp;#xA0;9, 2013. There can be no assurance that the
 conditions required for the purchase of the fourth tranche of the
 2019 notes will be met or met in a timeframe necessary to support
 the Company&amp;#x2019;s liquidity needs (see Note
 18).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On December&amp;#xA0;12,
 2001, the stockholders of AlleCure Corp. (&amp;#x201C;AlleCure&amp;#x201D;)
 and CTL ImmunoTherapies Corp. (&amp;#x201C;CTL&amp;#x201D;) voted to exchange
 their shares for shares of Pharmaceutical Discovery Corporation
 (&amp;#x201C;PDC&amp;#x201D;). Upon approval of the merger, PDC then changed
 its name to MannKind Corporation. PDC was incorporated in the State
 of Delaware on February&amp;#xA0;14, 1991. The stockholders of PDC did
 not vote on the merger. At the date of the merger, Mr.&amp;#xA0;Alfred
 Mann owned 76% of PDC, 59% of AlleCure and 69% of CTL. Accordingly,
 only the minority interest of AlleCure and CTL was stepped up to
 fair value using the purchase method of accounting. As a result of
 this purchase accounting, in-process research and development of
 $19.7 million and goodwill of $151.4 million were recorded at the
 entity level. The historical basis of PDC and the historical basis
 relating to the ownership interests of Mr.&amp;#xA0;Mann in AlleCure
 and CTL have been reflected in the financial statements. For
 periods prior to December&amp;#xA0;12, 2001, the results of operations
 have been presented on a combined basis. All references in the
 accompanying financial statements and notes to the financial
 statements to number of shares, sales price and per share amounts
 of the Company&amp;#x2019;s capital stock have been retroactively
 restated to reflect the share exchange ratios for each of the
 entities that participated in the merger.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;For periods subsequent to
 December&amp;#xA0;12, 2001, the accompanying financial statements have
 been presented on a consolidated basis and include the wholly-owned
 subsidiaries, AlleCure and CTL. On December&amp;#xA0;31, 2002, AlleCure
 and CTL merged with and into the Company and ceased to be separate
 entities.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Principles of
 Consolidation&amp;#xA0;&lt;/i&gt;&amp;#x2014; The consolidated
 financial statements include the accounts of the Company and its
 wholly-owned subsidiaries.&amp;#xA0;Intercompany balances and
 transactions have been eliminated.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Segment
 Information&amp;#xA0;&lt;/i&gt;&amp;#x2014; In accordance with
 Accounting Standards Codification (&amp;#x201C;ASC&amp;#x201D;)
 280-10-50&amp;#xA0;&lt;i&gt;Segment Reporting&lt;/i&gt;,
 operating segments are identified as components of an enterprise
 about which separate discrete financial information is available
 for evaluation by the chief operating decision-maker in making
 decisions regarding resource allocation and assessing performance.
 To date, the Company has viewed its operations and manages its
 business as one segment operating in the United States of
 America.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_FAE8F0EB-4C7E-4797-8BF2-B1A92E9DF72A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Net Loss Per
 Share of Common Stock&lt;/i&gt; &amp;#x2014; Basic net loss per common share
 is computed by dividing net loss by the weighted-average number of
 common shares outstanding during the period, excluding the dilutive
 effects of converting redeemable preferred stock, warrants to
 purchase redeemable convertible preferred stock and options.
 Diluted net loss per common share is computed by dividing the net
 loss by the sum of the weighted-average number of common shares
 outstanding during the period plus the potential dilutive effects
 of redeemable convertible preferred stock and warrants to purchase
 redeemable convertible preferred stock, and options outstanding
 during the period calculated in accordance with the treasury stock
 method, but are excluded if their effect is anti-dilutive. Because
 the impact of these items is anti-dilutive during periods of net
 loss, there was no difference between basic and diluted loss per
 common share for the year ended December&amp;#xA0;31, 2011, 2012 and
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_7C1C3EDF-0693-445A-9C80-5C118E626F3C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
 of Financial Instruments&lt;/i&gt; &amp;#x2014; The Company utilizes fair
 value measurement guidance prescribed by GAAP to value its
 financial instruments. The guidance includes a definition of fair
 value, prescribes methods for measuring fair value, establishes a
 fair value hierarchy based on the inputs used to measure fair value
 and expands disclosures about the use of fair value measurements.
 The valuation techniques utilized are based upon observable and
 unobservable inputs. Observable inputs reflect market data obtained
 from independent sources, while unobservable inputs reflect
 internal market assumptions. These two types of inputs create the
 following fair value hierarchy:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;1&amp;#xA0;&amp;#x2013; Quoted prices for identical
 instruments in active markets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;2&amp;#xA0;&amp;#x2013; Quoted prices for similar instruments
 in active markets; quoted prices for identical or similar
 instruments in markets that are not active; and model-derived
 valuations whose inputs are observable or whose significant value
 drivers are observable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;3&amp;#xA0;&amp;#x2013; Significant inputs to the valuation
 model are unobservable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other, approximate fair value due to their relatively
 short maturities.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_18">-0.64</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_4_5">463290</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_DAF58DE8-A168-472B-8988-C7D3AA4A9798_1_3">2.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_F11FD33A-BA94-415F-A48B-2F6DF8D47B90_1_2">6919900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_D3369916-E6B0-4FB8-8C75-6243F2B57D3D_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;18. Subsequent
 Event&lt;/b&gt;&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;January 2014, Deerfield
 elected to convert an aggregate of $33.5 million of principal
 amount of the Tranche 2 Notes, pursuant to which the Company issued
 Deerfield 6,559,251 shares of the Company&amp;#x2019;s common stock. As
 a result of this election, Deerfield has fully exercised the
 conversion option under the 2019 notes by converting all of the
 Tranche 2 Notes, or $40.0 million of principal, into 7,852,475
 shares of the Company&amp;#x2019;s common stock in the
 aggregate.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On February 28, 2014, the
 Company entered into a First Amendment to Facility Agreement and
 Registration Rights Agreement with Deerfield to provide for the
 issuance of tranche B notes to Deerfield in a maximum principal
 amount equal to (x) if the FDA approves the NDA for AFFREZZA and
 Deerfield purchased the fourth tranche of 2019 notes, 150% of the
 aggregate principal amount of the 2019 notes that Deerfield has
 converted into the Company&amp;#x2019;s common stock on and after the
 effective date of the amendment, up to $90.0 million, and (y)
 otherwise, 33.33% of the aggregate principal amount of the 2019
 notes that Deerfield has converted into the Company&amp;#x2019;s common
 stock on and after the effective date of the amendment, up to $20.0
 million, in each case subject to the satisfaction of certain other
 conditions. Any tranche B notes, if and when issued, would bear
 interest at the rate of 9.75% per year, subject to reduction to
 8.75% if the Company enters into a collaboration with a third party
 to commercialize AFFREZZA, on the outstanding principal amount,
 payable in cash quarterly in arrears on the last business day of
 December, March, June and September of each year. The Company is
 required to repay 25% of the original principal amount of any
 tranche B notes on the third, fourth, fifth and sixth anniversaries
 of the applicable issue dates of such notes, provided that the
 entire outstanding principal amount of all tranche B notes will
 become due and payable no later than December 31, 2019. The tranche
 B notes will be prepayable without penalty or premium commencing
 two years after issuance thereof.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In addition, pursuant to
 the amendment, the outstanding 2019 notes held by Deerfield were
 amended and restated such that Deerfield may, subject to certain
 limitations, convert up to an additional $60.0 million principal
 amount under such 2019 notes into common stock after the effective
 date of the amendment. Pursuant to the amendment, the Company also
 amended its Registration Rights Agreement with Deerfield dated July
 1, 2013 and agreed to register for resale up to 12,000,000 shares
 of common stock issuable upon conversion of the outstanding 2019
 notes, as amended and restated, as of the date of the amendment,
 with a minimum conversion price of $5.00 per share unless the
 Company otherwise consents. The conversion price will be determined
 by the average of the volume weighted average prices per share
 during the three trading days immediately preceding the election to
 convert.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On March 3, 2014, the
 Company entered into two At-The-Market Issuance Sales Agreements
 (the &amp;#x201C;ATM Agreements&amp;#x201D;), one with MLV &amp;amp; Co. LLC
 (&amp;#x201C;MLV&amp;#x201D;), and one with Meyers Associates, L.P. (doing
 business as Brinson Patrick, a division of Meyers Associates, L.P.)
 (&amp;#x201C;Brinson Patrick&amp;#x201D;), pursuant to which the Company may
 issue and sell its common stock having aggregate sales proceeds of
 up to $50.0 million from time to time through MLV or Brinson
 Patrick, acting as the Company&amp;#x2019;s sales agents. The Company
 currently anticipates that all or substantially all sales of common
 stock under the ATM Agreements will be made in &amp;#x201C;at the
 market&amp;#x201D; offerings as defined in Rule 415 of the Securities
 Act of 1933, as amended. The Company has not yet sold or issued any
 shares of its common stock under the ATM
 Agreements.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_02EA77E7-6888-4037-82DB-A80FC2DA058D_1_2">3.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_2FA011D7-9A97-49D3-8897-53128C247972_1_2">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_1EB0F669-C628-4985-87B5-A8E7D66DC5FA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;15. Income
 taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;There is no
 provision for income taxes because the Company has incurred
 operating losses since inception. At December&amp;#xA0;31, 2013, the
 Company has concluded that it is more likely than not that the
 Company may not realize the benefit of its deferred tax assets due
 to its history of losses. Accordingly, the net deferred tax assets
 have been fully reserved. The provision for income taxes consists
 of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="73%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,643&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,540&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59,379&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,199&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,470&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 Allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(57,225&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(60,739&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66,849&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred income
 taxes reflect the tax effects of temporary differences between the
 carrying amounts of assets and liabilities for financial reporting
 and income tax purposes. A valuation allowance is established when
 uncertainty exists as to whether all or a portion of the net
 deferred tax assets will be realized. Components of the net
 deferred tax asset as of December&amp;#xA0;31, 2012 and 2013 are
 approximately as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred tax
 assets:&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="5"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;609,471&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;653,896&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
 credits&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;65,315&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;70,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
 research&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;31,490&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,421&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Milestone Rights&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,608&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,922&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-qualified stock option
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,928&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;41,219&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized patent
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,891&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,811&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;837&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,134&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;750,151&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(750,151&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal tax benefit
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax benefit, net of
 federal benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent items&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Intercompany transfer of
 intellectual property&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.7&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective income tax
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As required by
 ASC 740 &lt;i&gt;Income Taxes&lt;/i&gt; (&amp;#x201C;ASC 740&amp;#x201D;), management of
 the Company has evaluated the positive and negative evidence
 bearing upon the realizability of its deferred tax assets.
 Management has concluded, in accordance with the applicable
 accounting standards, that it is more likely than not that the
 Company may not realize the benefit of its deferred tax assets due
 to net losses since inception. Accordingly, the net deferred tax
 assets have been fully reserved. Management reevaluates the
 positive and negative evidence on an annual basis. During the years
 ended December&amp;#xA0;31, 2011, 2012 and 2013, the change in the
 valuation allowance was $57.2 million, $60.7 million and $66.8
 million, respectively, for income taxes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2013, the Company had federal and state net
 operating loss carryforwards of approximately $1.7 billion and $1.2
 billion available, respectively, to reduce future taxable income
 and which will expire at various dates beginning in 2018 and 2014,
 respectively. As a result of the Company&amp;#x2019;s initial public
 offering, an ownership change within the meaning of Internal
 Revenue Code Section&amp;#xA0;382 occurred in August 2004. As a result,
 federal net operating loss and credit carry forwards of
 approximately $216.0 million are subject to an annual use
 limitation of approximately $13.0 million. The annual limitation is
 cumulative and therefore, if not fully utilized in a year can be
 utilized in future years in addition to the Section&amp;#xA0;382
 limitation for those years. The federal net operating losses
 generated subsequent to the Company&amp;#x2019;s initial public offering
 in August 2004 are currently not subject to any such limitation as
 there have been no ownership changes since August 2004 within the
 meaning of Internal Revenue Code Section&amp;#xA0;382. At
 December&amp;#xA0;31, 2013, the Company had research and development
 credits of $45 million and $38 million for federal and state
 purposes, respectively. The federal credits begin to expire in
 2024, and the state credits may be carried forward
 indefinitely.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A portion of
 the net operating loss carryforwards include amounts related to
 stock-based payment awards. Any excess tax benefits from
 stock-based compensation are only recognized for financial
 reporting purposes when income taxes payable is reduced, with a
 corresponding increase to additional paid-in capital.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 believes that its income tax filing positions and deductions will
 be sustained on audit and does not anticipate any adjustments that
 will result in a material change to its financial position.
 Therefore, no liabilities for uncertain income tax positions have
 been recorded. Tax years since 1998 remain subject to examination
 by the major tax jurisdictions in which the Company is subject to
 tax.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_B984A1F8-17CF-4841-8B0E-D191D14B9040_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Research and
 Development Expenses&lt;/i&gt; &amp;#x2014; Research and development expenses
 consist of costs associated with the clinical trials of the
 Company&amp;#x2019;s product candidates, manufacturing supplies and
 other development materials, including raw material purchases of
 insulin, compensation and other expenses for research and
 development personnel, costs for consultants and related contract
 research, facility costs, and depreciation. Research and
 development costs, which are net of any tax credit exchange
 recognized for the Connecticut state research and development
 credit exchange program, are expensed as incurred consistent with
 ASC 730-10 &lt;i&gt;Research and Development.&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_6230FC6D-57BD-4F0C-9882-7E814FF25290_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Senior
 convertible notes consist of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2013
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;115,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(557&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,443&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2015
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,417&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,561&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;97,583&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;98,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Senior convertible
 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;212,026&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;98,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_B334F4E9-396E-4D7E-8A04-8B2153E85FCA_3_2">P6Y10M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_32985385-C722-4DDA-A5F3-A6C231CAFA74_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12. Stock award
 plans&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;23,
 2013, the Company adopted the 2013 Equity Incentive Plan (the
 &amp;#x201C;2013 Plan&amp;#x201D;) as the successor to and continuation of
 the 2004 Equity Incentive Plan (the &amp;#x201C;2004 Plan&amp;#x201D;). The
 2013 Plan consists of 21.5 million newly requested shares and the
 number of unallocated shares remaining available for grant for new
 awards under the 2004 Plan. The 2013 Plan provides for the granting
 of stock awards including stock options and restricted stock units,
 to employees, directors and consultants. The Plan also provides for
 the automatic, non-discretionary grant of options to the
 Company&amp;#x2019;s non-employee directors. No additional awards will
 be granted under the 2004 Plan or under the 2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan (the &amp;#x201C;NED Plan&amp;#x201D;) as
 all future awards will be made out of the 2013 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2013, the Company has two active stock-based
 compensation plans &amp;#x2014; the 2013 Plan and the 2004 Employee
 Stock Purchase Plan (the &amp;#x201C;ESPP&amp;#x201D;). The following table
 summarizes information about the Company&amp;#x2019;s stock-based award
 plans as of December&amp;#xA0;31, 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Restricted&lt;br /&gt;
 Stock Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&amp;#xA0;Available&lt;br /&gt;
 for&lt;br /&gt;
 Future Issuance&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,792,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,949,202&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,754,325&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,166,619&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,590,564&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;690,831&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,590,564&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s board of directors determines eligibility, vesting
 schedules and exercise prices for stock awards granted under the
 2013 Plan. The 2013 Plan provides for automatic, non-discretionary
 grant of options to the Company&amp;#x2019;s non-employee directors.
 Options and other stock awards under the 2013 Plan expire not more
 than ten years from the date of the grant and are exercisable upon
 vesting. Stock options generally vest over four years. Current
 stock option grants vest and become exercisable at the rate of 25%
 after one year and ratably on a monthly basis over a period of 36
 months thereafter. Restricted stock units generally vest at a rate
 of 25%&amp;#xA0;per year over four years with consideration satisfied
 by service to the Company. Performance-based awards vest upon
 achieving pre-determined performance milestones, which are expected
 to occur over periods ranging from 11 months to 96 months from the
 date of grant. All but one of the milestones is considered probable
 as of December&amp;#xA0;31, 2013. The 2013 Plan provides for full
 acceleration of vesting if an employee is terminated within three
 months of a change in control, as defined in the 2013
 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;23,
 2013, the Compensation Committee also approved a management
 proposal designed to encourage employee retention. The proposal
 involved the grant of 5,598,100 performance-based stock options and
 1,687,900 performance-based restricted stock units to employees,
 including executive officers of the Company. These grants have
 vesting terms subject to the achievement of specified regulatory
 and business development milestones related to AFREZZA. The
 performance-based options and performance-based restricted stock
 units had a grant date per share fair value of $3.05 and $6.85,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 March&amp;#xA0;7, 2013, the Compensation Committee approved a
 management proposal designed to encourage employee retention. The
 proposal involved the grant of performance-based restricted stock
 units to employees, including executive officers of the
 Company.&amp;#xA0;A total of 5,846,000 restricted stock units were
 granted with vesting terms subject to the achievement of specified
 regulatory and business development milestones related to AFREZZA.
 The performance-based restricted stock units had a grant date fair
 value of $2.81.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;17,
 2012, the Compensation Committee also approved a management
 proposal designed to encourage employee retention.&amp;#xA0;The
 proposal involved the grant of stock options and restricted stock
 units to employees, including executive officers of the
 Company.&amp;#xA0;A total of 3,942,500 options were granted with
 vesting terms subject to MannKind Corporation&amp;#x2019;s achievement
 of specified regulatory and business development milestones related
 to AFREZZA. A total of 3,892,500 options were granted with
 time-based vesting terms of 25% every 6&amp;#xA0;months beginning
 November&amp;#xA0;1, 2012, to be fully vested on May&amp;#xA0;1,
 2014.&amp;#xA0;The performance-based options and time-based stock
 options had a grant date fair value of $0.60 and $1.12,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 March&amp;#xA0;3, 2011, the Compensation Committee approved a
 management proposal designed to encourage employee retention. The
 proposal involved the issuance of restricted stock units and stock
 options to the majority of employees and executive officers of the
 Company. A total of 1,177,300 restricted stock units and 1,467,500
 stock options were granted under the 2004 Plan. These units vested
 50% annually for two years and became fully vested on March&amp;#xA0;3,
 2013. Stock compensation expense associated with these grants was
 recorded on a straight line basis from March&amp;#xA0;3, 2011 through
 March&amp;#xA0;3, 2013 and was approximately $8.2 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On July&amp;#xA0;9,
 2008, the Company announced an Offer to Exchange Outstanding
 Options to Purchase Common Stock (the &amp;#x201C;Offer&amp;#x201D;) under
 which the Company offered eligible employees the opportunity to
 exchange out-of-the money stock options covering up to an aggregate
 of 5,417,840 shares on a grant by grant basis for a reduced number
 of restricted stock units. The Offer expired on August&amp;#xA0;6,
 2008. Pursuant to the Offer, the Company accepted for exchange
 options to purchase an aggregate of 4,493,509 shares of the
 Company&amp;#x2019;s common stock and issued restricted stock units
 covering an aggregate of 2,246,781 shares of the Company&amp;#x2019;s
 common stock. For the restricted stock units issued pursuant to the
 offer, both the remaining estimated unamortized stock compensation
 expense related to the exchanged options of approximately $13.9
 million and the estimated incremental stock compensation expense
 resulting from the exchange of approximately $3.7 million was
 amortized over the vesting period ending on August&amp;#xA0;1,
 2010.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2004,
 the Company&amp;#x2019;s board of directors approved the ESPP, which
 became effective upon the closing of the Company&amp;#x2019;s initial
 public offering. Initially, the aggregate number of shares that
 could be sold under the 2004 Plan was 2,000,000 shares of common
 stock. On January&amp;#xA0;1 of each year, for a period of ten years
 beginning January&amp;#xA0;1, 2005, the share reserve automatically
 increases by the lesser of: 700,000 shares, 1% of the total number
 of shares of common stock outstanding on that date, or an amount as
 may be determined by the board of directors. However, under no
 event can the annual increase cause the total number of shares
 reserved under the ESPP to exceed 10% of the total number of shares
 of capital stock outstanding on December&amp;#xA0;31 of the prior year.
 On January&amp;#xA0;1, 2011, 2012 and 2013 the ESPP share reserve was
 increased by 700,000, 700,000 and 700,000 shares, respectively. As
 of December&amp;#xA0;31, 2013, 2,679,007 shares were available for
 issuance under the ESPP. For the years ended December&amp;#xA0;31,
 2011, 2012 and 2013 the Company sold 282,816, 422,260 and
 463,290&amp;#xA0;shares, respectively, of its common stock to employees
 participating in the ESPP. The ESPP purchase for the period ending
 December&amp;#xA0;31, 2013 was initiated prior to year end but did not
 settle until January&amp;#xA0;6, 2014. As a result, the shares sold are
 reflected in the ESPP share reserves but is excluded from common
 stock outstanding as of December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In accordance
 with ASC 718, share-based payment transactions are recognized as
 compensation cost based on the fair value of the instrument on the
 date of grant. The Company accounts for non-employee stock-based
 compensation expense based on the estimated fair value of the
 options, which is determined using the Black-Scholes option
 valuation model and amortizes such expense on a straight-line basis
 over the service period for time-based awards and over the expected
 dates of achievement for performance-based awards. These awards are
 subject to re-measurement until service is complete. As of
 December&amp;#xA0;31, 2013, there were options to purchase 203,700
 shares of common stock outstanding to consultants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
 years ended December&amp;#xA0;31, 2011, 2012 and 2013 the Company
 recorded stock-based compensation expense related to its stock
 award plans and the ESPP of $11.2 million, $13.3 million, and $45.2
 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Employee-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,202&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,224&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;45,181&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Consultant-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;68&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,204&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,167&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;20,409&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,838&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,125&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,777&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,204&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 uses the Black-Scholes option valuation model to estimate the grant
 date fair value of employee stock options. The expected term of an
 option granted is based on combining historical exercise data with
 expected weighted time outstanding. Expected weighted time
 outstanding is calculated by assuming the settlement of outstanding
 awards is at the midpoint between the remaining weighted average
 vesting date and the expiration date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 estimates volatility using the historical volatility of its stock.
 The Company has selected risk-free interest rates based on U.S.
 Treasury securities with an equivalent expected term in effect on
 the date the options were granted. Additionally, the Company uses
 historical data and management judgment to estimate stock option
 exercise behavior and employee turnover rates to estimate the
 number of stock option awards that will eventually vest. The
 Company calculated the fair value of employee stock options granted
 during the years ended December&amp;#xA0;31, 2011, 2012 and 2013 using
 the following assumptions:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.10%&amp;#xA0;&amp;#x2014;&amp;#xA0;2.43%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.32%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.16%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.94%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.82%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected lives&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.1&amp;#xA0;&amp;#x2014;&amp;#xA0;6.1
 years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.4&amp;#xA0;&amp;#x2014;&amp;#xA0;6.1
 years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.64&amp;#xA0;&amp;#x2014;&amp;#xA0;5.77&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;76%&amp;#xA0;&amp;#x2014;&amp;#xA0;83%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;70%&amp;#xA0;&amp;#x2014;&amp;#xA0;84%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;75.83%&amp;#xA0;&amp;#x2014;&amp;#xA0;86.26%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information about stock options
 outstanding:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;br /&gt;
 per&amp;#xA0;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&lt;br /&gt;
 Value&amp;#xA0;($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 January&amp;#xA0;1, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;18,674,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.46&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,867&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,919,900&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.63&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(881,139&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.60&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(287,374&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expired&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(187,986&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10.65&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.35&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;40,972&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested and expected to vest
 at December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;23,533,436&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.35&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;40,972&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable at
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;12,358,495&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;22,126&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The weighted
 average grant date fair value of the stock options granted during
 the years ended December&amp;#xA0;31, 2011, 2012 and 2013 was $2.04,
 $0.99 and $3.26 per option, respectively. The total intrinsic value
 of options exercised during the years ended December&amp;#xA0;31, 2011,
 2012 and 2013 was $443,000, $1,000 and $3.1 million, respectively.
 Intrinsic value is measured using the fair market value at the date
 of exercise (for options exercised) or at December&amp;#xA0;31 (for
 outstanding options), less the applicable exercise
 price.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash received
 from the exercise of options during the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013 was approximately $625,000,
 $9,200 and $2.3 million, respectively. The weighted-average
 remaining contractual terms for options outstanding, vested and
 expected to vest, and exercisable at December&amp;#xA0;31, 2013 was
 7.80 years, 7.77 years and 6.84 years, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
 restricted stock unit activity for the year ended December&amp;#xA0;31,
 2013 is presented below:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Grant&amp;#xA0;Date&lt;br /&gt;
 Fair Value&lt;br /&gt;
 per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at January 1,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,761,031&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.73&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,481,459&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,861,059&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.82&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(265,610&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The total
 restricted stock units expected to vest as of December&amp;#xA0;31,
 2013 was 8,761,363 with a weighted average grant date fair value of
 $3.40. The total intrinsic value of restricted stock units expected
 to vest as of December&amp;#xA0;31, 2013 was $45.6 million. Intrinsic
 value of restricted stock units expected to vest is measured using
 the closing share price at December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total intrinsic
 value of restricted stock units vested during the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013 was $1.7 million, $2.9
 million and $13.9 million, respectively. Intrinsic value of
 restricted stock units vested is measured using the closing share
 price on the day prior to the vest date. The total fair value of
 restricted stock units vested during the years ended
 December&amp;#xA0;31, 2011, 2012 and 2013 was $1.6 million, $3.0
 million and $14.9&amp;#xA0;million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2013, there was $15.2 million and $23.2 million
 of unrecognized compensation expense related to options and
 restricted stock units, respectively, which is expected to be
 recognized over the weighted average vesting period of 1.6 years.
 The Company evaluates stock awards with performance conditions as
 to the probability that the performance conditions will be met and
 estimates the date at which the performance conditions will be met
 in order to properly recognize stock-based compensation expense
 over the requisite service period. As of December&amp;#xA0;31, 2013,
 there was $107,000 and $3.7 million of unrecognized expenses
 related to performance-based options and restricted stock units,
 respectively, for milestones not considered probable of
 achievement.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_A75E4CD7-B4F4-4704-89F7-70C304325F45_1_4">265610</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_16DED1ED-F053-49BE-8148-1C47FCD8D879_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
 restricted stock unit activity for the year ended December&amp;#xA0;31,
 2013 is presented below:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Grant&amp;#xA0;Date&lt;br /&gt;
 Fair Value&lt;br /&gt;
 per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at January 1,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,761,031&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.73&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,481,459&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,861,059&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.82&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(265,610&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4020747_A75E4CD7-B4F4-4704-89F7-70C304325F45_1_2">8481459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_62B8C9E3-BF7C-4191-91A7-8AB1551BE2BF_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;13. Commitments and
 contingencies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Operating
 Leases&lt;/i&gt; &amp;#x2014; The Company leases certain facilities and
 equipment under various operating leases, which expire at various
 dates through 2014 and beyond. Future payments are deemed
 insignificant.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Rent expense
 under all operating leases, including office space and equipment,
 for the years ended December&amp;#xA0;31, 2011, 2012, and 2013 was
 approximately $766,000, $675,000, and $645,000
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Capital
 Leases&lt;/i&gt; &amp;#x2014; The Company&amp;#x2019;s capital leases were not
 material for the years ended December&amp;#xA0;31, 2011, 2012 and
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Supply
 Agreement &amp;#x2014;&lt;/i&gt; In November 2007, the Company entered into a
 long-term supply agreement with N.V. Organon
 (&amp;#x201C;Organon&amp;#x201D;), now a subsidiary of Merck&amp;#xA0;&amp;amp; Co.,
 Inc. (the &amp;#x201C;Supply Agreement&amp;#x201D;), pursuant to which
 Organon manufactured and supplied specified quantities of
 recombinant human insulin to the Company. In June 2011, the Company
 entered into a letter agreement (the &amp;#x201C;Letter
 Agreement&amp;#x201D;) with Organon to settle a dispute that arose
 between the Company and Organon in connection with the termination
 by the Company of the Supply Agreement. Under the terms of the
 Letter Agreement, the Company paid Organon an aggregate of
 $16.0&amp;#xA0;million in two installments, each of which was paid
 after the Company received certain quantities of recombinant human
 insulin manufactured and supplied by Organon. The Letter Agreement
 is in full and final settlement of, and the Company and Organon
 agreed to release each other from, any and all actions and claims
 that the Company and Organon had or may have against each other in
 connection with the dispute regarding the Supply Agreement and
 related matters. The Company has concluded that the Letter
 Agreement represents a multiple element arrangement consisting of
 two elements representing the purchase of insulin and a contract
 cancellation fee. The Company has allocated the $16.0 million
 settlement in the following manner: first to the fair value of the
 insulin received, which was recorded as expense of $8.4 million and
 the remaining $7.6 million to the contract cancellation fee. These
 charges were recorded to &amp;#x201C;Research and development&amp;#x201D;
 operating expenses in the consolidated statements of operations of
 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Guarantees
 and Indemnifications&lt;/i&gt; &amp;#x2014; In the ordinary course of its
 business, the Company makes certain indemnities, commitments and
 guarantees under which it may be required to make payments in
 relation to certain transactions. The Company, as permitted under
 Delaware law and in accordance with its Bylaws, indemnifies its
 officers and directors for certain events or occurrences, subject
 to certain limits, while the officer or director is or was serving
 at the Company&amp;#x2019;s request in such capacity. The term of the
 indemnification period is for the officer&amp;#x2019;s or
 director&amp;#x2019;s lifetime. The maximum amount of potential future
 indemnification is unlimited; however, the Company has a director
 and officer insurance policy that may enable it to recover a
 portion of any future amounts paid. The Company believes the fair
 value of these indemnification agreements is minimal. The Company
 has not recorded any liability for these indemnities in the
 accompanying consolidated balance sheets. However, the Company
 accrues for losses for any known contingent liability, including
 those that may arise from indemnification provisions, when future
 payment is probable. No such losses have been recorded to
 date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Litigation&lt;/i&gt; &amp;#x2014; The Company is subject to legal
 proceedings and claims which arise in the ordinary course of its
 business. As of December&amp;#xA0;31, 2013, the Company believes that
 the final disposition of such matters will not have a material
 adverse effect on the financial position, results of operations or
 cash flows of the Company. The Company maintains liability
 insurance coverage to protect the Company&amp;#x2019;s assets from
 losses arising out of or involving activities associated with
 ongoing and normal business operations. In accordance with ASC 450
 &lt;i&gt;Contingencies&lt;/i&gt;, the Company records a provision for a
 liability when it is both probable that a liability has been
 incurred and the amount of the loss can be reasonably estimated.
 The Company&amp;#x2019;s policy is to accrue for legal expenses in
 connection with legal proceeding and claims as they are
 incurred.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;The
 Securities Action&lt;/b&gt;. Beginning January&amp;#xA0;31, 2011, several
 complaints were filed in the U.S. District Court for the Central
 District of California against the Company and four of our officers
 &amp;#x2014; Alfred E. Mann, Hakan S. Edstrom, Dr.&amp;#xA0;Peter&amp;#xA0;C.
 Richardson (a former officer) and Matthew J. Pfeffer &amp;#x2014; on
 behalf of certain purchasers of our common stock. The complaints
 include claims asserted under Sections 10(b) and 20(a) of the
 Exchange Act and were brought as purported shareholder class
 actions. In general, the complaints alleged that the defendants
 violated federal securities laws by making materially false and
 misleading statements regarding our business and prospects for
 AFREZZA, thereby artificially inflating the price of the
 Company&amp;#x2019;s common stock. The U.S.&amp;#xA0;District Court for the
 Central District of California consolidated the pending actions for
 all purposes. The consolidated action is referred to as the
 Securities Action.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On July&amp;#xA0;23,
 2012, the Company, while continuing to deny all allegations of
 wrongdoing or liability whatsoever arising out of the Securities
 Action, and without in any way admitting fault or liability,
 entered into a stipulation of settlement to resolve the Securities
 Action. The current and former officers and directors named as
 individual defendants in the consolidated lawsuits also entered
 into the stipulation of settlement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In exchange for
 a release of all claims by the class members, among others, and a
 dismissal of the consolidated lawsuits, the Company agreed
 (i)&amp;#xA0;to cause the Company&amp;#x2019;s insurers to pay class members
 and their attorneys a total of $16.0 million; and (ii)&amp;#xA0;to
 issue to class members and their attorneys 2,777,778 shares of the
 Company&amp;#x2019;s common stock. The Company also agreed that if the
 consolidated closing bid price for the Company&amp;#x2019;s common stock
 is below $1.00 per share on the date the U.S. District Court enters
 an order of final judgment, then the Company will issue into the
 Escrow Account an additional 1,000,000 shares of its common stock.
 On September&amp;#xA0;12, 2012, the U.S. District Court preliminarily
 approved the settlement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 December&amp;#xA0;21, 2012, the U.S. District Court issued the Order
 and Final Judgment, providing final approval of the settlement for
 the securities action. The Order and Final Judgment consisted of
 requiring the Company to cause its insurers to pay $16.0 million
 and to issue the 2,777,778 shares of its common stock in accordance
 with the stipulation of settlement. The Order and Final Judgment
 did not include the requirement of the Company to issue the
 additional 1,000,000 shares of its common stock. In late September
 and in early October, following the preliminary approval of the
 settlement, the Company&amp;#x2019;s insurers remitted payment of the
 $16.0 million into the Escrow Account. On December&amp;#xA0;31, 2012,
 following final approval of the settlement, the Company initiated
 the transfer of the 2,777,778 shares of its common stock into the
 Escrow Account. The stock transfer settled on January&amp;#xA0;2, 2013.
 The shares were issued pursuant to an exemption from registration
 provided by Section&amp;#xA0;3(a)(10) of the Securities Act of 1933, as
 amended. As of December&amp;#xA0;31, 2012, the Securities Action was
 concluded.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;The
 Derivative Actions&lt;/b&gt;. Beginning in February 2011, several
 shareholder derivative complaints were filed in the Superior Court
 of California for the County of Los Angeles and in the U.S.
 District Court for the Central District of California against all
 of the Company&amp;#x2019;s directors and certain of its officers. The
 complaints in the shareholder derivative actions allege breaches of
 fiduciary duties by the defendants and other violations of law. In
 general, the complaints allege that the defendants caused or
 allowed for the dissemination of materially false and misleading
 statements regarding its business and prospects for AFREZZA,
 thereby artificially inflating the price of its common stock. The
 Superior Court of California for the County of Los Angeles
 consolidated the actions pending before it. The consolidated state
 derivative actions are referred to as the State Derivative Action.
 The U.S. District Court for the Central District of California has
 also consolidated the derivative actions pending before it. The
 consolidated federal derivative actions are referred to as the
 Federal Derivative Action. The State Derivative Action and the
 Federal Derivative Action are collectively referred to as the
 Derivative Actions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 August&amp;#xA0;3, 2012, the Company, while continuing to deny all
 allegations of wrongdoing or liability whatsoever arising out of
 the Derivative Actions and without in any way admitting fault or
 liability, entered into a stipulation of settlement to resolve the
 Derivative Action. Subject to preliminary and final approval of the
 settlement by the U.S. District Court and notice to shareholders,
 and in an exchange for a release of all claims by the plaintiffs,
 among others, and a dismissal of the Derivative Actions, the
 Company agreed (i)&amp;#xA0;to adopt certain corporate governance
 measures, (ii)&amp;#xA0;to cause the Company&amp;#x2019;s insurers to pay
 the plaintiffs&amp;#x2019; attorneys a total of $800,000, and
 (iii)&amp;#xA0;to issue plaintiffs&amp;#x2019; attorneys 225,000 shares of
 the Company&amp;#x2019;s common stock. On September&amp;#xA0;12, 2012, the
 U.S. District Court preliminarily approved the
 settlement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 November&amp;#xA0;19, 2012, the U.S. District Court issued the Order
 and Final Judgment, providing final approval of the settlement for
 the derivative action. The Order and Final Judgment consisted of
 requiring the Company to cause its insurers to pay $800,000 and to
 issue the 225,000 shares of its common stock in accordance with the
 stipulation of settlement. In late September and in early October,
 following the preliminary approval of the settlement, the
 Company&amp;#x2019;s insurers remitted payment of the $800,000 into an
 account established by the plaintiffs&amp;#x2019; attorneys. In December
 2012, following final approval of the settlement, the Company
 transferred the 225,000 shares of its common stock into an
 investment brokerage account established by the plaintiffs&amp;#x2019;
 attorneys. The shares were issued pursuant to an exemption from
 registration provided by Section&amp;#xA0;3(a)(10) of the Securities
 Act of 1933, as amended. As of December&amp;#xA0;31, 2012, the
 Derivative Actions were concluded.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;As a result of
 settlement discussions with the plaintiffs taking place in the
 latter part of the quarter ended June&amp;#xA0;30, 2012 and entering
 into the stipulation of settlement for the Securities Action on
 July&amp;#xA0;23, 2012 and for the Derivative Action on August&amp;#xA0;3,
 2012, the Company determined that the liabilities pertaining to
 both the securities and derivative lawsuits were probable as of
 June&amp;#xA0;30, 2012. The Company&amp;#x2019;s financial statements as of
 and for the three months ended June&amp;#xA0;30, 2012 reflected the
 following accruals:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(i)&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Cash consideration&lt;/i&gt;.
 The Company recorded a current liability of $16.8 million under
 &amp;#x201C;Accrued expense and other current liabilities&amp;#x201D; and a
 corresponding current asset under &amp;#x201C;Prepaid expenses and other
 current asset&amp;#x201D; to reflect a receivable from the
 Company&amp;#x2019;s insurers. The Company has determined that the
 collectability of the receivable from the insurers is probable. The
 cash obligation resulted in no charge to the Company&amp;#x2019;s
 Condensed Consolidated Statements of Operations for the
 period.&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(ii)&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Stock consideration&lt;/i&gt;.
 The Company recorded a charge to &amp;#x201C;General and
 administrative&amp;#x201D; expenses and an estimated current liability
 under &amp;#x201C;Accrued expense and other current liabilities&amp;#x201D;
 of $7.7 million representing the estimated fair value of the
 3,002,778 common shares to be issued in the aggregate subject to
 court approval.&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(iii)&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Additional stock
 consideration&lt;/i&gt;. The Company concluded that the contingent
 obligation to issue an additional 1,000,000 shares of its common
 stock, as defined in the stipulation of settlement agreement for
 the Securities Action, met the definition of a derivative
 instrument in accordance with ASC 815. The Company estimated the
 fair value of the derivative instrument using the Monte Carlo
 simulation model to forecast the contingent obligation applying
 probabilities that the stock price will be lower than $1.00 based
 on the following assumptions: expected volatility of 60%, risk free
 interest rate of 0.16% and final judgment dates ranging from four
 to six months. As a result, the Company estimated the fair value of
 this contingent obligation to be immaterial.&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;As of
 September&amp;#xA0;30, 2012, the Company estimated the aggregate fair
 value of the stock consideration at $8.6&amp;#xA0;million and
 recognized an increase in the contingent liability of $901,000
 during the quarter ended September&amp;#xA0;30, 2012. During the
 quarter ended September&amp;#xA0;30, 2012, the Company remeasured the
 additional stock consideration using the Monte Carlo simulation
 model to forecast the contingent obligation applying probabilities
 that the stock price will be lower than $1.00 based on the
 following assumptions: expected volatility of 54%, risk free
 interest rate of 0.1% and final judgment date on or before
 December&amp;#xA0;31, 2012. As a result, the Company estimated the fair
 value of this contingent obligation related to the additional stock
 consideration to be immaterial.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 considered the following in its financial statements as of and for
 the year ended December&amp;#xA0;31, 2012:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(i)&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Cash consideration&lt;/i&gt;.
 Upon satisfying the conditions of cash payment during the fourth
 quarter of 2012 and receiving final approvals of settlement, the
 Company relieved from its balance sheet the $16.8&amp;#xA0;million of
 current liability and current receivable from insurers as of
 December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(ii)&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Stock consideration&lt;/i&gt;.
 As of December&amp;#xA0;31, 2012, the Company satisfied the conditions
 of issuing 225,000 shares of its common stock on the Derivative
 Action. With respect to the Securities Action, the issuance of
 2,777,778 shares was initiated prior to year end and subsequently
 settled after year end. The Company concluded that the requirement
 to deliver these shares of common stock met the definition of a
 financial instrument representing a contingent forward contract in
 accordance with ASC 815 and that the forward contract met the
 criteria for equity classification, and further remeasurement
 through settlement was not required. The forward contract to issue
 shares settled on January&amp;#xA0;2, 2013, upon consummation of the
 delivery of these shares. The final fair values of the stock
 consideration are summarized in the following table:&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="52%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Closing&amp;#xA0;Price&lt;br /&gt;
 Per&amp;#xA0;Share&amp;#xA0;on&lt;br /&gt;
 Final&lt;br /&gt;
 Approval&lt;br /&gt;
 Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Final&amp;#xA0;Fair&amp;#xA0;Value&amp;#xA0;of&lt;br /&gt;
 Stock&lt;br /&gt;
 Consideration&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Derivative Action&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;225,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.94&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;436,500&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Securities Action&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,777,778&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2.18&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,055,556&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:2.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,002,778&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,492,056&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:8%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In recognizing
 the fair value of the total stock consideration to equity on the
 date of final approval of the respective settlements, the Company
 released the previously recorded litigation accrual of
 $8.6&amp;#xA0;million, recognized the fair value of the total stock
 consideration of $6.5 million to equity, and recorded an adjustment
 to decrease legal expense by $2.1&amp;#xA0;million in the fourth
 quarter of 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700213">48888000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_26">7987000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_59">6500000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700207">2270000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_40">598000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_11">8000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_38">115000000</us-gaap:RepaymentsOfSeniorDebt>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_17">-191490000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_65">856000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_8">-635000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700219">998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_54">13452000</us-gaap:InterestPaid>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_355F9DF3-F088-40CA-8635-7FCEBB492B86_3_0">66800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_12">-191490000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_17">965000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:PaymentsForLegalSettlements contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4EFC7640-76EA-4016-94BA-7AD5C6E5F7EC_1_0">16000000</us-gaap:PaymentsForLegalSettlements>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_3_8">-191488000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_14">-2000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_7">-169401000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_14">-191490000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700208">-4801000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700218">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_3_7">2000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700216">1263000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700217">45186000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:InterestPaidCapitalized contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_66">7886000</us-gaap:InterestPaidCapitalized>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_10" />
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_3">59682000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2CCD153F-8D00-47C3-B7D9-80917E88B817_1_0">1400000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_48">145669000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:LineOfCreditFacilityAnnualPrincipalPayment contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_66C4E67D-DCE8-487D-935B-6CFBD30FA768_1_0">28375000</us-gaap:LineOfCreditFacilityAnnualPrincipalPayment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_4">45186000</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_3">14057000</us-gaap:DepreciationAndAmortization>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_49">8950000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_2" />
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_74F861B2-5530-405E-9B01-D127328E6D50_3_0">645000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B334F4E9-396E-4D7E-8A04-8B2153E85FCA_3_1">2300000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_1" />
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_445758D9-B950-474B-8B1A-1CDCF6F14278_3_0">533000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_10">15153000</us-gaap:InterestExpenseDebt>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_6">169401000</us-gaap:OperatingExpenses>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_9">-66849000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_36">94147000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E2D0D48-AF6A-43B1-8AC0-D6A18F63F663_3_2">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B40FE96E-FD3B-4D80-9797-B0E2981FB4E3_3_0">21500000</us-gaap:InterestExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_19">-1071000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_6">59379000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_2">109719000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_39">119500000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_21">591000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E735C6F-B052-4068-9E1D-4D2F1F130ABB_3_0">13900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_7">7470000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC318011-5C42-4E17-ACCF-F50AC3F4DF43_3_1">11500000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_4" />
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_3" />
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A26B142D-4608-4A1A-8A78-6896108503C5_3_0">45186000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_8" />
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_28">-7987000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_9">6309000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E735C6F-B052-4068-9E1D-4D2F1F130ABB_3_1">14900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B40FE96E-FD3B-4D80-9797-B0E2981FB4E3_3_1">400000</us-gaap:InterestCostsCapitalized>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_20">3675000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <mnkd:BasisOfPresentationPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_345D01E2-461A-43E4-8533-81BBA523F4F2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Basis of
 Presentation&lt;/i&gt; &amp;#x2014; The &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Company is considered to
 be in the development stage as its primary activities since
 incorporation have been establishing its facilities, recruiting
 personnel, conducting research and development, business
 development, business and financial planning, and raising capital.
 It is costly to develop therapeutic products and conduct clinical
 studies for these products. From its inception through
 December&amp;#xA0;31, 2013, the Company has reported accumulated net
 losses of $2.3 billion, which include a goodwill impairment charge
 of $151.4 million and cumulative negative cash flow from operations
 of $1.7 billion. At December&amp;#xA0;31, 2013, the Company&amp;#x2019;s
 capital resources consisted of cash and cash equivalents of $70.8
 million. These factors raise substantial doubt about the
 Company&amp;#x2019;s ability to continue as a going concern. The
 financial statements do not include any adjustments that might
 result from the outcome of these
 uncertainties.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of December&amp;#xA0;31,
 2013, the Company had $30.1 million principal amount of available
 borrowings under the loan arrangement with The Mann Group, or the
 Loan Arrangement, although the Company anticipates using a portion
 of these available borrowings to capitalize accrued interest into
 principal as it becomes due and payable under the Loan Arrangement,
 upon mutual agreement of the parties (see Note 6). As described in
 Note 16, the Facility Agreement contains a financial covenant that
 requires the Company&amp;#x2019;s cash and cash equivalents, which
 include available borrowings under this Loan Arrangement, on the
 last day of each fiscal quarter to not be less than $25 million
 (see Note 16). Based on our current expectations, the Company
 believes that its existing capital resources will enable it to
 continue planned operations at least into the third quarter of
 2014. However, the Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company will need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available whether through the sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Capital resources
 potentially available to the Company include proceeds from the
 exercise of warrants issued in its February 2012 public offering,
 the Company&amp;#x2019;s at-the-market issuance sales agreements (see
 Note 18) and issuance of additional&amp;#xA0;2019 notes and/or tranche
 B notes (see Note 18) to Deerfield, as more fully described
 below:&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In February 2012, the
 Company sold in an underwritten public offering 35,937,500 units at
 an aggregate price to the public of $86.3 million, with each unit
 consisting of one share of common stock and a warrant to purchase
 0.6 of a share of common stock. As of December&amp;#xA0;31, 2013, there
 were 32,843,733 warrants outstanding that, if exercised, would
 result in proceeds of $47.3
 million.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On March&amp;#xA0;18, 2013,
 the Company entered into at-the-market issuance sales agreements
 with two sales agents, under which the Company was permitted to
 issue and sell shares of its common stock having an aggregate
 offering price of up to $50.0 million under each agreement
 (provided that in no event was the Company permitted to issue and
 sell more than $50.0 million of shares of its common stock under
 both agreements in the aggregate) from time to time through either
 of the sales agents. As of December&amp;#xA0;31, 2013 the Company had
 sold $48.9 million in common stock through these agreements, net of
 fees, and no further sales through these agreements are
 permitted.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On July&amp;#xA0;1, 2013, the
 Company entered into the Facility Agreement, providing for the sale
 of up to $160.0 million of 2019 notes to Deerfield in four equal
 tranches of $40.0 million principal amount. In connection with the
 Facility Agreement, on July&amp;#xA0;1, 2013 the Company also entered
 into a Milestone Rights Purchase Agreement with Deerfield Private
 Design Fund and Horizon Sant&amp;#xE9; FLML S&amp;#xC1;RL (&amp;#x201C;HS&amp;#x201D;
 and together with Deerfield Private Design Fund, the
 &amp;#x201C;Milestone Purchasers&amp;#x201D;), pursuant to which, the Company
 sold the Milestone Purchasers certain rights to receive payments of
 up to $90.0 million upon the occurrence of specified strategic and
 sales milestones including the first commercial sale of an AFREZZA
 product and the achievement of specified net sales figures (see
 Note 16).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On July&amp;#xA0;1, 2013,
 Deerfield purchased the first tranche of 2019 notes and the
 Milestone Rights for an aggregate of $40.0 million. The closing of
 the second tranche of 2019 notes, which was subject to achievement
 and reporting of certain results from the Company&amp;#x2019;s two Phase
 3 clinical studies of AFREZZA, occurred on September&amp;#xA0;5, 2013.
 The closing of the third tranche of 2019 notes occurred in
 conjunction with the payment, at maturity, of the 2013 notes on
 December&amp;#xA0;9, 2013. There can be no assurance that the
 conditions required for the purchase of the fourth tranche of the
 2019 notes will be met or met in a timeframe necessary to support
 the Company&amp;#x2019;s liquidity needs (see Note
 18).&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On December&amp;#xA0;12,
 2001, the stockholders of AlleCure Corp. (&amp;#x201C;AlleCure&amp;#x201D;)
 and CTL ImmunoTherapies Corp. (&amp;#x201C;CTL&amp;#x201D;) voted to exchange
 their shares for shares of Pharmaceutical Discovery Corporation
 (&amp;#x201C;PDC&amp;#x201D;). Upon approval of the merger, PDC then changed
 its name to MannKind Corporation. PDC was incorporated in the State
 of Delaware on February&amp;#xA0;14, 1991. The stockholders of PDC did
 not vote on the merger. At the date of the merger, Mr.&amp;#xA0;Alfred
 Mann owned 76% of PDC, 59% of AlleCure and 69% of CTL. Accordingly,
 only the minority interest of AlleCure and CTL was stepped up to
 fair value using the purchase method of accounting. As a result of
 this purchase accounting, in-process research and development of
 $19.7 million and goodwill of $151.4 million were recorded at the
 entity level. The historical basis of PDC and the historical basis
 relating to the ownership interests of Mr.&amp;#xA0;Mann in AlleCure
 and CTL have been reflected in the financial statements. For
 periods prior to December&amp;#xA0;12, 2001, the results of operations
 have been presented on a combined basis. All references in the
 accompanying financial statements and notes to the financial
 statements to number of shares, sales price and per share amounts
 of the Company&amp;#x2019;s capital stock have been retroactively
 restated to reflect the share exchange ratios for each of the
 entities that participated in the
 merger.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;For periods subsequent to
 December&amp;#xA0;12, 2001, the accompanying financial statements have
 been presented on a consolidated basis and include the wholly-owned
 subsidiaries, AlleCure and CTL. On December&amp;#xA0;31, 2002, AlleCure
 and CTL merged with and into the Company and ceased to be separate
 entities.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:BasisOfPresentationPolicyTextBlock>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="shares" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_3_19">299591000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <mnkd:WarrantsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_8696D9C9-B1E0-486C-AF82-62813B2F4CC5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;
 &amp;#x2014; The Company has issued warrants to purchase shares of its
 common stock. Warrants have been accounted for within equity in
 accordance with the provisions of ASC 815-40, Contracts in an
 Entity&amp;#x2019;s Own Stock, previously EITF Issue No. 00-19:
 &lt;i&gt;Accounting for Derivative Financial Instruments Indexed to, and
 Potentially Settled in, a Company&amp;#x2019;s Own Stock&lt;/i&gt;.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:WarrantsPolicyTextBlock>
  <mnkd:AmortizationPeriodOfLeaseHoldImprovements contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_DC318011-5C42-4E17-ACCF-F50AC3F4DF43_1_0">P4Y</mnkd:AmortizationPeriodOfLeaseHoldImprovements>
  <mnkd:CommonAndPreferredStockTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_7754D45D-031B-4E76-BA78-515E36FF5D56_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;10. Common and preferred
 stock&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Private
 Placements&lt;/i&gt; &amp;#x2014; On August&amp;#xA0;5, 2005, the Company closed a
 $175.0 million private placement of common stock and the concurrent
 issuance of warrants for the purchase of additional shares of
 common stock to accredited investors including the Company&amp;#x2019;s
 principal stockholder who purchased $87.3 million of the private
 placement. The Company sold 17,132,000 shares of common stock in
 the private placement, together with warrants to purchase up to
 3,426,000 shares of common stock at an exercise price of $12.228
 per share which became exercisable on February&amp;#xA0;1, 2006 and
 expired on August&amp;#xA0;5, 2010. In connection with this private
 placement, the Company paid $4.5 million in commissions to the
 placement agents and incurred $300,000 in other offering expenses
 which resulted in net proceeds of approximately
 $170.2&amp;#xA0;million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Public
 Equity Offerings&lt;/i&gt; &amp;#x2014; On August&amp;#xA0;5, 2009, the Company
 sold 8,360,000 shares of its common stock, including 960,000 shares
 sold pursuant to the full exercise of an over-allotment option
 granted to the underwriters of the offering, at a public offering
 price of $7.35 per share. The Company&amp;#x2019;s principal stockholder
 purchased 1,000,000 of these shares from the underwriters at a
 price per share of $8.11. The sale of common stock resulted in
 aggregate net proceeds to the Company of approximately $59.7
 million after deducting offering expenses.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; PADDING-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Included in the
 common stock outstanding as of December&amp;#xA0;31, 2011, 2012 and
 2013 are 9,000,000 shares of common stock loaned to Bank of America
 under a share lending agreement in connection with the offering of
 the $100.0 million aggregate principal amount of 2015 notes (see
 Note 7). Bank of America is obligated to return the borrowed shares
 (or, in certain circumstances, the cash value thereof) to the
 Company on or about the 45&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;sup style="VERTICAL-ALIGN: baseline; POSITION: relative; BOTTOM: 0.8ex"&gt;th&lt;/sup&gt;&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;business day following the date as of which the
 entire principal amount of the notes ceases to be outstanding,
 subject to extension or acceleration in certain circumstances or
 early termination at Bank of America&amp;#x2019;s option. The Company
 did not receive any proceeds from the sale of the borrowed shares
 by Bank of America, but the Company did receive a nominal lending
 fee of $0.01 per share from Bank of America for the use of borrowed
 shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;10, 2010, the Company entered into an agreement with
 Seaside for the sale of up to 18,200,000&amp;#xA0;shares of common
 stock in increments of 700,000 shares on a bi-weekly basis with the
 first closing date scheduled for September&amp;#xA0;22, 2010 provided
 that certain conditions are met, including for a particular closing
 to take place, the &lt;font style="WHITE-SPACE: nowrap"&gt;ten-day&lt;/font&gt;
 volume weighted average trading price for the Company&amp;#x2019;s
 common stock immediately prior to such closing must be at least
 $6.50 per share. If the ten-day volume weighted average trading
 price for a particular closing was below $6.50 per share, then that
 closing did not occur and the aggregate number of shares to be
 purchased was reduced by 700,000 shares. The purchase price per
 share at each closing was equal to 92% of that 10-day volume
 weighted average price. During the years ended December&amp;#xA0;31,
 2010 and 2011, the Company issued and sold a total of 2,100,000 and
 1,400,000 shares of common stock, respectively, to Seaside for net
 proceeds of $14.1 million and $9.7 million, respectively, in
 accordance with the agreement. The agreement with Seaside
 terminated during the quarter ended September&amp;#xA0;30, 2011. During
 the agreement, the Company issued and sold a total of 3,500,000
 shares of common stock to Seaside for net proceeds of $23.8
 million. In conjunction with the Seaside agreement, on
 August&amp;#xA0;10, 2010, the Company entered into a common stock
 purchase agreement with The Mann Group. Under this common stock
 purchase agreement, the Company was required to issue and sell, and
 The Mann Group was obligated to purchase at a price equal to the
 greater of $7.15 per share (the closing bid price of the
 Company&amp;#x2019;s common stock on August&amp;#xA0;10, 2010) and the
 closing bid price of common stock on the trading day immediately
 preceding the applicable closing date, the same number of shares of
 the Company&amp;#x2019;s common stock that Seaside purchased on each
 closing date under its agreement with the Company (see Note 6).
 Concurrently with the Seaside closing, the Company issued and sold
 2,100,000 and 1,400,000 shares to The Mann Group as of
 December&amp;#xA0;31, 2010 and 2011, respectively, for a total purchase
 price of $16.7 million and $11.1 million, respectively, which was
 paid by the cancellation of outstanding principal under the
 Company&amp;#x2019;s loan agreement with The Mann Group. The agreement
 with The Mann Group terminated during the quarter ended
 September&amp;#xA0;30, 2011. During the agreement, the Company issued
 and sold a total of 3,500,000 shares of common stock to The Mann
 Group that had resulted in total reduction in the note payable to
 The Mann Group of $27.8 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 February&amp;#xA0;8, 2012, the Company sold 35,937,500 units in an
 underwritten public offering, including 4,687,500 units sold
 pursuant to the full exercise of an over-allotment option granted
 to the underwriters, with each unit consisting of one share of
 common stock and a warrant to purchase 0.6 of a share of common
 stock. All of the securities were offered by the Company at a
 combined price to the public of $2.40 per unit and the underwriters
 purchased the units at a price of $2.256 per unit. Net proceeds
 from this offering were approximately $80.6 million, excluding any
 warrant exercises. The 21,562,500 shares of common stock underlying
 the warrants are exercisable at $2.40 per share and expire four
 years from the date of the issuance. The shares of common stock and
 warrants are immediately separable and were issued separately.
 Concurrent with the February 2012 underwritten public offering, the
 Company entered into a common stock purchase agreement with The
 Mann Group, pursuant to which the Company agreed to sell and The
 Mann Group agreed to purchase 31,250,000 shares of the
 Company&amp;#x2019;s restricted common stock at a price of $2.47 per
 share, the closing of which was subject to the expiration or
 termination of the waiting period under the Hart-Scott-Rodino
 Antitrust Improvements Act of 1976, as amended (&amp;#x201C;HSR
 Clearance&amp;#x201D;), and the Company&amp;#x2019;s receipt of stockholder
 approval to increase the authorized number of shares of our common
 stock. In June 2012, following HSR Clearance and the
 Company&amp;#x2019;s receipt of such stockholder approval, The Mann
 Group purchased $77.2 million worth of restricted shares of common
 stock which were paid through the cancellation of principal
 indebtedness under the amended loan arrangement with The Mann Group
 (see Note 6). For the twelve months ended December&amp;#xA0;31, 2013,
 the Company received $4.5 million in proceeds from the exercise of
 the February 2012 public offering warrants, with $47.3 million
 remaining unexercised.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 concluded that The Mann Group common stock purchase agreement
 represented a contingent forward purchase contract that met the
 definition of a derivative instrument in accordance with ASC
 815&lt;i&gt;.&lt;/i&gt; Of the 31,250,000 shares issuable pursuant to the
 common stock purchase agreement, the portion of the derivative
 instrument representing 14.7&amp;#xA0;million shares were recorded as
 equity (&amp;#x201C;Equity Portion&amp;#x201D;) as they met the criteria for
 equity classification under ASC 815-40 &lt;i&gt;Derivatives and Hedging,
 Contracts in an Entity&amp;#x2019;s Own Stock.&amp;#xA0;&lt;/i&gt;The remaining
 16.5&amp;#xA0;million shares (&amp;#x201C;Non-Equity Portion&amp;#x201D;)
 required classification outside of equity as the Company did not
 have sufficient available shares at the time of issuance.&amp;#xA0;The
 Company revalued the Non-Equity Portion of the forward purchase
 contract at each reporting date and recorded a fair value
 adjustment within &amp;#x201C;Other income (expense)&amp;#x201D;.&amp;#xA0;At the
 time of issuance, the fair value of the forward purchase contract
 was $2.0 million. The Equity Portion of $0.9 million
 was&amp;#xA0;classified as equity, and the Non-Equity Portion of $1.1
 million was initially recorded to&amp;#xA0;&amp;#x201C;Prepaid expenses and
 other current assets.&amp;#x201D;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;17,
 2012, the Company&amp;#x2019;s stockholders approved an increase in its
 authorized shares of common stock from 250,000,000 to 350,000,000.
 Accordingly, the shares of common stock needed to consummate The
 Mann Group common stock purchase agreement dated February&amp;#xA0;2,
 2012 became available.&amp;#xA0;As of May&amp;#xA0;17, 2012, the fair value
 of the Non-Equity Portion was $13.1 million.&amp;#xA0;As of result of
 receiving stockholder approval of the increase in authorized
 shares, the Non-Equity Portion met the criteria for equity
 classification. Consequently, the Company reclassified the $13.1
 million from &amp;#x201C;Prepaid expenses and other current
 assets&amp;#x201D; to &amp;#x201C;Additional paid-in
 capital.&amp;#x201D;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
 of the forward purchase contract is highly sensitive to the
 discount applied for lack of marketability and the stock price, and
 changes in this discount and/or the stock price caused the value of
 the forward purchase contract to change significantly. As of and
 for the year ended December&amp;#xA0;31, 2012, the Company recognized
 the change in fair value of $12.0 million in &amp;#x201C;Other income
 (expense).&amp;#x201D; The Company revalued the Non-Equity Portion using
 a forward contract valuation formula, in which the forward contract
 was estimated to be equal to the valuation date stock price of
 $2.40 at issuance and $1.69 at May&amp;#xA0;17, 2012 minus the strike
 price discounted to the valuation date using a risk-free rate of
 0.08% at issuance and 0.18% at May&amp;#xA0;17, 2012.&amp;#xA0;As the
 shares which would be received upon settlement were unregistered,
 the Company applied a discount for lack of marketability of 2.57%
 at issuance and 0.42% at May&amp;#xA0;17, 2012 based on quantitative
 put models, adjusted to take into account qualitative factors,
 including the fact that the Company&amp;#x2019;s stock was publicly
 traded and the fact that there was no contractual restriction on
 the unregistered shares being registered.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
 2012, pursuant to a previously filed Shelf Registration, which was
 declared effective by the SEC on September&amp;#xA0;24, 2012, the
 Company sold in an underwritten public offering 40,000,000 shares
 of its common stock, together with warrants to purchase up to
 30,000,000 shares of the Company&amp;#x2019;s common stock. In addition,
 the Company sold pursuant to the full exercise of an over-allotment
 option granted to the underwriters, an additional 6,000,000 shares
 of common stock, together with warrants to purchase up to an
 aggregate of 4,500,000&amp;#xA0;shares of common stock. All of the
 securities were sold together with a warrant for a combined
 purchase price of $2.00 per unit. The shares of common stock and
 warrants are immediately separable and were issued separately. Net
 proceeds from this offering were approximately $86.3 million (after
 deducting discounts and commissions to the underwriters and
 offering expenses), excluding any future proceeds from the exercise
 of the warrants. Each warrant entitles the holder to purchase 0.75
 of a share of common stock. The warrants are exercisable at $2.60
 per share and expired in October 2013. The Company received $89.7
 million in proceeds from the exercise of such warrants prior to
 their expiration. The Company performed an analysis of the warrants
 to determine their appropriate classification and concluded that
 the warrants should be classified within equity.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Concurrently
 with the underwritten public offering, the Company entered into a
 Common Stock and Warrant Purchase agreement, in which the Company
 was required to issue and sell and The Mann Group was obligated to
 purchase 40,000,000 restricted shares of the Company&amp;#x2019;s common
 stock and 40,000,000 warrants to purchase up to an aggregate of
 30,000,000 restricted shares of the Company&amp;#x2019;s common stock in
 a separate private placement. The restricted shares were sold to
 The Mann Group at $2.59 per share (the consolidated closing bid
 price of the Company&amp;#x2019;s common stock on October&amp;#xA0;17,
 2012), and the warrants were sold to The Mann Group at a purchase
 price of $0.125 for each share of the Company&amp;#x2019;s common stock
 underlying the warrants, in exchange for cancellation of
 outstanding principal under the $350.0 million amended and restated
 promissory note with The Mann Group. The restricted shares and
 warrants were sold to The Mann Group for an aggregate purchase
 price of $107.4 million. Following receipt of stockholder approval,
 in December 2012, to increase the Company&amp;#x2019;s authorized shares
 of common stock from 350,000,000 to 550,000,000, the Common Stock
 and Warrant Purchase agreement was consummated, and the shares of
 common stock and warrants were issued to The Mann Group.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On the date the
 Common Stock and Warrant Purchase agreement was entered into with
 The Mann Group, the Company did not have a sufficient number of
 authorized, unissued and available common shares to satisfy their
 commitments under this agreement. The Company characterized the
 Common Stock and Warrant Purchase agreement as a forward contract,
 in accordance with ASC 815-40, to deliver a single unit comprising
 40,000,000&amp;#xA0;shares of restricted common stock and 40,000,000
 warrants to purchase 30,000,000 shares of restricted common stock
 that should be classified as assets or liabilities accounted for at
 fair value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At the time of
 issuance, the Company determined the fair value of the forward
 contract to be $28.2 million and recorded a current asset. On
 December&amp;#xA0;20, 2012, the date at which a sufficient number of
 authorized and unissued common shares became available following
 approval by the stockholders to increase its authorized shares of
 common stock, the Company re-valued the forward contract and
 recorded a fair value adjustment to &amp;#x201C;Other income
 (expense)&amp;#x201D; of $13.2 million expense. Therefore, having met
 the criteria for equity classification, the Company reclassified
 the remaining balance of the forward contract of $15.0 million to
 additional paid in capital. In addition, the Company performed an
 analysis of the warrants to determine their appropriate
 classification once the forward contract settled and concluded that
 the warrants should be classified within equity.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
 of the forward purchase contract is highly sensitive to the
 discount applied for lack of marketability and the stock price, and
 changes in this discount and/or the stock price caused the value of
 the Forward Contract to change significantly. The value of the
 derivative instrument was calculated using a forward contract
 valuation formula in which the forward contract is estimated to be
 equal to the valuation date stock price minus the strike price
 discounted to the valuation date using a risk-free rate of 0.11% at
 issuance on October&amp;#xA0;18, 2012 and 0.00% at closing on
 December&amp;#xA0;20, 2012.&amp;#xA0;As the shares which would be received
 upon settlement are currently unregistered, the Company applied a
 discount for lack of marketability of 2.3% at October&amp;#xA0;18, 2012
 and 1.5% at December&amp;#xA0;20, 2012 to reflect this lack of
 marketability based on quantitative put models, adjusted to take
 into account qualitative factors, including the fact that the
 Company&amp;#x2019;s stock is publicly traded and the fact that there is
 no contractual restriction on the unregistered shares being
 registered.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 then determined that upon the settlement of the forward contracts,
 the common stock and warrants represent freestanding financial
 instruments and should be initially recorded at their relative fair
 values based on the total consideration received. The total
 consideration received equaled the $107.4 million principal amount
 of indebtedness cancelled less the recorded value of the forward
 contracts on December&amp;#xA0;20, 2012, the date immediately before
 settlement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 October&amp;#xA0;31, 2013, under the Amended and Restated Promissory
 Note, the Company issued 30,000,000&amp;#xA0;shares of common stock to
 The Mann Group upon the exercise of warrants. In exchange, the
 Company and The Mann Group agreed to cancel $78.0 million of
 outstanding principal indebtedness and to capitalize into principal
 the approximately $7.9 million of accrued interest that became due
 and payable upon cancellation of such principal
 indebtedness.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On July&amp;#xA0;1,
 2013, the Company entered into the Facility Agreement (see Note 16)
 pursuant to which the Company had sold $120.0 million aggregate
 principal amount of notes to Deerfield in three tranches occurring
 on July&amp;#xA0;1, 2013,&amp;#xA0;September&amp;#xA0;5, 2013 and
 December&amp;#xA0;9, 2013. Subject to certain conditions, as of
 December&amp;#xA0;31, 2013, Deerfield was permitted to convert a
 portion of the 2019 notes into shares of the Company&amp;#x2019;s common
 stock as described under &amp;#x201C;Conversion Option&amp;#x201D; in Note 16
 below. As of December&amp;#xA0;31, 2013, Deerfield converted
 $6.5&amp;#xA0;million of principal from the 2019 notes, resulting in an
 issuance of 1,293,224 shares of common stock. The outstanding
 principal amount as of December&amp;#xA0;31, 2013 was $113.5 million
 (see Note 18).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company is
 authorized to issue 550,000,000 shares of common stock, par value
 $0.01 per share, and 10,000,000 shares of undesignated preferred
 stock, par value $0.01 per share, issuable in one or more series
 designated by the Company&amp;#x2019;s board of directors. No other
 class of capital stock is authorized. As of December&amp;#xA0;31, 2012
 and 2013, 286,035,082 and 369,391,972 shares of common stock,
 respectively, were issued and outstanding and no shares of
 preferred stock were outstanding.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:CommonAndPreferredStockTextBlock>
  <mnkd:StockOptionsGrantedVestingRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_1_0">0.25</mnkd:StockOptionsGrantedVestingRate>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700210">172149000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_6">-817000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_F80ECDF4-80AF-44FA-A4E6-6CA2E1317400_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Recently
 Issued Accounting Standards&lt;/i&gt; &amp;#x2014; From time to time, new
 accounting pronouncements are issued by the Financial Accounting
 Standards Board (FASB) or other standard setting bodies that are
 adopted by the Company as of the specified effective date. Unless
 otherwise discussed, we believe that the impact of recently issued
 standards that are not yet effective will not have a material
 impact on our financial position or results of operations upon
 adoption.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In February
 2013, the FASB issued Accounting Standards Update (ASU) 2013-02,
 Comprehensive Income (Topic 220) &amp;#x2014; Reporting of Amounts
 Reclassified out of Accumulated Other Comprehensive
 Income.&amp;#xA0;These amendments do not change the current
 requirements for reporting net income or other comprehensive income
 in the financial statements. These amendments provide for
 additional disclosure requirements for amounts reclassified out of
 accumulated other comprehensive income. These amendments are
 effective prospectively for interim and annual periods beginning
 after December&amp;#xA0;15, 2012. Early adoption is permitted.
 Effective January&amp;#xA0;1, 2013, the Company adopted the new
 requirements as set forth in ASU 2013-02 in the disclosure of
 comprehensive income on the Company&amp;#x2019;s consolidated financial
 statements. The adoption of the new requirements did not have a
 significant impact on the Company&amp;#x2019;s consolidated financial
 statements.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In July 2013,
 the FASB ASU 2013-11, Income Taxes (Topic 740): Presentation of an
 Unrecognized Tax Benefit when a Net Operating Loss Carryforward, a
 Similar Tax Loss, or a Tax Credit Carryforward Exists
 (a&amp;#xA0;consensus of the FASB Emerging Issues Task Force). The
 amendments in this ASU provide guidance on the financial statements
 presentation of an unrecognized tax benefit when a net operating
 loss carryforward, a similar tax loss, or a tax credit carryforward
 exists. An unrecognized tax benefit should be presented in the
 financial statements as a reduction to a deferred tax asset for a
 net operating loss carryforward, a similar tax loss, or a tax
 credit carryforward with certain exceptions, in which case such an
 unrecognized tax benefit should be presented in the financial
 statements as a liability. The amendments in this ASU do not
 require new recurring disclosures. The amendments in this ASU are
 effective for fiscal years, and interim periods within those years,
 beginning after December&amp;#xA0;15, 2013. The Company does not expect
 the adoption of ASU 2013-11 will have an impact on the
 Company&amp;#x2019;s consolidated financial statements.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock>
  <mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_47">4801000</mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits>
  <mnkd:PercentageOfCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4020747_D3298CFD-5FEE-46C6-B6DC-15FB9919447E_1_0">0.65</mnkd:PercentageOfCreditExchangeReceivable>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49014_1700212">5501000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:MaturityPeriodOfCashEquivalents contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_DC83FA65-96C8-4967-AB3A-382718594443_1_0">90 days or less at the time of  purchase</mnkd:MaturityPeriodOfCashEquivalents>
  <mnkd:BusinessPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_B8A46033-76DE-41A6-8218-5FBDD99C4A31_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Business&lt;/i&gt;
 &amp;#x2014; MannKind Corporation and subsidiaries (the
 &amp;#x201C;Company&amp;#x201D;) is a biopharmaceutical company focused on
 the discovery, development and commercialization of therapeutic
 products for diseases such as diabetes. The Company&amp;#x2019;s lead
 product candidate, AFREZZA, (insulin human [rDNA origin])
 inhalation powder, is an ultra rapid-acting insulin therapy that is
 in late-stage clinical investigation for the treatment of adults
 with type 1 or type 2 diabetes for the control of
 hyperglycemia.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;AFREZZA
 consists of the Company&amp;#x2019;s proprietary Technosphere particles
 onto which insulin molecules are loaded. These loaded particles are
 then aerosolized and inhaled deep into the lung using the
 Company&amp;#x2019;s AFREZZA inhaler.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:BusinessPolicyTextBlock>
  <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="pure" xsi:nil="true" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_3_2" />
  <mnkd:ValueOfRestrictedStockUnitsVested contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_D84AED40-8E33-4ACE-A258-AF1FDE08310A_1_2">45600000</mnkd:ValueOfRestrictedStockUnitsVested>
  <mnkd:ClinicalTrialExpensePolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_68C3CE89-38BC-48DC-AFAD-E0063A32B258_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Clinical
 Trial Expenses&lt;/i&gt; &amp;#x2014; Clinical trial expenses, which are
 reflected in research and development expenses in the accompanying
 statements of operations, result from obligations under contracts
 with vendors, consultants, and clinical site agreements in
 connection with conducting clinical trials. The financial terms of
 these contracts are subject to negotiations which vary from
 contract to contract and may result in payment flows that do not
 match the periods over which materials or services are provided to
 the Company under such contracts. The appropriate level of trial
 expenses are reflected in the Company&amp;#x2019;s financial statements
 by matching period expenses with period services and efforts
 expended. These expenses are recorded according to the progress of
 the trial as measured by patient progression and the timing of
 various aspects of the trial. Clinical trial accrual estimates are
 determined through discussions with internal clinical personnel and
 outside service providers as to the progress or state of completion
 of trials, or the services completed. Service provider status is
 then compared to the contractually obligated fee to be paid for
 such services. During the course of a clinical trial, the Company
 may adjust the rate of clinical expense recognized if actual
 results differ from management&amp;#x2019;s estimates.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:ClinicalTrialExpensePolicyTextBlock>
  <mnkd:ForwardContractsPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_F1F4E4C6-2029-41B9-9054-84F61651C3C5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Forward
 Contracts&lt;/i&gt; &amp;#x2014; The Company has entered into agreements with
 The Mann Group whereby the Company agreed to sell and The Mann
 Group agreed to purchase common stock and/or warrants. These
 agreements have been accounted for as forward contracts, having met
 the definition of derivative instruments in accordance with the
 provisions of ASC 815 &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. The Company
 determines the fair value of the forward contract upon its
 issuance, records fair value adjustments of the forward contract to
 Other income (expense) during the reporting period and through the
 settlement of the forward contract, and reclassifies the forward
 contract to equity upon settlement of the forward
 contract.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:ForwardContractsPolicyTextBlock>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_67">78000000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_16">466000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_140FB25F-F8EE-4F4C-B786-4B576F9D424E_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;3. State research and
 development credit exchange receivable&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The State of
 Connecticut provides certain companies with the opportunity to
 exchange certain research and development income tax credit
 carryforwards for cash in exchange for forgoing the carryforward of
 the research and development income tax credits. The program
 provides for an exchange of research and development income tax
 credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses. During the years ended December&amp;#xA0;31, 2011, 2012 and
 2013, research and development expenses were offset by $609,000,
 $289,000 and $282,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:StateResearchAndDevelopmentCreditExchangeReceivableTextBlock>
  <mnkd:ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E8B2C803-7E08-4339-A27A-FABB4B317736_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,366&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,167&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;20,409&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,838&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,125&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;24,777&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;11,204&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mnkd:ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock>
  <mnkd:ScheduleOfPrincipalAmountOutstandingUnderLoanArrangementTableTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_5A999734-5CD4-413F-9018-24E33246EA3A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The principal
 amount outstanding under the Loan Arrangement as of
 December&amp;#xA0;31, 2012 and 2013, respectively, subsequent to the
 completion of the common stock purchase agreements was as follows
 (in&amp;#xA0;thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="90%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount
 outstanding at December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;119,635&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalization of accrued
 and unpaid interest due and payable as of October&amp;#xA0;31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,886&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Reduction of principal
 indebtedness related to the issuance of common stock pursuant to
 The Mann Group Warrants completed on October&amp;#xA0;31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(78,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Principal amount
 outstanding at December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;49,521&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mnkd:ScheduleOfPrincipalAmountOutstandingUnderLoanArrangementTableTextBlock>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_3_30">52421000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_483DB2C9-1020-4904-A5BF-E26DEF73D3C5_1_0">82000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_3_11" />
  <mnkd:CommitmentAssetPolicyTextBlock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0" id="id_4020747_E85A49E2-72BC-4978-B92D-16E8CE5B9F16_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Commitment
 Asset&lt;/i&gt; &amp;#x2014; In connection with issuance of the first tranche
 of 2019 notes and the Milestone Rights, the Company recorded the
 Commitment Asset on July&amp;#xA0;1, 2013.&amp;#xA0;The Commitment Asset
 represents the right to receive additional funding under future
 tranches of 2019 notes pursuant to the Facility Agreement. The
 initial value of the Commitment Asset was calculated using the
 income approach by estimating the fair value of the future tranches
 using a market debt rate commensurate with the risk of the future
 tranches and the fair value of the cash expected to be received by
 us and assessing the probability of the commitments being funded in
 the future based on the operational hurdles required for funding
 being met. The Commitment Asset attributable to each future tranche
 of 2019 notes under the Facility Agreement is derecognized and
 recorded as a debt discount on the 2019 notes when issued. The debt
 discount is amortized using the effective interest rate method over
 the life of the 2019 notes. Prior to derecognition occurring, the
 Company monitors the Commitment Asset on an ongoing basis to
 determine whether an impairment indicator is present that would
 result in a full or partial write down of the Commitment Asset as a
 result of events that may lead to the subsequent tranches of 2019
 notes not being issued. Based on the monitoring procedures
 performed through December&amp;#xA0;31, 2013, the Company did not
 identify any indicators of impairment.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:CommitmentAssetPolicyTextBlock>
  <us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289" unitRef="D" decimals="0" id="id_4020747_60159B84-4FD5-4C36-BB3B-C10C5DED7B8D_1001_0">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289" unitRef="iso4217_USD" decimals="-3" id="id_4020747_EBDEAF87-589D-4EE5-A68F-43658F74D561_1002_1">1113000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289" unitRef="iso4217_USD" decimals="-3" id="id_4020747_EBDEAF87-589D-4EE5-A68F-43658F74D561_1002_0">42000</us-gaap:AmortizationOfFinancingCosts>
  <mnkd:NumberOfDays contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289" id="id_4020747_464D42C7-287A-4FE2-B593-981332F3E98F_1001_0">P20D</mnkd:NumberOfDays>
  <mnkd:LegalSettlementsAndCommitments contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289" unitRef="iso4217_USD" decimals="0" id="id_4020747_E92302CE-726E-4C34-BE4A-998B3D6B6EC5_1001_1">100000</mnkd:LegalSettlementsAndCommitments>
  <mnkd:NumberOfBusinessDays contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289" unitRef="D" decimals="0" id="id_4020747_464D42C7-287A-4FE2-B593-981332F3E98F_1001_1">2</mnkd:NumberOfBusinessDays>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708502x883668_714378x735725" unitRef="shares" decimals="INF" id="id_4020747_6C48B433-B1D4-47D4-BC95-5B596945CBAD_1002_2">1293224</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708502x883668_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_6C48B433-B1D4-47D4-BC95-5B596945CBAD_1002_1">6500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x732192" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_1001_4">40000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:DebtInstrumentConvertibleStockPriceTrigger contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x732192_711502x711169" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_2001_5">3.33</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
  <us-gaap:DebtInstrumentConvertibleStockPriceTrigger contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x732192_711502x716112" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_3001_6">6.67</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
  <us-gaap:DebtInstrumentConvertibleStockPriceTrigger contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x784846" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_4001_3">6.67</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x784846" unitRef="shares" decimals="-5" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_4001_2">6000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtInstrumentConvertibleStockPriceTrigger contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x825279" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_5001_1">3.33</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x825279" unitRef="shares" decimals="-5" id="id_4020747_4FD5378C-0AFF-4DBB-9A3C-D8AE7FA8FE02_5001_0">12000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_714378x735725" unitRef="shares" decimals="INF" id="id_4020747_C9CFC34A-F0CA-4CE2-8BBE-6AB98B9A92DB_1001_1">1293224</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_714378x735725" unitRef="iso4217_USD" decimals="-5" id="id_4020747_C9CFC34A-F0CA-4CE2-8BBE-6AB98B9A92DB_1001_0">6500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_707179x753998" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21B9FC62-1588-4493-BDC7-42A12FC52889_1003_1">5000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_707179x768389" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21B9FC62-1588-4493-BDC7-42A12FC52889_2003_0">45181000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_708873x716845" unitRef="iso4217_USD" decimals="-5" id="id_4020747_02F60DAA-47E5-4375-8FBA-C6382E03D0F8_1002_4">47300000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200213">48789000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200207">2261000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200219">998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200208">-4821000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200216">1258000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200217">45186000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200210">171485000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200215">-28000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49009_1200212">5489000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000213">9824000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000208">1870000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000207">880000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000216">557000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100213">99000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100207">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100208">20000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100216">5000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000209">66353000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100210">664000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100215">28000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1100212">12000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000214">2778000</mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodSharesForDebtExchange contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49007_1000211">1095000</mnkd:StockIssuedDuringPeriodSharesForDebtExchange>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49012_1500218">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_49013_1600220">-191490000</us-gaap:NetIncomeLoss>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_709863x713171_711672x762619_717061x739260" unitRef="pure" decimals="2" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_1001_6">0.05</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <mnkd:NetOperatingLossCarryforwardsBeginsToExpire contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_710844x707398" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_1001_2">2018</mnkd:NetOperatingLossCarryforwardsBeginsToExpire>
  <mnkd:ResearchAndDevelopmentCreditsBeginToExpire contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_710844x707398" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_1001_8">2024</mnkd:ResearchAndDevelopmentCreditsBeginToExpire>
  <mnkd:NetOperatingLossCarryforwardsBeginsToExpire contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_710844x711886" id="id_4020747_26049B63-8707-448D-AD02-47E8268908AF_2001_3">2014</mnkd:NetOperatingLossCarryforwardsBeginsToExpire>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1003_0">0.0094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1003_4">0.7583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1003_2">P2Y7M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_1001_4">P11M</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod>
  <mnkd:NumberOfMonthsAdvancesOutstanding contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_711672x712230_717061x772809" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_2001_3">P12M</mnkd:NumberOfMonthsAdvancesOutstanding>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x707341" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_1001_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x714221" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_2001_4">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x715869" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_3001_0">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x767832" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_4001_6">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2003_1">0.0182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2003_5">0.8626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2003_3">P5Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_2001_7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_2001_5">P96M</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod>
  <mnkd:RelatedPartyTransactionDebtInstrumentPrepayment contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_711672x712230_717061x772809" unitRef="iso4217_USD" decimals="-5" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_3001_2">200000000</mnkd:RelatedPartyTransactionDebtInstrumentPrepayment>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x707341" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_5001_3">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x714221" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_6001_5">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x715869" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_7001_1">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x767832" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_8001_7">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <mnkd:AvailableLoanBalanceCancelled contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x712230_717061x772809" unitRef="iso4217_USD" decimals="-5" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_4001_5">105000000</mnkd:AvailableLoanBalanceCancelled>
  <mnkd:RelatedPartyTransactionPrepaymentPeriod contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x712230_717061x772809" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_4001_4">P90D</mnkd:RelatedPartyTransactionPrepaymentPeriod>
  <mnkd:BorrowingRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x712230_717061x772809" unitRef="pure" decimals="4" id="id_4020747_D912E0B3-6836-4A6C-8799-BBA2306E7CDF_3003_3">0.0584</mnkd:BorrowingRate>
  <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x762619_717061x739260" id="id_4020747_9915A37A-83C6-4380-BCCD-AAD89234F41D_5001_7">The interest rate will increase to the one-year LIBOR rate  calculated on the date of the initial advance or in effect on the date of  default, whichever is greater, plus 5% per annum.</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x768251" unitRef="iso4217_USD" decimals="-3" id="id_4020747_08FD00DD-3E45-4A5C-B54D-7C81CB7F649F_1_1">7886000</us-gaap:InterestCostsCapitalized>
  <mnkd:RelatedPartyTransactionDebtInstrumentPrepaymentMinimum contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x768251" unitRef="iso4217_USD" decimals="-3" id="id_4020747_08FD00DD-3E45-4A5C-B54D-7C81CB7F649F_1_2">78000000</mnkd:RelatedPartyTransactionDebtInstrumentPrepaymentMinimum>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712080x726565" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A3A7CE56-7FFB-48D6-9E38-AABE288E6AAB_1003_0">20409000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712080x782834" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A3A7CE56-7FFB-48D6-9E38-AABE288E6AAB_2003_1">24777000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x708177" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_1003_1">25415366</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x708980" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_2003_0">24237940</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x715581" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_3003_2">19706240</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x716908" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_4003_3">9115821</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <mnkd:ClosingBidPriceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712948x786588" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_E3478E6F-0D3B-4E7A-B749-32CAC4FCA085_1001_2">1.00</mnkd:ClosingBidPriceOfCommonStock>
  <mnkd:NumberOfCommonStockToBeIssuedToClassMembersAndAttorneys contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712948x786588" unitRef="shares" decimals="0" id="id_4020747_E3478E6F-0D3B-4E7A-B749-32CAC4FCA085_1001_1">2777778</mnkd:NumberOfCommonStockToBeIssuedToClassMembersAndAttorneys>
  <mnkd:AdditionalNumberOfCommonStockToBeIssuedToClassMembersAndAttorneys contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_712948x786588" unitRef="shares" decimals="0" id="id_4020747_E3478E6F-0D3B-4E7A-B749-32CAC4FCA085_1001_3">1000000</mnkd:AdditionalNumberOfCommonStockToBeIssuedToClassMembersAndAttorneys>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_713115x708980" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_3001_2">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_713115x716908" id="id_4020747_C26227A5-8C2C-4096-9AB4-2579921A4526_4001_3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_714378x732890" unitRef="pure" decimals="2" id="id_4020747_C92460C1-F947-43B8-BE33-C3A3AE097D96_1002_1">0.65</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:PaymentsForLegalSettlements contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_714807x764236" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4EFC7640-76EA-4016-94BA-7AD5C6E5F7EC_1001_1">8400000</us-gaap:PaymentsForLegalSettlements>
  <us-gaap:PaymentsForLegalSettlements contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_714807x819294" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4EFC7640-76EA-4016-94BA-7AD5C6E5F7EC_2001_2">7600000</us-gaap:PaymentsForLegalSettlements>
  <us-gaap:FairValueInputsComparabilityAdjustments contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_715632x806573" unitRef="pure" decimals="INF" id="id_4020747_E92302CE-726E-4C34-BE4A-998B3D6B6EC5_2001_3">0.0</us-gaap:FairValueInputsComparabilityAdjustments>
  <us-gaap:FairValueInputsComparabilityAdjustments contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_715632x883633" unitRef="pure" decimals="3" id="id_4020747_E92302CE-726E-4C34-BE4A-998B3D6B6EC5_3001_2">0.008</us-gaap:FairValueInputsComparabilityAdjustments>
  <us-gaap:FairValueInputsComparabilityAdjustments contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_715632x883634" unitRef="pure" decimals="3" id="id_4020747_E92302CE-726E-4C34-BE4A-998B3D6B6EC5_4001_4">0.001</us-gaap:FairValueInputsComparabilityAdjustments>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_715832x716297" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_9001_9">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_715832x740890" id="id_4020747_E561F4A7-65F1-475F-8098-7B48CD4474DB_10001_8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_716833x715326_733234x883632" unitRef="pure" decimals="3" id="id_4020747_52525C82-7561-4ED3-9CC1-A672874AF84D_3002_0">0.127</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_786923x827982" unitRef="iso4217_USD" decimals="-5" id="id_4020747_4F086303-D110-4D14-87C9-A2289E537E4B_2003_13">4500000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_365_20131231_0_803904x806301" unitRef="iso4217_USD" decimals="-5" id="id_4020747_3AE7DE53-3DED-48AC-A951-E4D25CC8A1DF_1002_1">48900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14014_1700023">59000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14014_1700024">12000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14014_1700026">-2570000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14014_1700025">126000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14009_1200023">59000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14009_1200024">12000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14009_1200025">126000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14007_1000023">1000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14007_1000024">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_14013_1600026">-2570000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700046">31633000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700049">-993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700053">-24661000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700044">1074000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700052">9609000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700051">149000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700048">117000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalAmountInExcessOfRedemptionObligation contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700050">999000</mnkd:AdjustmentsToAdditionalPaidInCapitalAmountInExcessOfRedemptionObligation>
  <mnkd:NotesReceivableFromStockholdersDiscountOnNotesBelowMarketRate contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700047">241000</mnkd:NotesReceivableFromStockholdersDiscountOnNotesBelowMarketRate>
  <mnkd:StockIssuedDuringPeriodValue contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22014_1700045">15000000</mnkd:StockIssuedDuringPeriodValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22009_1200046">33945000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22009_1200049">-993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22009_1200044">1073000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22009_1200052">9609000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22009_1200051">149000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalAmountInExcessOfRedemptionObligation contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22009_1200050">999000</mnkd:AdjustmentsToAdditionalPaidInCapitalAmountInExcessOfRedemptionObligation>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22007_1000046">4690000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22007_1000044">63000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22007_1100046">46000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22007_1100044">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22010_1300046">-2358000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22010_1300048">117000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:NotesReceivableFromStockholdersDiscountOnNotesBelowMarketRate contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22010_1300047">241000</mnkd:NotesReceivableFromStockholdersDiscountOnNotesBelowMarketRate>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22013_1600053">-24661000</us-gaap:NetIncomeLoss>
  <mnkd:StockIssuedDuringPeriodValue contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x827132" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22001_500045">15000000</mnkd:StockIssuedDuringPeriodValue>
  <mnkd:StockIssuedDuringPeriodShares contextRef="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x827132" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_22001_400045">193000</mnkd:StockIssuedDuringPeriodShares>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700099">1079000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700115">19822000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700119">-75992000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700096">18153000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700113">430000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700118">6810000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700117">60000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700102">107000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:NotesReceivableFromOfficersRepayment contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700103">3000</mnkd:NotesReceivableFromOfficersRepayment>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700116">19822000</mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700107">5248000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700114">83176000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <mnkd:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30014_1700101">46000</mnkd:StockIssuedDuringPeriodValueWarrantsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200099">1079000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200115">19822000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200113">430000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200118">6810000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200117">60000</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesC contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200111">49955000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesC>
  <mnkd:NotesReceivableFromOfficersRepayment contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200103">-225000</mnkd:NotesReceivableFromOfficersRepayment>
  <mnkd:StockRepaidDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200105">1518000</mnkd:StockRepaidDuringPeriodValueNotesReceivable>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesB contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200109">14992000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesB>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200116">19822000</mnkd:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200107">5239000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200114">83110000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <mnkd:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30009_1200101">46000</mnkd:StockIssuedDuringPeriodValueWarrantsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000099">86000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000113">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesA contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000106">891000</mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesA>
  <mnkd:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000100">4000</mnkd:StockIssuedDuringPeriodSharesWarrantsExercised>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesC contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1100111">45000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesC>
  <mnkd:StockRepaidDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1100105">1000</mnkd:StockRepaidDuringPeriodValueNotesReceivable>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesB contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1100109">8000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesB>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1100107">9000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA>
  <mnkd:StockRepaidDuringPeriodSharesNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000104">90000</mnkd:StockRepaidDuringPeriodSharesNotesReceivable>
  <mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesC contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000110">4464000</mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesC>
  <mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesB contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000108">811000</mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesB>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1100114">66000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <mnkd:StockIssuedDuringPeriodSharesExchangeOfWarrants contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000112">22000</mnkd:StockIssuedDuringPeriodSharesExchangeOfWarrants>
  <mnkd:StockIssuedDuringPeriodSharesInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30007_1000114">6557000</mnkd:StockIssuedDuringPeriodSharesInitialPublicOffering>
  <mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30010_1300102">107000</mnkd:NotesReceivableFromStockholdersAccruedInterestOnNotes>
  <mnkd:StockRepaidDuringPeriodValueNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x728560" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30010_1300105">-1519000</mnkd:StockRepaidDuringPeriodValueNotesReceivable>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30003_600096">356000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30003_700096">18153000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesC contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30003_700111">-50000000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesC>
  <mnkd:StockIssuedDuringPeriodSharesCash contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30003_600097">624000</mnkd:StockIssuedDuringPeriodSharesCash>
  <mnkd:StockIssuedDuringPeriodValueCash contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30003_700098">31847000</mnkd:StockIssuedDuringPeriodValueCash>
  <mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesC contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30003_600110">-980000</mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesC>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30013_1600119">-75992000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x780368" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30006_900096">18153000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <mnkd:NotesReceivableFromOfficersRepayment contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x796933" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30011_1400103">228000</mnkd:NotesReceivableFromOfficersRepayment>
  <mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesB contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x827132" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30001_500109">-15000000</mnkd:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesB>
  <mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesB contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x827132" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30001_400108">-193000</mnkd:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesSeriesB>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x831084" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30005_800096">-18153000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <mnkd:StockIssuedDuringPeriodValueCash contextRef="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x831084" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_30005_800098">-31847000</mnkd:StockIssuedDuringPeriodValueCash>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38014_1700157">295000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38014_1700154">-18000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38014_1700158">-303039000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38014_1700155">-315000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38014_1700153">900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38014_1700156">24811000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38009_1200154">-18000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38009_1200155">-317000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38009_1200153">896000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38009_1200156">24811000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38007_1000155">248000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38007_1000154">30000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38007_1000153">349000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38007_1100155">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38007_1100153">4000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38012_1500157">295000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_38013_1600158">-303039000</us-gaap:NetIncomeLoss>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_2_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_2_3">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_2_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_2_4">-0.310</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_8E2D0D48-AF6A-43B1-8AC0-D6A18F63F663_2_0">0.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" xsi:nil="true" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2_6" />
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_22">-119860000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" xsi:nil="true" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_2_1" />
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_2_4">128324123</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_18">-0.94</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4020747_18A5FD47-F8E8-4184-AF8E-2CDE1707A3AF_3_5">422260</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" id="id_4020747_B334F4E9-396E-4D7E-8A04-8B2153E85FCA_2_2">P7Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_0">35000</us-gaap:SalesRevenueNet>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_26">637000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_11">-1237000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700191">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_11">7000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_17">-169366000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_65">4072000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_8">-1191000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_2_6">-48000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_54">9755000</us-gaap:InterestPaid>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_355F9DF3-F088-40CA-8635-7FCEBB492B86_2_0">60700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_12">-169774000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_17">1545000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_2_8">-169416000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_14">2000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_7">-146960000</us-gaap:OperatingIncomeLoss>
  <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_10">-117000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_14">-169366000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700192">-906000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700203">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_2_7">-50000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700195">184537000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700201">862000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700202">13292000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:InterestPaidCapitalized contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_66">14219000</us-gaap:InterestPaidCapitalized>
  <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_13">6056000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_10" />
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_3">45473000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_2CCD153F-8D00-47C3-B7D9-80917E88B817_2_0">1400000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_48">179579000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_4">13292000</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_3">14402000</us-gaap:DepreciationAndAmortization>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_49">59159000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_2" />
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_74F861B2-5530-405E-9B01-D127328E6D50_2_0">675000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_B334F4E9-396E-4D7E-8A04-8B2153E85FCA_2_0">9200</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_1" />
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_445758D9-B950-474B-8B1A-1CDCF6F14278_2_0">571000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_10">11139000</us-gaap:InterestExpenseDebt>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_6">146995000</us-gaap:OperatingExpenses>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_13">-408000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_9">-60739000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_8E2D0D48-AF6A-43B1-8AC0-D6A18F63F663_2_1">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B40FE96E-FD3B-4D80-9797-B0E2981FB4E3_2_0">21600000</us-gaap:InterestExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_19">44000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_27">77000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_6">51540000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_2">101522000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E735C6F-B052-4068-9E1D-4D2F1F130ABB_2_0">2900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_7">9199000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC318011-5C42-4E17-ACCF-F50AC3F4DF43_4_1">13000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_42">12750000</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_4" />
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_3" />
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A26B142D-4608-4A1A-8A78-6896108503C5_2_0">13292000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_8" />
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_28">-560000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700204">48000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_9">10491000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_8E735C6F-B052-4068-9E1D-4D2F1F130ABB_2_1">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_B40FE96E-FD3B-4D80-9797-B0E2981FB4E3_2_1">300000</us-gaap:InterestCostsCapitalized>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_20">15075000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <mnkd:NominalLendingFee contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_1A82A271-72C1-461C-A984-8ACC6688890F_2_2">0.01</mnkd:NominalLendingFee>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="shares" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_2_19">180855000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700199">6056000</mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_6">-682000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700198">438000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_47">906000</mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits>
  <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="pure" xsi:nil="true" id="id_4020747_C006C514-AD0B-4B5E-84C5-83EC0758D690_2_2" />
  <mnkd:ChangeInFairValueOfForwardExchangeRateContracts contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700196">-1237000</mnkd:ChangeInFairValueOfForwardExchangeRateContracts>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_67">184537000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_16">-290000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_69">28080000</mnkd:ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46014_1700194">166864000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <mnkd:ForwardPurchaseContractContributionToAdditionalPaidInCapital contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_68">29317000</mnkd:ForwardPurchaseContractContributionToAdditionalPaidInCapital>
  <mnkd:LossContingencySettlementAgreementStockIssuable contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="shares" decimals="0" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_3_1">3002778</mnkd:LossContingencySettlementAgreementStockIssuable>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_30">167735000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:CommonSharesIssuedPursuantToLitigationSettlement contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_2_12">438000</mnkd:CommonSharesIssuedPursuantToLitigationSettlement>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4020747_483DB2C9-1020-4904-A5BF-E26DEF73D3C5_2_0">200000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4020747_32A5574A-323D-4C6C-BB17-46641517F75C_2_11" />
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_707179x753998" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21B9FC62-1588-4493-BDC7-42A12FC52889_1002_1">68000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_707179x768389" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21B9FC62-1588-4493-BDC7-42A12FC52889_2002_0">13224000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200191">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200192">-915000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200195">183824000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200201">860000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200202">13292000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200199">6056000</mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200198">436000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:ChangeInFairValueOfForwardExchangeRateContracts contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200196">-1237000</mnkd:ChangeInFairValueOfForwardExchangeRateContracts>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46009_1200194">166045000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1000195">71250000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1000192">886000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1000191">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1000200">211000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1100192">9000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1100195">713000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1100201">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1100198">2000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1000197">225000</mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1100194">819000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <mnkd:StockIssuedDuringPeriodSharesInitialPublicOffering contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46007_1000193">81938000</mnkd:StockIssuedDuringPeriodSharesInitialPublicOffering>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46012_1500203">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x714212" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46012_1500204">48000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_46013_1600205">-169366000</us-gaap:NetIncomeLoss>
  <mnkd:ConversionOfConvertiblePreferredStockAmountConverted contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711196x710990" unitRef="shares" decimals="-6" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_1002_70">15000000</mnkd:ConversionOfConvertiblePreferredStockAmountConverted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x711169" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1002_0">0.0032</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x711169" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1002_4">0.7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x711169" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_1002_2">P1Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <mnkd:RangeOfFinalJudgment contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x711169_712948x768253" id="id_4020747_099F95E2-37A4-46F6-82D8-86705FD902F2_1001_3">P4M</mnkd:RangeOfFinalJudgment>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x716112" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2002_1">0.0116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x716112" unitRef="pure" decimals="4" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2002_5">0.8400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x716112" id="id_4020747_FEBF65CB-A36F-4080-93A8-3514CA2734E9_2002_3">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <mnkd:RangeOfFinalJudgment contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x716112_712948x768253" id="id_4020747_099F95E2-37A4-46F6-82D8-86705FD902F2_2001_4">P6M</mnkd:RangeOfFinalJudgment>
  <us-gaap:RestructuringReserveAccrualAdjustment contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_711976x780975" unitRef="iso4217_USD" decimals="-3" id="id_4020747_436EA9ED-9340-4A97-B160-5022E89E024B_7001_5">-67000</us-gaap:RestructuringReserveAccrualAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712080x726565" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A3A7CE56-7FFB-48D6-9E38-AABE288E6AAB_1002_0">6167000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712080x782834" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A3A7CE56-7FFB-48D6-9E38-AABE288E6AAB_2002_1">7125000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x708177" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_1002_1">19826113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x708980" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_2002_0">18674539</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x715581" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_3002_2">86062440</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x716908" unitRef="shares" decimals="INF" id="id_4020747_12F37F5E-9BDA-4159-97A8-43FFD7F762AA_4002_3">3761031</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <mnkd:PaymentByInsurerToPlaintiff contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x745900" unitRef="iso4217_USD" decimals="0" id="id_4020747_9C391435-CD95-4205-990B-30DC49C074F8_1001_0">800000</mnkd:PaymentByInsurerToPlaintiff>
  <mnkd:LossContingencySettlementAgreementStockIssuable contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x745900" unitRef="shares" decimals="0" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_1_1">225000</mnkd:LossContingencySettlementAgreementStockIssuable>
  <mnkd:LossContingencySharesIssuedPricePerShare contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x745900" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_1_2">1.94</mnkd:LossContingencySharesIssuedPricePerShare>
  <mnkd:StockPriceUsedToForecastFutureLiability contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x768253" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_099F95E2-37A4-46F6-82D8-86705FD902F2_3001_0">1.00</mnkd:StockPriceUsedToForecastFutureLiability>
  <mnkd:LossContingencySettlementAgreementStockIssuable contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x768253" unitRef="shares" decimals="0" id="id_4020747_C43C159B-AB33-4550-9610-FD00E9F29A33_1001_1">3002778</mnkd:LossContingencySettlementAgreementStockIssuable>
  <mnkd:DepositsToLitigationEscrowAccount contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x786588" unitRef="iso4217_USD" decimals="-5" id="id_4020747_5352706A-A56E-494E-90FF-576C6465539F_1001_0">16000000</mnkd:DepositsToLitigationEscrowAccount>
  <mnkd:LossContingencySettlementAgreementStockIssuable contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x786588" unitRef="shares" decimals="0" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_2_1">2777778</mnkd:LossContingencySettlementAgreementStockIssuable>
  <mnkd:LossContingencySharesIssuedPricePerShare contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x786588" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_A50E4F2C-3362-4416-9124-B1CECBA1D0EA_2_2">2.18</mnkd:LossContingencySharesIssuedPricePerShare>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x793592_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5001_3">12011</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3 contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x793592_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5001_2">1080</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x793592_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5001_4">13091</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x817344_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5002_3">-13248</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3 contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x817344_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5002_2">28237</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x817344_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5002_4">14989</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5003_3">-1237</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3 contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5003_2">29317</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements contextRef="eol_PE126000--1310-K0014_STD_366_20121231_0_715757x715798" unitRef="iso4217_USD" decimals="INF" id="id_4020747_905520E4-E846-4888-8E3F-70F34601DB77_5003_4">28080</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_381_19920229_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_4014_1700002">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_381_19920229_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_4014_1700003">-911000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_4009_1200002">890000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x713713" unitRef="shares" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_4007_1000002">998000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_4007_1100002">10000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x769283" unitRef="iso4217_USD" decimals="-3" id="id_4020747_21F045B5-7EFD-466F-8752-074B72FF5686_4013_1600003">-911000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_730_20111231_0_711672x768251" unitRef="shares" decimals="INF" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_1004_8">3500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_730_20111231_0_711672x768251" unitRef="iso4217_USD" decimals="-5" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_1004_9">11100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_730_20111231_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2004_5">3500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_730_20111231_0_711672x786262" unitRef="iso4217_USD" decimals="-5" id="id_4020747_495D27C2-6451-427B-881A-7FA59128A3DA_2004_6">23800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_22">-1724993000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_0">3166000</us-gaap:SalesRevenueNet>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_26">335733000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_59">6500000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_11">-1237000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_4_4">48000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:IncomeTaxesPaid contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_53">26000</us-gaap:IncomeTaxesPaid>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_40">598000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_11">37004000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:StockIssued1 contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_58">2758000</us-gaap:StockIssued1>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_18">230000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_24">796779000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_38">115000000</us-gaap:RepaymentsOfSeniorDebt>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_17">-2319614000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:RepaymentsOfNotesPayable contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_45">1667000</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_65">856000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_8">-2902000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_54">72604000</us-gaap:InterestPaid>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_12">-2296784000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_17">3535000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_4_8">-2296406000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_14">-1101000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_7">-2230666000</us-gaap:OperatingIncomeLoss>
  <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_10">-990000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
  <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_43">70000000</us-gaap:RepaymentsOfRelatedPartyDebt>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_34">1028000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_14">-2296402000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_4_2">-4000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_4_7">-4000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_56">3331000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:InterestPaidCapitalized contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_66">22105000</us-gaap:InterestPaidCapitalized>
  <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_13">6056000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
  <us-gaap:ConversionOfStockAmountConverted1 contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_64">5248000</us-gaap:ConversionOfStockAmountConverted1>
  <us-gaap:ProceedsFromNotesPayable contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_44">3460000</us-gaap:ProceedsFromNotesPayable>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_3">485386000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_48">2131448000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_16">952000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_4">183104000</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_3">140834000</us-gaap:DepreciationAndAmortization>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_49">70790000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_32">15000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_10">55086000</us-gaap:InterestExpenseDebt>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_6">2233832000</us-gaap:OperatingExpenses>
  <us-gaap:ProceedsFromConvertibleDebt contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_46">207050000</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_13">-382000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:ProceedsFromCollectionOfNotesReceivable contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_41">1742000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_36">94147000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_19">3347000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_33">3900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_27">454000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_2">1577292000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_39">119500000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_21">589000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:ProceedsFromLongTermLinesOfCredit contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_37">4220000</us-gaap:ProceedsFromLongTermLinesOfCredit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4020747_DC318011-5C42-4E17-ACCF-F50AC3F4DF43_2_1">133300000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:PreferredStockConversionsInducements contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_15">22260000</us-gaap:PreferredStockConversionsInducements>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_42">387750000</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:ResearchAndDevelopmentInProcess contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_4">19726000</us-gaap:ResearchAndDevelopmentInProcess>
  <us-gaap:GoodwillImpairmentLoss contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_5">151428000</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_25">796393000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_28">-335665000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_5F3D989A-61F5-4525-86C3-B1B568D81884_4_5">48000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_3DD83963-7D0B-4BA8-A489-74BCF89FFD55_4_9">45134000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_20">38724000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <mnkd:CollectionOfConvertiblePreferredStockSubscriptionsReceivable contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_31">50000000</mnkd:CollectionOfConvertiblePreferredStockSubscriptionsReceivable>
  <mnkd:AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_7">191000</mnkd:AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_6">-25070000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_47">17828000</mnkd:PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits>
  <mnkd:IssuanceOfPutOptionByStockholder contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_60">2949000</mnkd:IssuanceOfPutOptionByStockholder>
  <mnkd:PutOptionRedemptionByStockholder contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_61">1921000</mnkd:PutOptionRedemptionByStockholder>
  <mnkd:StockExpenseForSharesIssuedPursuantToResearchAgreement contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_5">3018000</mnkd:StockExpenseForSharesIssuedPursuantToResearchAgreement>
  <mnkd:PutSharesSoldToMajorityStockholder contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_35">623000</mnkd:PutSharesSoldToMajorityStockholder>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_67">290334000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:IssuanceOfRedeemableConvertiblePreferredStock contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_63">4296000</mnkd:IssuanceOfRedeemableConvertiblePreferredStock>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_16">-297000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_69">28080000</mnkd:ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital>
  <mnkd:ForwardPurchaseContractContributionToAdditionalPaidInCapital contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_68">29317000</mnkd:ForwardPurchaseContractContributionToAdditionalPaidInCapital>
  <mnkd:IncreaseInAdditionalPaidInCapitalResultingFromMerger contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_57">171154000</mnkd:IncreaseInAdditionalPaidInCapitalResultingFromMerger>
  <mnkd:IssuanceOfConvertiblePreferredStockSubscriptions contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_62">50000000</mnkd:IssuanceOfConvertiblePreferredStockSubscriptions>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_30">1450177000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:CommonSharesIssuedPursuantToLitigationSettlement contextRef="eol_PE126000--1310-K0014_STD_8357_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_A1E29F58-3746-4167-8437-E8482C472117_4_12">438000</mnkd:CommonSharesIssuedPursuantToLitigationSettlement>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_90_20130331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_1_2">-0.15</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_90_20130331_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_1_1">-40965000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_90_20130331_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_1_0">-40965000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_90_20130331_0" unitRef="shares" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_1_3">280058000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_90_20110331_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_2002_0">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_90_20110331_0_711672x786262" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_2002_1">9700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_91_20120331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_1_2">-0.27</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_91_20120331_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_1_1">-38173000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_91_20120331_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_1_0">-38173000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_91_20120331_0" unitRef="shares" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_1_3">143154000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_91_20120630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_2_2">-0.23</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_91_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_2_1">-36578000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_91_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_2_0">-36578000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_91_20120630_0" unitRef="shares" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_2_3">159859000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_91_20130630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_2_2">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_91_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_2_1">-46124000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_91_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_2_0">-46124000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_91_20130630_0" unitRef="shares" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_2_3">284044000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_91_20130930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_3_2">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_91_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_3_1">-50818000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_91_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_3_0">-50818000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_91_20130930_0" unitRef="shares" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_3_3">296386000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1310-K0014_STD_92_20101231_0_711672x786262" unitRef="shares" decimals="INF" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_2001_0">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1310-K0014_STD_92_20101231_0_711672x786262" unitRef="iso4217_USD" decimals="-5" id="id_4020747_EF85D7AF-0893-4B32-A5F7-347904E498BF_2001_1">14100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_92_20120930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_3_2">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_3_1">-42834000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_3_0">-42834000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_92_20120930_0" unitRef="shares" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_3_3">190534000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_92_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_4_2">-0.23</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_4_1">-51781000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_4_0">-51781000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_92_20121231_0" unitRef="shares" decimals="-3" id="id_4020747_AC87F821-5A65-4301-97E8-5D7C87BD6C30_4_3">229234000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1310-K0014_STD_92_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_4_2">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE126000--1310-K0014_STD_92_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_4_1">-53582000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1310-K0014_STD_92_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_4_0">-53582000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1310-K0014_STD_92_20131231_0" unitRef="shares" decimals="-3" id="id_4020747_47C76A1B-2901-4E96-AB48-E8E3CFAF8F2F_4_3">337284000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1310-K0014_STD_92_20131231_0_705999x857289" unitRef="iso4217_USD" decimals="-3" id="id_4020747_EBDEAF87-589D-4EE5-A68F-43658F74D561_1001_1">923000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE126000--1310-K0014_STD_92_20131231_0_705999x857289" unitRef="iso4217_USD" decimals="-3" id="id_4020747_EBDEAF87-589D-4EE5-A68F-43658F74D561_1001_0">34000</us-gaap:AmortizationOfFinancingCosts>
  <context id="eol_PE126000--1310-K0014_STD_92_20131231_0_705999x857289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_92_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_92_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_92_20120930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-07-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_92_20101231_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_91_20130930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-07-02</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_91_20130630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-04-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_91_20120630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_91_20120331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_90_20110331_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_90_20130331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_8357_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1991-02-14</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_730_20111231_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_730_20111231_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1991-02-14</startDate>
      <endDate>1992-02-29</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1991-02-14</startDate>
      <endDate>1992-02-29</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_381_19920229_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1991-02-14</startDate>
      <endDate>1992-02-29</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_381_19920229_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1991-02-14</startDate>
      <endDate>1992-02-29</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x817344_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:OctoberTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_713399x793592_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:FebruaryTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x786588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesActionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x768253">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesAndDerivativeLawsuitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712948x745900">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:DerivativeActionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712382x708177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712080x782834">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GeneralAndAdministrativeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_712080x726565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_711976x780975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mnkd:WorkforceReductionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x716112_712948x768253">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesAndDerivativeLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x711169_712948x768253">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesAndDerivativeLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_707179x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20081231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x831084">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockIssuableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x796933">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromOfficersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x780368">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockSubscriptionsReceivableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20041231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20001231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_20001231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1996-01-01</startDate>
      <endDate>1996-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1996-01-01</startDate>
      <endDate>1996-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_19961231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1996-01-01</startDate>
      <endDate>1996-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_366_19961231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1996-01-01</startDate>
      <endDate>1996-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_803904x806301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:AgreementTypeAxis">mnkd:AtMarketSalesAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_786923x827982">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_716833x715326_733234x883632">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CreditAgreementAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_715832x740890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_715832x716297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_715632x883634">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mnkd:AccelerationUponLegalJudgmentInExcessOfOneHundredThousandDollarMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_715632x883633">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mnkd:MajorTransactionPutOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_715632x806573">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mnkd:ConversionRightFeatureOfConvertibleNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_714807x819294">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TerminationCostsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_714807x764236">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:ExpensesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_714378x732890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_713115x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_713115x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712948x786588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesActionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712382x708177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712080x782834">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GeneralAndAdministrativeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_712080x726565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x762619_717061x739260">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LetterAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711672x712230_717061x772809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x767832">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x715869">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x714221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_715832x707341">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112_711672x712230_717061x772809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x767832">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x715869">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x714221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_715832x707341">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169_711672x712230_717061x772809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_710844x711886">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_710844x707398">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_709863x713171_711672x762619_717061x739260">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LetterAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_708873x716845">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_707179x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x825279">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnkd:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x784846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnkd:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x732192_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnkd:ScenarioThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x732192_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnkd:ScenarioThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708873x732192">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnkd:ScenarioThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289_708502x883668_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInThreeEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0_705999x857289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_712382x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_712382x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_712382x708177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_712080x782834">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GeneralAndAdministrativeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_712080x726565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_707179x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20110331_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20110331_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20091231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20071231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20061231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20061231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20051231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20051231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x831084">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockIssuableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x796933">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromOfficersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x780368">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockSubscriptionsReceivableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20031231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20021231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20011231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1999-01-01</startDate>
      <endDate>1999-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1999-01-01</startDate>
      <endDate>1999-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19991231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1999-01-01</startDate>
      <endDate>1999-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19991231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1999-01-01</startDate>
      <endDate>1999-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1998-01-01</startDate>
      <endDate>1998-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1998-01-01</startDate>
      <endDate>1998-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19981231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1998-01-01</startDate>
      <endDate>1998-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19981231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1998-01-01</startDate>
      <endDate>1998-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1997-01-01</startDate>
      <endDate>1997-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1997-01-01</startDate>
      <endDate>1997-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19971231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1997-01-01</startDate>
      <endDate>1997-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19971231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1997-01-01</startDate>
      <endDate>1997-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1995-01-01</startDate>
      <endDate>1995-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1995-01-01</startDate>
      <endDate>1995-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19951231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1995-01-01</startDate>
      <endDate>1995-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19951231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1995-01-01</startDate>
      <endDate>1995-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x831084">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockIssuableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x796933">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromOfficersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x780368">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockSubscriptionsReceivableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19940228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1993-03-01</startDate>
      <endDate>1994-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1992-03-01</startDate>
      <endDate>1993-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1992-03-01</startDate>
      <endDate>1993-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19930228_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1992-03-01</startDate>
      <endDate>1993-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_19930228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1992-03-01</startDate>
      <endDate>1993-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_365_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_324_20111231_0_711976x780975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mnkd:WorkforceReductionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-02-11</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2009-12-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2002-12-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20131031_0_717061x750999_789193x712230">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20131031_0_711672x712230_717061x750999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20131031_0_711672x712230">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20131031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20121031_0_713115x716908_714777x709629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20121031_0_713115x715581_714777x709629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20071031_0_711672x712230">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2007-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20040831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-08-01</startDate>
      <endDate>2004-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20120531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-05-01</startDate>
      <endDate>2012-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20040331_0_713879x809015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20040331_0_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20040331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20140131_0_705999x857289_710720x714667_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_31_20140131_0_705999x857289_708502x744870_710720x714667_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1994-03-01</startDate>
      <endDate>1994-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1994-03-01</startDate>
      <endDate>1994-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1994-03-01</startDate>
      <endDate>1994-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_306_19941231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>1994-03-01</startDate>
      <endDate>1994-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_306_19941231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>1994-03-01</startDate>
      <endDate>1994-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_716833x715326_733234x883632">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CreditAgreementAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_716833x715326_733234x883631">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CreditAgreementAxis">mnkd:CommitmentAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_708873x716845_716833x715326_733234x883632">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CreditAgreementAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x883669_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x883632_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x744308">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289_708502x737742_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_3_20130701_0_705999x857289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-29</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_28_20090228_0_711672x712230_717061x772809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_274_20120930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20131215_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-12-14</startDate>
      <endDate>2013-12-15</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20121220_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-12-19</startDate>
      <endDate>2012-12-20</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20110303_0_713879x737814">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-03-02</startDate>
      <endDate>2011-03-03</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20061212_0_714378x774250">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-12-11</startDate>
      <endDate>2006-12-12</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20011212_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2001-12-11</startDate>
      <endDate>2001-12-12</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20121018_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-10-17</startDate>
      <endDate>2012-10-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20080709_0_841045x778627">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:StockAwardPlanTypeAxis">mnkd:StockOptionAndAwardPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-07-08</startDate>
      <endDate>2008-07-09</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20130307_0_713115x843588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-06</startDate>
      <endDate>2013-03-07</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_710720x714667_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-02-27</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x883669_710720x714667_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-02-27</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x805183_710720x714667_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-02-27</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20140228_0_705999x857289_708502x744308_710720x714667_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-02-27</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20130523_0_713115x843588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-05-22</startDate>
      <endDate>2013-05-23</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20130523_0_713115x800027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-05-22</startDate>
      <endDate>2013-05-23</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x830452">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:PerformanceBasedShareAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-05-16</startDate>
      <endDate>2012-05-17</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20120517_0_713115x812459">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:TimeBasedAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-05-16</startDate>
      <endDate>2012-05-17</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20120517_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-05-16</startDate>
      <endDate>2012-05-17</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20120208_0_716644x726394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:WarrantLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-02-07</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20120208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-02-07</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20110210_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2011-02-09</startDate>
      <endDate>2011-02-10</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20100818_0_714378x732890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-08-17</startDate>
      <endDate>2010-08-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-08-09</startDate>
      <endDate>2010-08-10</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20100810_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-08-09</startDate>
      <endDate>2010-08-10</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20100801_0_841045x778627">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:StockAwardPlanTypeAxis">mnkd:StockOptionAndAwardPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-31</startDate>
      <endDate>2010-08-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982_789193x764239">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:UnderwritersOverallotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-04</startDate>
      <endDate>2009-08-05</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982_789193x712230">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-04</startDate>
      <endDate>2009-08-05</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20090805_0_786923x827982">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-04</startDate>
      <endDate>2009-08-05</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629_789193x712230">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-08-04</startDate>
      <endDate>2005-08-05</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_2_20050805_0_714777x709629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-08-04</startDate>
      <endDate>2005-08-05</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_841045x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:StockAwardPlanTypeAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_786923x827982">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715990x761648">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnkd:CurrentAssetMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x767832">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x740890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x716297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x715944">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x715869">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x714221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x710555">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_715832x707341">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x883632">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x774250">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_714378x732890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x824029">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x809015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x788580">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713879x737814">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x843588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x800027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x715834">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_713115x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_712948x786588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesActionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_712546x710575">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_712080x814753">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:OtherIncomeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716644x745094">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716421x837810_716644x745094">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251_716421x756949_716644x745094">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:EquityComponentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_711672x712230_717061x772809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_711502x716112_821864x769826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:AgreementsAxis">mnkd:FacilityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_710844x711886">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_710844x707398">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_708502x839462">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_708502x744870">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_705999x857289_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_705999x857289_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0_705999x857289_708502x883668_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInThreeEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x767832">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x740890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x716297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x715944">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x715869">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x714221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x710555">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715832x707341">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x774250">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_714378x732890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_713399x817344_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:OctoberTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_713399x793592_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:FebruaryTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x786588">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesActionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x768253">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:SecuritiesAndDerivativeLawsuitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_712948x745900">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:DerivativeActionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_712546x710575">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_709714x813109">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">mnkd:AdjustmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_709714x708730">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:EquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121220_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-20</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121220_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-12-20</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_715632x710071">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_713399x817344_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:OctoberTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_713399x793592_715757x715798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:FebruaryTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_711976x780975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mnkd:WorkforceReductionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20091231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20081231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20071231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20061231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20061231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250_789193x764239">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:UnderwritersOverallotmentOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-12</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20061212_0_714378x774250">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-12</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20051231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20051231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20041231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20041231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x831084">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockIssuableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x796933">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromOfficersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x780368">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesCConvertiblePreferredStockSubscriptionsReceivableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20031231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20021231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011212_0_705999x840283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:AllecureCorpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-12</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011212_0_705999x831745">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:PharmaceuticalDiscoveryCorporationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-12</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011212_0_705999x776793">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:CtlImmunoTherapiesCorpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-12</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20011212_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2001-12-12</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x827132">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20001231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20001231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1999-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1999-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19991231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1999-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19991231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1999-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1998-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1998-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19981231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1998-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19981231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1998-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1997-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1997-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19971231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1997-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19971231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1997-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1996-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1996-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19961231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1996-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19961231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1996-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1995-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1995-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19951231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1995-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19951231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1995-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19941231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19941231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1994-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x728560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:NotesReceivableFromStockholdersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19940228_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1994-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19940228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1994-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1993-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1993-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19930228_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1993-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19930228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1993-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1992-02-29</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1992-02-29</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19920229_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>1992-02-29</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_19920229_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>1992-02-29</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131031_0_717061x750999_789193x712230">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20131031_0_711672x712230_717061x750999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121031_0_713115x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251_713115x715581_714777x709629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251_713115x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121031_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-06-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20101231_0_715632x710071">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x769283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x714212">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20101231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20040831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2004-08-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_711502x716112_821864x769826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:AgreementsAxis">mnkd:FacilityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_708890x840565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">mnkd:RegistrationRightsAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883669_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883669_711502x716112_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883668_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInThreeEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883632_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x883632_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x839462_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x744870_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130701_0_705999x857289_708502x737742_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130628_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2013-06-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120627_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-06-27</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-05-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20080709_0_841045x778627">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:StockAwardPlanTypeAxis">mnkd:StockOptionAndAwardPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-07-09</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20140303_0_710720x714667_711502x716112_803904x806301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:AgreementTypeAxis">mnkd:AtMarketSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-03</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130318_0_711502x716112_803904x806301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:AgreementTypeAxis">mnkd:AtMarketSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-03-18</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20040331_0_713879x809015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-03-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20140228_0_705999x857289_708502x805183_710720x714667_711502x716112_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20140228_0_705999x857289_708502x805183_710720x714667_711502x711169_714378x735725">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20140217_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2014-02-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20130523_0_713879x788580">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-05-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120803_0_712948x745900">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">mnkd:DerivativeActionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-08-03</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120517_0_716421x837810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120517_0_713115x812459">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:TimeBasedAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120517_0_711672x768251_716644x745094">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120517_0_711672x768251_716421x837810_716644x745094">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120517_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120208_0_789193x821037">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:PublicMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120208_0_789193x729060">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:UnderwritersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120208_0_716644x726394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:WarrantLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120208_0_711672x825177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120208_0_711672x768251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20120208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20110210_0_711976x780975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mnkd:WorkforceReductionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-02-10</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20100818_0_714378x732890">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-08-18</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20100810_0_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-08-10</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20100810_0_711502x711169_711672x786262">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:SeasideEightEightLimitedPartnershipMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-08-10</instant>
    </period>
  </context>
  <context id="eol_PE126000--1310-K0014_STD_0_20050805_0_714777x709629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-08-05</instant>
    </period>
  </context>
  <unit id="iso4217_USD_per_Right">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>mnkd:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="Derivative">
    <measure>mnkd:Derivative</measure>
  </unit>
  <unit id="D">
    <measure>utr:D</measure>
  </unit>
  <unit id="Employee">
    <measure>mnkd:Employee</measure>
  </unit>
  <unit id="Tranche">
    <measure>mnkd:Tranche</measure>
  </unit>
</xbrl>
